data_7jn6_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 7jn6 _Structure_validation_residue.Date_analyzed 2020-09-04 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 98.3 m . . . . . 0 C--O 1.225 -0.236 0 CA-C-O 121.431 0.634 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -87.15 1.67 52.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.119 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 34.6 m80 -107.96 147.52 30.94 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -91.03 128.83 37.01 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.5 mt -91.5 -38.73 12.35 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.28 -151.62 14.07 Favored Glycine 0 N--CA 1.416 -2.658 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.855 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -131.67 151.04 51.93 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.572 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -122.03 137.23 27.1 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.77 94.73 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.123 1.882 . . . . 0.0 111.353 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.5 t -127.56 113.53 32.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -143.76 124.77 7.99 Favored Pre-proline 0 N--CA 1.434 -1.23 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.58 149.88 93.05 Favored 'Cis proline' 0 C--O 1.246 0.907 0 C-N-CA 123.421 -1.491 . . . . 0.0 110.429 -0.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.2 t -94.7 109.3 21.26 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.192 0.52 . . . . 0.0 110.564 -173.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.73 138.79 36.32 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 173.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -47.03 -49.24 21.5 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 124.35 1.031 . . . . 0.0 112.548 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -73.02 -37.67 66.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.945 0.403 . . . . 0.0 111.466 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.414 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -67.68 -39.38 84.48 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.8 t -59.2 -49.34 78.22 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.423 0.689 . . . . 0.0 109.461 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HG3' ' HA ' ' A' ' 33' ' ' LYS . 58.7 tttm -57.61 -34.87 69.73 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.256 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 m -76.54 -46.06 28.03 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.881 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 19' ' ' ALA . 73.3 t -68.04 -33.79 63.1 Favored 'Isoleucine or valine' 0 C--O 1.254 1.34 0 CA-C-O 121.297 0.57 . . . . 0.0 110.449 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.6 m -56.98 -38.72 73.42 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.304 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -71.7 -21.79 61.73 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.925 0.393 . . . . 0.0 111.409 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -73.45 -48.54 32.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -77.35 -47.17 20.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.961 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -116.8 107.97 15.29 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -69.58 -21.43 63.6 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -98.26 16.71 20.57 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.159 0.504 . . . . 0.0 110.415 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.48 142.8 31.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.611 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 2.0 p -115.41 -44.01 3.01 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.855 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HA ' ' HG3' ' A' ' 21' ' ' LYS . 82.3 tttt -120.46 153.35 36.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -141.05 140.08 10.1 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 107.161 -2.376 . . . . 0.0 107.161 174.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -144.52 144.19 31.21 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 118.02 0.91 . . . . 0.0 109.977 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.5 m -92.58 127.07 37.94 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.2 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -137.73 147.16 44.52 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.415 ' CE2' ' HB ' ' A' ' 43' ' ' VAL . 74.5 m-85 -86.15 126.69 34.42 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.187 0.518 . . . . 0.0 110.485 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.36 111.03 14.02 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.524 ' O ' ' HD2' ' A' ' 41' ' ' ARG . . . 81.31 -101.59 2.12 Favored Glycine 0 N--CA 1.413 -2.847 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 40' ' ' GLY . 12.7 mmm180 -125.72 -31.87 2.9 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -87.29 159.94 18.6 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.201 0.524 . . . . 0.0 111.206 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 38' ' ' TYR . 12.7 p -95.85 127.26 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.091 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -108.75 139.89 42.93 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.648 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 35.8 t -91.16 108.1 19.64 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -94.93 125.72 39.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.992 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.6 m -96.51 121.57 38.47 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.101 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.419 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 62.9 m-85 -105.24 141.25 37.11 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.611 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -178.96 -174.64 45.32 Favored Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--N 1.286 -2.195 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.676 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.435 -1.21 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -119.99 9.16 11.15 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.413 ' HD1' HD23 ' A' ' 7' ' ' LEU . 63.2 t-80 -107.04 114.04 27.88 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -69.22 123.44 21.15 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.413 HD23 ' HD1' ' A' ' 5' ' ' HIS . 91.9 mt -96.95 -49.48 5.01 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.567 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.444 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -177.78 -179.33 47.87 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.5 127.99 56.29 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.082 0.468 . . . . 0.0 110.246 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.19 141.93 25.33 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.625 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.99 104.92 1.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.473 2.115 . . . . 0.0 111.104 176.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -123.25 103.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -136.24 122.81 14.04 Favored Pre-proline 0 C--N 1.304 -1.412 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.223 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.25 147.16 86.69 Favored 'Cis proline' 0 C--O 1.245 0.847 0 C-N-CA 123.66 -1.392 . . . . 0.0 111.826 1.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.4 t -68.31 120.17 14.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.477 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -141.54 140.82 33.53 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.98 -48.13 79.14 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.359 0.664 . . . . 0.0 111.109 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -62.47 -44.61 95.97 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.427 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.41 -45.16 94.61 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.566 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -54.67 -52.57 61.95 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.177 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 25.3 ttmm -59.71 -38.06 80.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 122.991 0.182 . . . . 0.0 110.938 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 t -72.37 -51.16 21.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.763 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.9 t -60.69 -37.98 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.584 0.354 . . . . 0.0 110.606 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.8 m -61.16 -37.99 84.86 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 21' ' ' LYS . 98.5 mttt -66.93 -35.25 79.58 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.713 0.768 . . . . 0.0 109.87 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.41 -35.39 70.97 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.474 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -84.32 -45.76 12.47 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.88 176.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.444 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 25.0 m-85 -126.28 130.42 50.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -72.95 -21.68 60.83 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.46 0.648 . . . . 0.0 110.916 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -94.5 -2.83 51.01 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.408 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . . . -83.82 126.73 33.24 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.397 0.617 . . . . 0.0 111.381 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.629 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 1.7 p -116.69 -28.86 6.25 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.44 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -124.32 135.18 53.16 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 122.07 -0.394 . . . . 0.0 110.77 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.94 136.04 9.17 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -147.28 131.51 17.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -175.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.6 m -91.21 137.16 32.58 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 120.985 0.421 . . . . 0.0 111.798 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -133.99 132.51 40.21 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.461 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 65.8 m-85 -88.57 136.23 33.1 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.328 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -127.46 90.09 3.07 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.54 -113.72 3.69 Favored Glycine 0 N--CA 1.432 -1.584 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -172.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -98.95 -33.46 10.83 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -76.21 150.98 36.99 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.938 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' A' ' 38' ' ' TYR . 7.8 p -146.58 133.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -126.28 160.34 30.6 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.691 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.5 t -97.74 119.92 37.19 Favored 'General case' 0 N--CA 1.41 -2.469 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -87.71 122.72 31.73 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.0 m -97.27 126.49 42.52 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.038 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -114.68 149.64 36.43 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.629 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -155.98 -170.13 20.96 Favored Glycine 0 C--N 1.288 -2.132 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 C--N 1.3 -1.564 0 CA-C-N 117.043 0.421 . . . . 0.0 109.871 176.874 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.0 m . . . . . 0 C--O 1.242 0.695 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -144.67 15.13 1.58 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.523 0.678 . . . . 0.0 110.441 175.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 t60 -105.64 136.27 45.54 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -81.82 126.92 32.43 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.704 0.288 . . . . 0.0 110.483 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.419 HD13 ' HA3' ' A' ' 49' ' ' GLY . 85.7 mt -86.13 -44.49 12.2 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.7 -168.93 42.06 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 12.2 pt-20 -115.75 149.88 37.77 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 120.767 0.318 . . . . 0.0 110.506 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.19 138.11 18.85 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.5 141.91 22.94 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 121.887 1.724 . . . . 0.0 111.307 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 p -140.23 149.71 21.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -160.01 123.7 2.01 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.83 169.85 45.15 Favored 'Cis proline' 0 C--O 1.241 0.651 0 C-N-CA 124.557 -1.018 . . . . 0.0 111.364 -1.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.1 t -75.84 94.81 3.38 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -126.94 139.66 52.89 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 168.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.16 -45.78 75.71 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 123.555 0.534 . . . . 0.0 112.315 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -61.01 -39.36 89.44 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.583 0.552 . . . . 0.0 111.32 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -41.47 67.16 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.163 0.506 . . . . 0.0 110.061 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -60.73 -48.77 80.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.775 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.497 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 88.2 tttt -59.85 -41.61 91.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.779 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.9 m -59.56 -55.01 39.87 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.614 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.461 ' O ' ' HD2' ' A' ' 27' ' ' HIS . 13.0 p -65.76 -36.3 77.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.525 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.0 m -59.01 -39.5 82.09 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.804 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 30.4 mtpp -73.06 -27.59 61.83 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.703 0.287 . . . . 0.0 111.066 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -67.55 -37.6 82.92 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.208 0.528 . . . . 0.0 110.2 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.461 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 40.4 m-70 -77.73 -60.02 2.54 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.502 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 18.6 m-85 -120.23 106.45 11.93 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -175.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -56.57 -31.46 64.23 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -174.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -79.53 4.86 14.49 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.44 126.97 30.5 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.381 0.61 . . . . 0.0 109.989 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 p -124.16 -11.19 7.54 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.022 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 58.1 tptt -148.16 123.82 10.49 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.797 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.32 135.75 13.09 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -122.71 127.16 48.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 93.0 m -76.38 116.45 17.07 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.092 0.472 . . . . 0.0 111.759 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -110.19 98.86 8.02 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -78.61 103.02 8.28 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -113.28 89.23 3.03 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -174.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.53 -81.99 0.6 Allowed Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.585 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -85.09 -68.37 0.73 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -128.3 -179.17 4.87 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -172.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.24 126.21 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 121.876 0.846 . . . . 0.0 112.583 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -107.34 133.33 52.03 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 5.3 m -92.03 126.75 37.24 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.342 176.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -87.45 113.07 22.83 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 m -90.77 109.73 20.92 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.09 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.453 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 97.8 m-85 -89.79 139.46 30.55 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.419 ' HA3' HD13 ' A' ' 7' ' ' LEU . . . -134.04 168.1 23.46 Favored Glycine 0 N--CA 1.419 -2.478 0 C-N-CA 118.997 -1.573 . . . . 0.0 114.544 -175.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--N 1.303 -1.437 0 CA-C-N 114.223 -0.989 . . . . 0.0 110.36 -178.753 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.439 -0.988 0 CA-C-O 120.924 0.392 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -122.15 -1.11 9.3 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.545 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 5.4 t-160 -80.38 110.79 16.16 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 -178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -66.67 104.88 1.39 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.56 -52.49 5.79 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.591 -177.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.52 -161.21 20.69 Favored Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -134.04 148.42 51.07 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.008 0.432 . . . . 0.0 110.741 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.556 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -129.12 151.82 78.33 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.194 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -93.06 131.68 0.88 Allowed 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 122.14 1.893 . . . . 0.0 112.878 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -160.65 127.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 123.125 0.57 . . . . 0.0 109.844 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -142.19 129.92 11.51 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.37 145.44 83.5 Favored 'Cis proline' 0 C--O 1.244 0.818 0 C-N-CA 123.344 -1.523 . . . . 0.0 110.63 -0.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 t -87.44 101.52 13.67 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.744 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -98.48 148.91 23.26 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.446 ' H ' ' CD ' ' A' ' 17' ' ' GLU . 1.9 mp0 -51.51 -54.57 25.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.211 0.604 . . . . 0.0 110.42 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.79 -42.07 99.55 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.256 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.85 95.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.418 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.9 t -61.04 -48.91 79.57 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 87.6 tttt -56.24 -42.17 76.88 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.557 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -66.36 -52.41 47.19 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.869 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.5 t -62.01 -37.7 78.97 Favored 'Isoleucine or valine' 0 C--O 1.257 1.472 0 CA-C-O 121.292 0.568 . . . . 0.0 111.018 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.0 m -59.32 -33.24 70.87 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 21' ' ' LYS . 52.9 mtmt -75.43 -18.96 59.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.062 0.392 . . . . 0.0 111.033 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -83.76 -40.54 18.67 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -79.43 -44.25 21.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.9 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -121.64 108.21 13.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -67.01 -18.87 65.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -90.84 -5.19 55.92 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.49 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.1 140.42 37.84 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 121.108 0.48 . . . . 0.0 110.191 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.447 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -139.45 4.9 2.21 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.509 -178.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -150.87 142.66 23.77 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.77 139.36 10.14 Favored Glycine 0 C--N 1.298 -1.575 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -135.9 137.58 41.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 61.6 m -85.12 129.71 34.75 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.628 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -126.11 130.15 50.5 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -93.38 115.96 28.52 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.355 0.597 . . . . 0.0 111.454 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -111.3 92.27 3.98 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.72 -113.57 4.26 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -101.3 -12.77 18.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.84 125.8 40.65 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.568 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.3 p -95.02 125.74 47.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -107.61 139.24 42.45 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 35.4 t -96.65 109.65 22.23 Favored 'General case' 0 C--N 1.279 -2.462 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -92.63 124.51 36.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.235 0.54 . . . . 0.0 110.367 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.8 m -94.35 122.52 36.98 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.721 -173.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 67.5 m-85 -113.62 136.62 52.63 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.34 178.91 26.56 Favored Glycine 0 N--CA 1.416 -2.676 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.293 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.0 t70 . . . . . 0 C--N 1.288 -2.075 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 175.242 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.439 -0.999 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -131.16 -59.47 0.98 Allowed 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.628 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -89.65 153.61 20.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.084 0.468 . . . . 0.0 110.923 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -77.46 136.61 38.38 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.614 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.2 mt -95.27 -19.12 20.26 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.51 -178.99 34.5 Favored Glycine 0 N--CA 1.405 -3.386 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.338 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -112.75 149.93 32.28 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.85 152.75 77.99 Favored Pre-proline 0 C--N 1.283 -2.289 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -83.65 142.71 10.44 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.268 1.978 . . . . 0.0 110.766 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p -151.92 136.81 10.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.29 0.567 . . . . 0.0 111.822 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -160.42 132.01 4.04 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.07 159.51 93.12 Favored 'Cis proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.31 -1.121 . . . . 0.0 112.044 -0.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.571 ' SG ' HG22 ' A' ' 43' ' ' VAL . 48.3 t -78.48 127.82 32.71 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 23.4 tptp -166.66 143.67 4.87 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -48.05 76.84 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.79 -36.9 84.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 117.947 0.34 . . . . 0.0 111.714 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.462 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -62.9 -50.5 70.62 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.9 t -63.85 -40.11 95.8 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.545 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -62.74 -32.02 73.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 19.0 t -77.45 -46.9 21.12 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 19' ' ' ALA . 78.7 t -52.41 -47.96 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.138 0.575 . . . . 0.0 110.11 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 58.0 m -55.59 -43.14 75.73 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HE2' ' HA ' ' A' ' 32' ' ' CYS . 94.7 mttt -75.87 -25.93 56.62 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.931 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 22' ' ' SER . 45.0 mt-10 -81.07 -19.07 44.51 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.889 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.428 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 50.7 m-70 -102.53 -39.53 7.06 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.31 174.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -121.2 115.04 22.29 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -66.43 -29.07 69.13 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -84.81 3.69 36.57 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.18 137.65 39.0 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.146 0.498 . . . . 0.0 110.684 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.405 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 5.6 p -124.42 -23.47 4.45 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.297 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -136.21 142.2 44.07 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -136.13 125.25 3.47 Favored Glycine 0 C--N 1.292 -1.909 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -115.39 135.67 53.88 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 117.652 0.726 . . . . 0.0 110.974 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.505 ' SG ' HG22 ' A' ' 43' ' ' VAL . 9.6 t -96.0 100.61 12.27 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -174.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.95 131.01 53.49 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.003 0.43 . . . . 0.0 111.876 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 74.7 m-85 -75.94 126.24 30.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.042 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -140.21 130.83 25.63 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.164 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.28 -116.17 5.12 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -120.06 0.23 10.69 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.084 0.468 . . . . 0.0 111.005 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -130.63 -169.91 2.24 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.11 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.571 HG22 ' SG ' ' A' ' 15' ' ' CYS . 11.8 p -114.42 138.32 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-O 120.899 0.381 . . . . 0.0 110.731 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -111.71 137.12 50.03 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.6 t -94.85 109.12 21.14 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.422 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 28.5 m170 -89.52 113.68 25.11 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 121.156 0.503 . . . . 0.0 110.65 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.4 m -94.24 109.68 21.47 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.151 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -97.07 132.82 42.49 Favored 'General case' 0 C--O 1.255 1.385 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -135.2 -176.23 14.25 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 119.125 -1.512 . . . . 0.0 113.433 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--N 1.3 -1.58 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.617 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 N--CA 1.439 -0.984 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -125.74 -32.04 2.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.81 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.429 ' HD1' HD22 ' A' ' 7' ' ' LEU . 57.9 t-80 -70.69 124.12 23.51 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.478 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -70.63 105.96 3.33 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 124.238 0.961 . . . . 0.0 108.821 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.429 HD22 ' HD1' ' A' ' 5' ' ' HIS . 84.1 mt -77.65 -31.67 52.84 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.572 0.701 . . . . 0.0 109.155 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.68 -162.37 33.93 Favored Glycine 0 N--CA 1.412 -2.957 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -124.48 124.92 43.34 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 124.02 0.483 . . . . 0.0 109.699 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.13 138.05 21.24 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.914 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.31 103.26 1.71 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.157 1.904 . . . . 0.0 110.492 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 t -129.99 108.89 16.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -136.94 123.7 13.82 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.54 139.33 60.51 Favored 'Cis proline' 0 C--O 1.24 0.612 0 C-N-CA 123.466 -1.473 . . . . 0.0 110.715 -1.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 29.1 t -81.53 118.41 22.72 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.32 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -130.23 161.06 32.03 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.19 -65.51 0.66 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 124.434 1.094 . . . . 0.0 111.537 -172.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -64.64 -37.26 86.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.771 0.319 . . . . 0.0 110.96 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.407 ' O ' HG21 ' A' ' 23' ' ' VAL . . . -62.96 -43.19 99.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.948 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.8 t -68.9 -39.35 79.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.398 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.421 ' NZ ' ' HB3' ' A' ' 21' ' ' LYS . 8.0 mtpm? -56.06 -38.06 70.13 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 120.935 0.398 . . . . 0.0 110.036 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.4 m -67.89 -55.56 12.38 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.978 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 19' ' ' ALA . 80.0 t -59.42 -38.0 72.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.215 0.606 . . . . 0.0 111.567 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 80.7 m -61.46 -31.45 71.41 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -79.27 -10.99 59.95 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.597 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -93.77 -33.0 13.76 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.283 0.563 . . . . 0.0 109.888 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -92.42 -21.46 20.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.255 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -136.23 172.59 12.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -105.96 -47.44 3.86 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.074 0.464 . . . . 0.0 110.495 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -82.0 19.28 1.16 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.65 126.56 35.03 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.412 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.618 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 1.6 p -121.96 -27.41 4.61 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.849 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -131.28 131.4 43.82 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.63 130.11 8.33 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -134.46 133.94 41.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 118.042 0.921 . . . . 0.0 110.72 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 60.0 m -77.78 128.61 34.29 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.264 -174.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -101.55 99.85 10.2 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.31 105.62 17.78 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.073 0.463 . . . . 0.0 110.4 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -146.58 111.46 5.32 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.63 -138.54 14.32 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -98.56 -30.6 12.41 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 116.949 0.374 . . . . 0.0 110.078 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -84.41 176.91 8.37 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.366 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.46 119.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.517 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -95.36 160.07 14.7 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 14.5 t -132.61 122.4 24.66 Favored 'General case' 0 C--N 1.282 -2.355 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.788 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -90.06 134.57 34.17 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 121.454 0.645 . . . . 0.0 112.03 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.1 m -96.46 110.83 23.13 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.439 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -99.87 142.22 31.63 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.43 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.618 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -163.95 -163.66 17.38 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 t70 . . . . . 0 C--N 1.295 -1.783 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 174.443 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.48 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 99.1 m . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 122.563 1.173 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -105.49 -28.22 10.94 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.541 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -85.32 121.96 28.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.729 -175.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -67.24 112.63 4.61 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.91 -29.59 17.39 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.705 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.82 175.74 39.64 Favored Glycine 0 N--CA 1.422 -2.297 0 C-N-CA 119.713 -1.232 . . . . 0.0 111.957 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -116.97 121.51 41.59 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 123.63 0.772 . . . . 0.0 109.567 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.65 133.14 20.74 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.43 114.61 4.02 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.242 1.961 . . . . 0.0 111.166 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -133.33 115.22 22.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -140.18 124.28 10.76 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -80.85 -179.69 26.06 Favored 'Cis proline' 0 C--N 1.352 0.76 0 C-N-CA 124.43 -1.071 . . . . 0.0 112.174 1.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.7 t -85.15 132.72 34.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.623 0.725 . . . . 0.0 112.392 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -149.04 132.04 16.22 Favored 'General case' 0 N--CA 1.402 -2.855 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 169.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER -52.39 -42.85 64.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -72.88 -35.55 67.18 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.27 -45.49 91.24 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.2 t -56.53 -53.18 60.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.738 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HE3' ' O ' ' A' ' 32' ' ' CYS . 87.8 tttt -61.17 -43.28 99.14 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.373 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -61.08 -46.57 90.11 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.542 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 19' ' ' ALA . 84.3 t -67.75 -39.82 82.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.583 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.5 m -57.8 -37.93 74.62 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.39 -15.32 60.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -81.6 -37.16 28.06 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -77.95 -48.99 15.02 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.772 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -130.99 117.73 19.61 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -176.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -78.46 0.37 26.16 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.781 0.801 . . . . 0.0 110.861 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -96.71 -1.83 45.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.654 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.4 127.49 44.37 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.153 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.434 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 16.7 p -109.24 -20.52 12.93 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -121.52 136.31 54.96 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.097 -173.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.51 122.51 2.4 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -124.43 134.17 53.16 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.864 0.364 . . . . 0.0 110.894 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 81.7 m -72.65 133.82 44.82 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -126.43 110.64 13.54 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.265 0.555 . . . . 0.0 110.805 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.42 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 73.7 m-85 -78.35 108.6 11.81 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.286 175.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -118.46 97.46 5.77 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.05 -89.64 0.98 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.994 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -126.16 -17.72 5.18 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -103.62 123.05 46.26 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.42 ' HB ' ' CD1' ' A' ' 38' ' ' TYR . 9.9 p -100.07 122.49 52.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.452 0.644 . . . . 0.0 109.434 174.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -125.37 161.27 27.39 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.1 t -95.85 121.9 38.07 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -94.14 119.0 32.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.36 126.46 36.45 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.572 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -117.95 140.75 49.28 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.073 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.48 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -173.37 -149.57 6.97 Favored Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--N 1.301 -1.543 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.527 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.565 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 84.1 m . . . . . 0 N--CA 1.44 -0.946 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -152.17 -33.77 0.13 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.81 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -75.21 123.75 25.83 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.853 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -63.55 119.66 10.24 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.679 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.402 HD11 ' HB1' ' A' ' 31' ' ' ALA . 91.9 mt -96.7 -55.69 2.82 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.6 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.491 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -164.77 -172.91 32.82 Favored Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.095 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -118.28 131.48 56.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -175.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.25 138.92 23.21 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.123 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.23 94.25 0.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.185 1.924 . . . . 0.0 110.37 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.9 t -116.24 102.22 13.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 122.157 -0.339 . . . . 0.0 110.735 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 47.2 t80 -145.28 135.55 11.93 Favored Pre-proline 0 N--CA 1.432 -1.332 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 36.3 Cg_endo -65.12 151.49 76.43 Favored 'Cis proline' 0 C--O 1.249 1.074 0 C-N-CA 123.821 -1.325 . . . . 0.0 112.015 -1.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -81.56 112.29 18.64 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -174.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -125.66 146.27 49.8 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -69.22 -39.97 78.24 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -58.14 -37.08 73.94 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.404 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.4 -57.28 4.99 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.624 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.9 m -54.0 -46.41 71.76 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -66.09 -22.02 66.39 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 120.682 0.277 . . . . 0.0 110.9 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -88.99 -55.13 3.81 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.4 t -56.97 -38.07 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 C-N-CA 124.265 1.026 . . . . 0.0 111.782 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 90.1 m -63.35 -28.79 70.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -78.78 -22.43 46.36 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.335 0.588 . . . . 0.0 109.465 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -80.65 -39.73 26.81 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.691 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -75.7 -47.05 27.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.786 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.491 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 53.5 m-85 -125.43 117.99 24.87 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -70.77 -14.53 62.46 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.145 0.498 . . . . 0.0 111.127 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -91.36 -1.68 57.55 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.834 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.402 ' HB1' HD11 ' A' ' 7' ' ' LEU . . . -100.01 141.64 32.56 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.5 p -137.33 -5.52 1.82 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.318 0.58 . . . . 0.0 110.865 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -131.04 130.03 42.75 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -148.98 137.04 6.1 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 120.328 -0.939 . . . . 0.0 110.966 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -150.46 145.36 25.98 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.685 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 34.2 m -78.93 152.0 31.36 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -132.57 107.49 8.47 Favored 'General case' 0 N--CA 1.422 -1.826 0 C-N-CA 125.418 1.487 . . . . 0.0 108.604 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -84.33 103.49 13.54 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.586 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -148.91 113.2 5.25 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.976 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.09 -155.06 21.35 Favored Glycine 0 C--N 1.299 -1.522 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.403 ' HD2' ' OE2' ' A' ' 42' ' ' GLU . 27.8 ttm180 -79.47 -37.76 36.1 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.403 ' OE2' ' HD2' ' A' ' 41' ' ' ARG . 55.4 mm-40 -92.53 154.19 18.6 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.359 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.52 130.56 52.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -106.84 116.16 31.45 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 53.2 t -93.6 120.83 34.35 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.439 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 24.7 m170 -85.44 117.84 24.6 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.778 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.8 m -97.49 116.56 29.93 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.712 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -105.35 143.59 33.31 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.56 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.565 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -161.89 -146.97 4.83 Favored Glycine 0 N--CA 1.427 -1.906 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 C--N 1.299 -1.617 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.009 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.43 -1.456 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -120.85 -51.89 2.12 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.528 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.0 m80 -91.88 150.06 21.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -82.64 115.76 21.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.991 -1.913 . . . . 0.0 108.237 -178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.8 mt -78.62 -30.0 46.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.11 179.34 40.05 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -99.93 158.55 15.73 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.69 125.57 26.72 Favored Pre-proline 0 C--N 1.287 -2.138 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.51 95.42 1.0 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.834 2.356 . . . . 0.0 114.31 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 m -137.13 116.86 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.45 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 28.2 t80 -154.17 127.8 4.39 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 42.4 Cg_endo -65.72 131.96 14.82 Favored 'Cis proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.698 0.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.8 t -80.87 139.6 35.84 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.579 -1.192 . . . . 0.0 111.953 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -131.9 150.83 52.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.376 1.07 . . . . 0.0 109.167 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.35 -50.81 70.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -64.61 -41.27 96.32 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.885 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.63 93.89 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 123.833 0.708 . . . . 0.0 110.096 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -59.01 -55.12 39.18 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.382 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.19 -24.02 65.82 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.305 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -68.78 -60.73 2.19 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.0 p -59.68 -35.55 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 123.858 0.724 . . . . 0.0 111.761 -175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.0 m -58.42 -45.51 88.31 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -82.3 -9.97 59.28 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.9 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -85.46 -42.05 14.83 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.62 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -80.89 -44.85 17.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.218 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -117.06 108.3 15.57 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -74.75 -10.07 59.16 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.415 0.626 . . . . 0.0 111.369 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -93.47 -2.33 54.6 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.106 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.5 140.8 35.71 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.136 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.5 p -115.41 -31.69 5.84 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.919 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -127.53 161.34 29.01 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 120.92 0.39 . . . . 0.0 110.679 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.62 110.95 0.5 Allowed Glycine 0 N--CA 1.42 -2.383 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -125.1 143.01 51.14 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.525 ' SG ' HG22 ' A' ' 43' ' ' VAL . 11.4 t -88.58 126.96 35.52 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.207 -174.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -139.37 161.26 37.89 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -71.34 124.64 25.01 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.058 0.456 . . . . 0.0 109.987 177.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -122.72 89.4 3.1 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.78 -106.74 2.39 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -103.49 -45.6 4.8 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.12 158.19 34.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.286 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.525 HG22 ' SG ' ' A' ' 36' ' ' CYS . 11.1 p -103.48 122.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.41 160.78 29.51 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.542 0.686 . . . . 0.0 112.217 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.68 126.5 32.94 Favored 'General case' 0 C--N 1.274 -2.683 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.508 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -110.94 125.97 54.24 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.307 0.575 . . . . 0.0 110.305 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.3 m -95.99 118.43 32.6 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.007 -175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -103.07 139.96 37.92 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -175.03 -163.79 28.7 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.096 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 t70 . . . . . 0 C--N 1.307 -1.279 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.529 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.1 m . . . . . 0 N--CA 1.441 -0.877 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -117.42 -16.47 10.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -83.26 129.5 35.01 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.95 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -79.58 130.58 35.51 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.921 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.3 mt -94.93 -44.24 7.81 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.357 0.599 . . . . 0.0 109.997 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.02 -174.42 47.06 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -123.99 164.36 19.51 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.919 0.36 . . . . 0.0 110.681 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.63 140.59 30.47 Favored Pre-proline 0 C--N 1.308 -1.213 0 O-C-N 123.807 0.692 . . . . 0.0 109.706 177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.05 109.08 1.21 Allowed 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 123.027 2.485 . . . . 0.0 112.969 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 m -141.8 125.05 15.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 122.843 0.457 . . . . 0.0 110.399 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -156.4 130.73 4.95 Favored Pre-proline 0 C--N 1.308 -1.22 0 O-C-N 122.024 -0.423 . . . . 0.0 109.964 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.55 148.26 83.32 Favored 'Cis proline' 0 C--O 1.245 0.826 0 C-N-CA 123.601 -1.416 . . . . 0.0 111.024 -4.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -89.41 132.49 34.97 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.304 0.573 . . . . 0.0 111.801 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.575 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 3.0 mppt? -110.47 131.39 55.09 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 171.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.574 ' OE1' ' HG2' ' A' ' 18' ' ' LYS 0.302 0.0 OUTLIER -57.8 -43.98 86.0 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -177.954 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.574 ' HG2' ' OE1' ' A' ' 17' ' ' GLU . 47.5 mmtm -61.0 -41.72 97.04 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.734 0.302 . . . . 0.0 110.424 174.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.418 ' O ' HG21 ' A' ' 23' ' ' VAL . . . -63.58 -47.84 79.83 Favored 'General case' 0 C--O 1.201 -1.469 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.465 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.8 t -55.56 -46.35 77.18 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.629 0.771 . . . . 0.0 109.685 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.4 -40.19 95.69 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.131 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -67.12 -47.14 72.04 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 19' ' ' ALA . 83.3 t -58.47 -42.33 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 122.841 0.456 . . . . 0.0 109.972 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.8 m -59.65 -46.38 89.21 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.472 173.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.25 -23.15 67.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.467 0.544 . . . . 0.0 112.467 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -94.63 -32.68 13.3 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -84.98 -51.96 6.32 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.046 -0.409 . . . . 0.0 111.031 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -118.39 102.16 8.72 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -75.31 -4.18 37.69 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -93.08 -4.74 51.84 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.11 144.09 31.94 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.775 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.7 p -119.08 -20.64 7.97 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.155 0.503 . . . . 0.0 109.705 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -138.85 164.0 30.8 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.98 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.05 133.65 4.11 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -143.42 131.69 22.02 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 89.8 m -85.05 114.29 22.1 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.016 0.436 . . . . 0.0 109.828 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.43 154.04 27.64 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.98 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -84.7 99.56 10.91 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.342 0.592 . . . . 0.0 112.125 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -149.28 102.72 3.24 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.54 -152.25 16.85 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -88.17 -45.26 10.26 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.168 0.509 . . . . 0.0 109.818 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -110.25 158.14 18.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.97 127.38 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.509 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 13.4 m170 -106.53 141.18 38.25 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.622 -0.674 . . . . 0.0 112.173 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.8 t -79.27 109.16 13.35 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.719 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -94.26 123.12 37.46 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 66.3 m -94.84 121.78 36.79 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.917 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -102.2 131.46 48.72 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -153.28 179.94 29.26 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 119.297 -1.43 . . . . 0.0 113.259 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 C--N 1.302 -1.486 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.75 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.434 -1.267 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -114.19 -30.72 6.55 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 71.6 m80 -69.77 118.63 12.86 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.567 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -73.43 114.15 11.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.7 mt -92.84 -38.94 11.47 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.15 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.74 175.38 44.02 Favored Glycine 0 N--CA 1.423 -2.19 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -107.79 163.02 13.46 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 117.955 0.877 . . . . 0.0 108.979 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -131.8 144.46 53.36 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.63 113.06 2.78 Favored 'Trans proline' 0 C--O 1.249 1.06 0 C-N-CA 122.3 2.0 . . . . 0.0 111.428 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.1 t -137.52 123.37 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -150.24 127.57 5.54 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -69.01 134.45 28.1 Favored 'Cis proline' 0 C--N 1.356 0.952 0 C-N-CA 123.545 -1.44 . . . . 0.0 111.445 -1.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 9.0 t -79.11 103.13 8.84 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.308 -172.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.485 ' HG3' ' OE2' ' A' ' 17' ' ' GLU . 21.8 tptp -111.24 152.79 26.73 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.485 ' OE2' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -67.2 -39.54 86.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.488 0.585 . . . . 0.0 111.068 -178.078 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.81 -34.36 77.64 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.833 0.349 . . . . 0.0 110.392 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.37 83.08 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.3 m -60.99 -40.34 93.14 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -64.84 -17.69 64.48 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.254 0.549 . . . . 0.0 110.668 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -90.47 -56.18 3.3 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' A' ' 26' ' ' GLU . 66.0 t -62.04 -36.14 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 123.414 0.686 . . . . 0.0 112.67 -175.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 91.6 m -66.78 -27.31 67.48 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.842 -0.536 . . . . 0.0 112.299 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.93 -17.81 36.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.655 0.741 . . . . 0.0 109.73 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 9.0 tp10 -77.07 -45.2 27.9 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.447 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -81.44 -44.08 17.99 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.776 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -118.39 148.56 42.4 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -173.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -92.66 -21.63 19.91 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -99.99 -5.09 28.71 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.779 0.323 . . . . 0.0 111.328 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.78 123.46 26.73 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.023 0.439 . . . . 0.0 110.005 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.593 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 2.3 p -116.7 -9.47 11.29 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.473 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -144.4 152.88 41.3 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.68 130.39 2.94 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 177.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -134.38 146.32 49.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 117.231 0.515 . . . . 0.0 110.589 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.2 m -90.29 114.43 26.47 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -120.17 147.58 44.73 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 88.0 m-85 -93.28 143.51 26.19 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.047 0.451 . . . . 0.0 111.494 -173.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -131.56 89.51 2.72 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.12 -72.4 2.49 Favored Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.796 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -123.91 -59.71 1.49 Allowed 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.439 -0.448 . . . . 0.0 110.294 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -81.74 158.41 24.2 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.368 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.428 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 10.7 p -103.11 135.41 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.673 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -120.95 139.36 53.37 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.154 0.502 . . . . 0.0 109.924 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 41.3 t -88.42 114.69 25.3 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.988 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -102.77 126.11 49.77 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.129 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.3 m -94.77 126.7 40.26 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.397 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 71.7 m-85 -115.58 145.99 42.17 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.593 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -170.56 -147.81 5.72 Favored Glycine 0 C--N 1.287 -2.186 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--N 1.296 -1.72 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.115 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.431 -1.403 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -123.97 -21.35 5.12 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.994 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -74.23 118.15 16.85 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.374 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -67.35 111.15 3.87 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.76 -42.05 18.44 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.581 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.92 -170.91 44.04 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -110.92 119.29 38.57 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 124.07 0.512 . . . . 0.0 109.809 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.1 127.28 26.99 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.31 110.99 3.21 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.25 1.967 . . . . 0.0 111.283 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.7 t -119.73 123.44 70.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -142.88 133.78 12.58 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.25 168.54 76.96 Favored 'Cis proline' 0 C--O 1.241 0.64 0 C-N-CA 123.705 -1.373 . . . . 0.0 112.154 -0.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -80.23 114.52 19.2 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.768 0.794 . . . . 0.0 111.237 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -144.05 138.93 28.67 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 174.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.44 -44.79 95.44 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.465 0.478 . . . . 0.0 110.332 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.88 -42.68 99.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.732 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.48 -49.4 69.2 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.097 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -55.6 -53.61 54.31 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 124.113 0.965 . . . . 0.0 110.55 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -63.49 -29.5 70.76 Favored 'General case' 0 CA--C 1.554 1.135 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.705 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -79.86 -45.47 18.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.548 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.21 -31.42 53.8 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 CA-C-O 121.242 0.544 . . . . 0.0 109.845 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.0 m -58.6 -29.0 66.12 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.694 173.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -85.4 -10.78 55.79 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -87.57 -30.86 20.22 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -86.32 -44.27 12.23 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.011 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.69 161.05 25.88 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -98.07 -40.03 8.63 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.633 0.254 . . . . 0.0 111.306 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -76.57 -2.58 33.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.74 112.48 7.88 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.14 0.495 . . . . 0.0 110.894 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.2 p -116.09 -1.55 12.43 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.261 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -155.71 150.25 26.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.57 129.68 2.66 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -122.59 142.17 50.92 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.637 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 85.3 m -71.06 116.01 10.86 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 123.686 0.616 . . . . 0.0 109.824 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.536 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 7.6 mm-40 -104.14 105.44 15.6 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -86.08 123.65 31.62 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.407 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -141.81 89.52 2.2 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.15 -115.34 6.04 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.115 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -82.66 -52.29 6.94 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 122.498 0.319 . . . . 0.0 111.537 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -89.0 114.73 25.94 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.63 123.62 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -120.25 152.92 37.07 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 36.4 m -96.17 119.58 34.9 Favored 'General case' 0 C--N 1.267 -2.997 0 CA-C-O 120.817 0.341 . . . . 0.0 110.998 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.536 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 15.3 m170 -83.54 110.84 18.55 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 170.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -84.82 122.36 29.04 Favored 'General case' 0 N--CA 1.412 -2.343 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.462 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.1 133.07 43.9 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.134 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -130.76 178.07 17.94 Favored Glycine 0 N--CA 1.413 -2.843 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.401 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.5 t70 . . . . . 0 C--N 1.298 -1.667 0 C-N-CA 123.138 0.575 . . . . 0.0 109.725 -176.608 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.1 m . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 120.905 0.383 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -106.02 -0.19 25.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.423 0.63 . . . . 0.0 110.025 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 35.5 t60 -108.18 125.91 52.18 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.936 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -81.15 119.75 23.98 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.337 0.655 . . . . 0.0 110.162 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.4 mt -94.88 -50.58 5.06 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.288 0.566 . . . . 0.0 110.395 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 28' ' ' TYR . . . -165.07 -170.58 30.21 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.264 -176.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -131.97 144.73 51.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -128.04 138.58 33.26 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.7 111.82 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.257 1.972 . . . . 0.0 110.948 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.73 120.55 52.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 122.116 -0.365 . . . . 0.0 110.643 -177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.464 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 61.0 t80 -158.4 120.07 1.95 Allowed Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.464 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 50.0 Cg_endo -65.71 150.61 77.8 Favored 'Cis proline' 0 C--N 1.356 0.968 0 C-N-CA 124.133 -1.195 . . . . 0.0 113.17 3.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.5 t -115.01 124.38 51.48 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.61 -174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -138.75 168.36 19.96 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -58.52 -57.11 14.38 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.815 0.697 . . . . 0.0 112.74 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.65 -37.31 85.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.431 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -51.86 63.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.273 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.3 t -61.87 -45.66 92.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.138 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.449 ' HG3' ' HA ' ' A' ' 33' ' ' LYS . 38.7 ttpt -64.78 -37.53 87.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -65.96 -57.59 7.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.435 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.77 -33.19 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.081 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.3 m -61.05 -33.67 73.67 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HZ3' ' HB3' ' A' ' 25' ' ' LYS . 9.5 mtpm? -85.43 -9.43 57.53 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.817 0.342 . . . . 0.0 111.231 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.67 -37.71 10.69 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.582 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -72.24 -43.98 63.57 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.423 ' CZ ' ' HA3' ' A' ' 8' ' ' GLY . 46.6 m-85 -124.65 99.52 6.21 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -68.03 -2.95 8.65 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.316 0.579 . . . . 0.0 112.322 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -97.82 -9.09 27.06 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.585 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.11 162.41 26.68 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.342 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.8 p -119.6 -41.88 2.67 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.901 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.449 ' HA ' ' HG3' ' A' ' 21' ' ' LYS . 57.5 tttm -142.71 149.34 38.68 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.676 -176.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -116.69 165.02 12.29 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 174.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -151.47 130.69 12.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 118.03 0.915 . . . . 0.0 110.261 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.51 103.55 16.23 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.185 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -125.68 138.25 53.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.292 -172.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.549 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 88.8 m-85 -85.32 103.56 14.36 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 172.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -126.93 118.56 24.78 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.888 -172.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.51 -72.15 2.69 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -130.04 -67.4 0.75 Allowed 'General case' 0 C--N 1.311 -1.071 0 O-C-N 122.71 -0.288 . . . . 0.0 110.25 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -108.36 -172.52 2.08 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.191 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.549 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 7.3 p -88.35 140.18 16.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.545 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -129.28 146.87 51.1 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 39.3 t -95.33 102.27 14.06 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -85.96 130.23 34.6 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.4 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.0 m -100.54 123.68 45.07 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 123.388 0.43 . . . . 0.0 110.158 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 70.5 m-85 -114.03 151.87 31.82 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 122.551 0.341 . . . . 0.0 111.243 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.8 -150.95 22.62 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 C--N 1.299 -1.618 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.082 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -116.63 -17.82 10.47 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.949 -167.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -76.43 114.74 15.47 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.393 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.33 118.56 10.86 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.893 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.5 mt -92.88 -57.6 2.6 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.844 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.483 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -163.24 -168.59 25.44 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.647 -176.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -124.33 125.0 43.61 Favored 'General case' 0 C--O 1.249 1.043 0 C-N-CA 123.636 0.774 . . . . 0.0 110.521 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -107.86 148.61 37.73 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.808 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -86.82 113.06 1.02 Allowed 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 121.955 1.77 . . . . 0.0 110.695 174.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 47.8 t -139.75 113.54 6.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -177.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -144.35 128.26 8.98 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.92 143.87 78.32 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 123.914 -1.286 . . . . 0.0 110.391 -2.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 16.2 t -96.15 134.76 38.84 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.225 -174.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -136.02 156.65 48.42 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -48.38 -51.14 27.91 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.492 1.117 . . . . 0.0 112.053 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -76.5 -35.65 58.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.005 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.43 92.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.565 0.221 . . . . 0.0 110.434 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.3 t -61.65 -47.33 85.85 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -55.11 -46.98 75.61 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.674 0.789 . . . . 0.0 110.493 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.8 t -67.62 -46.33 72.82 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.828 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.83 -31.41 41.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.172 0 CA-C-O 121.422 0.63 . . . . 0.0 110.715 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 60.2 m -60.16 -28.09 67.63 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.557 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -80.83 -15.07 57.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 0.0 111.371 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -85.53 -33.38 21.79 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -87.51 -43.17 12.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.939 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.483 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 87.6 m-85 -120.61 140.99 50.75 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.091 0.472 . . . . 0.0 110.645 -175.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -85.03 -27.56 26.3 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -91.42 6.92 43.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.39 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.33 159.92 29.19 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.531 0.681 . . . . 0.0 111.222 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.0 t -143.95 -48.45 0.28 Allowed 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.617 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -125.72 153.42 43.94 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -140.87 131.2 4.83 Favored Glycine 0 N--CA 1.423 -2.219 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -119.37 144.22 47.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 120.959 0.409 . . . . 0.0 110.972 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 59.8 m -100.26 117.48 34.56 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.502 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -113.81 105.73 13.62 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 120.926 0.393 . . . . 0.0 111.096 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.502 ' CD2' ' HB ' ' A' ' 43' ' ' VAL . 88.6 m-85 -81.32 99.67 8.78 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -118.81 105.3 11.39 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.84 -123.68 6.72 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.0 mtm180 -89.26 -32.83 17.2 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -96.44 165.23 12.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.322 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.502 ' HB ' ' CD2' ' A' ' 38' ' ' TYR . 7.4 p -124.12 130.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.43 -0.805 . . . . 0.0 108.926 174.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -101.54 117.26 34.55 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 37.2 t -88.19 104.15 16.44 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.536 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 66.7 m170 -83.68 110.95 18.7 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.053 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 65.4 m -88.77 112.67 23.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.143 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -102.82 148.36 25.73 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.96 -148.66 6.8 Favored Glycine 0 C--N 1.294 -1.752 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 . . . . . 0 C--N 1.304 -1.388 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.883 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 91.9 m . . . . . 0 C--O 1.233 0.23 0 CA-C-O 121.502 0.668 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.34 -2.54 2.48 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.692 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.525 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 55.3 m80 -81.08 126.12 31.05 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -73.04 102.83 3.62 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.864 0.728 . . . . 0.0 109.993 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.8 mt -81.07 -35.14 32.14 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.079 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.29 -174.06 41.8 Favored Glycine 0 N--CA 1.427 -1.943 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -124.97 143.64 50.78 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 117.287 0.543 . . . . 0.0 110.855 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.61 142.07 33.47 Favored Pre-proline 0 C--N 1.297 -1.686 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.601 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.83 106.43 2.09 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.405 2.07 . . . . 0.0 111.438 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.4 t -128.02 103.73 10.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 O-C-N 121.859 -0.526 . . . . 0.0 109.866 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -142.35 132.21 12.34 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -74.65 167.86 78.88 Favored 'Cis proline' 0 C--O 1.237 0.474 0 C-N-CA 123.744 -1.357 . . . . 0.0 111.434 -2.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 t -83.67 131.65 34.93 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 122.018 0.913 . . . . 0.0 112.86 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -137.62 125.77 23.01 Favored 'General case' 0 N--CA 1.387 -3.622 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 170.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -41.41 70.0 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -176.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.74 -41.04 84.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.576 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -47.01 82.55 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.038 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.5 t -54.96 -50.55 68.63 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.359 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.72 -41.23 99.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.164 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 27.4 t -61.78 -55.51 29.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.427 ' O ' ' HD2' ' A' ' 27' ' ' HIS . 98.2 t -55.35 -43.89 73.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 123.684 0.615 . . . . 0.0 110.511 -177.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.1 m -58.06 -42.21 84.99 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.845 0.684 . . . . 0.0 112.845 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 54.9 mtpt -75.34 -23.96 57.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.279 0.562 . . . . 0.0 111.431 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 22' ' ' SER . 45.1 mt-10 -77.89 -33.46 51.96 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.957 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.427 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 44.4 m-70 -85.27 -44.86 12.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.152 0.501 . . . . 0.0 110.285 175.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -116.7 107.16 14.33 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -64.62 -19.74 65.86 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -89.96 0.93 56.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 25' ' ' LYS . . . -78.07 138.14 38.61 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.095 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.5 p -134.82 1.0 3.0 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.722 0.772 . . . . 0.0 110.454 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 59.2 tptt -148.94 142.42 25.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.19 126.63 2.07 Favored Glycine 0 CA--C 1.481 -2.08 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.85 140.08 52.62 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.621 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 59.6 m -76.14 102.31 5.7 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.402 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 5.9 mm-40 -94.61 110.69 22.49 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.458 0.647 . . . . 0.0 109.762 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -77.61 103.93 7.84 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.839 -174.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -127.05 99.38 5.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.53 -149.72 21.34 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -175.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -95.95 -50.59 4.81 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.014 0.435 . . . . 0.0 110.603 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -78.64 103.08 8.34 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.6 0.714 . . . . 0.0 109.797 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.8 p -76.21 150.0 6.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.621 -175.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -123.51 151.52 42.72 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 39.3 m -96.87 126.29 41.91 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-O 120.72 0.295 . . . . 0.0 110.492 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.402 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 46.7 m170 -90.61 117.99 29.71 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.9 m -92.5 123.1 35.56 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.912 -174.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 67.3 m-85 -117.73 141.98 47.78 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.215 -177.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 5' ' ' HIS . . . -170.6 -168.68 32.73 Favored Glycine 0 C--N 1.289 -2.083 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 C--N 1.293 -1.865 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.267 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.432 -1.362 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -144.53 -34.95 0.35 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.8 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -75.13 120.55 20.79 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -65.19 119.97 11.86 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.1 mt -94.15 -43.47 8.46 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.105 0.479 . . . . 0.0 110.043 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.417 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -177.53 -160.47 24.28 Favored Glycine 0 N--CA 1.419 -2.45 0 C-N-CA 119.49 -1.338 . . . . 0.0 112.98 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -131.69 131.22 42.92 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 123.677 0.791 . . . . 0.0 110.29 -171.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.56 143.96 44.82 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -89.09 111.1 0.53 Allowed 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 122.714 2.276 . . . . 0.0 112.558 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.4 t -132.12 104.05 7.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -138.21 124.01 12.62 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -74.58 147.45 89.42 Favored 'Cis proline' 0 C--N 1.347 0.466 0 C-N-CA 123.66 -1.392 . . . . 0.0 110.818 -2.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.5 t -91.23 142.17 28.01 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.367 0.603 . . . . 0.0 111.748 -174.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -137.03 152.77 50.48 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 172.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.25 -47.29 85.02 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.14 -40.44 86.74 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.076 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.11 -46.8 89.14 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.929 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t -59.3 -48.59 81.07 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 123.622 0.769 . . . . 0.0 109.712 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -55.77 -46.04 78.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.812 0.845 . . . . 0.0 110.182 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.3 t -64.66 -45.76 85.37 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.626 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.51 -38.6 83.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 CA-C-O 121.048 0.451 . . . . 0.0 110.322 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 83.2 m -58.92 -38.9 80.0 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.24 175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -64.04 -37.58 87.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.908 0.385 . . . . 0.0 110.621 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.28 -47.57 79.02 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.838 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -81.94 -39.48 23.66 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.417 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 63.1 m-85 -127.5 112.93 15.49 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -60.2 -37.33 79.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.872 0.367 . . . . 0.0 111.81 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -89.3 6.76 38.96 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.3 140.8 35.99 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.3 p -123.96 -28.75 3.73 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 121.013 0.435 . . . . 0.0 111.426 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -140.65 147.88 39.98 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.13 150.75 20.78 Favored Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -121.58 144.15 48.9 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 123.844 0.379 . . . . 0.0 110.197 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.5 m -84.83 102.1 12.8 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.473 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 8.4 mm-40 -92.14 109.38 20.74 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.135 0.493 . . . . 0.0 110.387 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -86.97 101.34 13.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.667 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -144.73 110.01 5.18 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.43 -159.48 28.47 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -88.93 -20.73 24.14 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.374 0.587 . . . . 0.0 110.692 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -91.94 146.39 23.78 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.11 124.4 67.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -98.3 123.75 42.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.927 -172.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 m -87.69 114.36 24.23 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.01 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.473 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 42.0 m170 -94.36 120.42 34.57 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 174.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.5 m -94.94 128.89 42.08 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.297 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -108.35 141.67 39.82 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.7 175.64 46.92 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 119.663 -1.256 . . . . 0.0 112.772 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 C--N 1.3 -1.548 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.732 -176.431 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 88.1 m . . . . . 0 N--CA 1.417 -2.096 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -117.83 -22.92 7.74 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.026 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 52.3 m80 -89.03 134.82 33.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.874 -176.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -66.58 131.14 45.36 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.855 0.36 . . . . 0.0 110.377 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.425 HD13 ' HB3' ' A' ' 31' ' ' ALA . 25.2 mt -103.04 -19.26 14.63 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.997 0.903 . . . . 0.0 108.849 175.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.07 -174.63 30.29 Favored Glycine 0 N--CA 1.409 -3.152 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -177.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -123.0 158.97 29.35 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.03 132.29 24.25 Favored Pre-proline 0 C--N 1.298 -1.633 0 O-C-N 123.318 0.386 . . . . 0.0 110.401 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HA ' ' NE2' ' A' ' 44' ' ' HIS . 58.8 Cg_endo -76.07 102.05 1.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.502 2.134 . . . . 0.0 112.752 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 m -143.95 140.75 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 123.357 0.663 . . . . 0.0 109.815 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.433 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 68.8 t80 -160.07 128.46 2.94 Favored Pre-proline 0 C--N 1.314 -0.96 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 8.9 Cg_exo -68.56 145.3 76.31 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 124.048 -1.23 . . . . 0.0 112.097 3.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.1 t -99.55 106.45 18.44 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -115.27 151.26 34.85 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.11 -41.55 68.42 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 124.049 0.843 . . . . 0.0 113.237 -175.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.6 -45.54 75.16 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.459 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.09 75.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.34 -51.12 69.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.878 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.27 -39.1 81.82 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.424 0.69 . . . . 0.0 111.149 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -70.12 -49.35 51.63 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.69 -40.9 80.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 123.39 0.676 . . . . 0.0 110.996 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 67.5 m -59.44 -44.07 92.99 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -72.61 -24.2 61.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.066 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -75.3 -47.72 26.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.397 177.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -79.99 -35.33 37.58 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.953 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -126.21 112.27 15.57 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -74.78 -18.21 60.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -92.17 8.81 36.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.098 0.475 . . . . 0.0 110.912 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.425 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -96.49 139.48 32.52 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.3 p -124.43 -20.07 5.28 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.103 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.58 134.78 35.99 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.55 -176.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.05 148.71 16.84 Favored Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.24 138.9 33.59 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.1 m -87.91 122.11 31.14 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -128.73 143.23 50.88 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.12 100.81 10.76 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -115.8 100.49 8.05 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 -102.57 2.55 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.06 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -98.09 -55.61 2.73 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.173 0.511 . . . . 0.0 110.245 -177.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -99.53 167.36 10.65 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.404 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.3 p -99.17 135.94 32.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.516 ' NE2' ' HA ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -138.09 160.26 39.86 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.807 -178.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.6 t -85.97 114.79 23.14 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.276 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -102.61 125.72 49.44 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 68.4 m -95.59 127.06 41.31 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.854 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 80.6 m-85 -112.06 147.97 34.89 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.326 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.62 -141.57 6.3 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 C--N 1.306 -1.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.11 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.422 -1.855 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -121.3 -43.23 2.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.912 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -83.9 135.6 34.43 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.084 -177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -85.99 116.41 24.19 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.9 mt -74.86 -33.47 62.12 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.609 0.718 . . . . 0.0 109.125 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.63 -178.3 37.57 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.94 143.13 38.59 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.08 132.9 24.25 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.15 140.97 18.15 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.503 2.135 . . . . 0.0 111.36 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.402 HG11 ' SG ' ' A' ' 45' ' ' CYS . 13.8 p -141.8 143.68 26.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 120.73 0.3 . . . . 0.0 110.688 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 84.3 t80 -148.43 123.34 5.0 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 2.0 Cg_endo -84.98 163.88 61.92 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.822 -1.324 . . . . 0.0 110.939 -2.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.21 92.36 3.83 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.1 0.952 . . . . 0.0 112.78 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -117.77 141.92 47.86 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 168.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.08 -43.22 91.8 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 118.218 0.463 . . . . 0.0 111.63 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.65 -48.69 80.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.234 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.43 -42.36 92.52 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.034 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.7 t -56.44 -54.76 41.92 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 124.115 0.966 . . . . 0.0 110.983 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -59.44 -38.24 80.18 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 121.168 0.508 . . . . 0.0 110.098 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.567 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 49.1 m -66.78 -54.62 20.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.592 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.6 t -60.65 -37.46 75.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-O 121.241 0.543 . . . . 0.0 110.457 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.8 t -56.19 -46.28 79.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.009 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 60.6 mtpt -72.82 -19.78 61.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.627 0.371 . . . . 0.0 111.689 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 22' ' ' SER . 24.6 mm-40 -74.92 -42.51 57.59 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -75.83 -45.54 35.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.246 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 54.3 m-85 -123.51 104.97 9.39 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -65.63 -24.15 66.98 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -175.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -84.02 0.03 49.8 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.28 123.86 23.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.427 0.632 . . . . 0.0 111.531 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.0 p -101.61 -29.09 12.14 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.999 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -136.37 128.84 30.34 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.847 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -133.89 118.45 2.06 Favored Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -135.13 140.44 45.44 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.056 -0.658 . . . . 0.0 112.735 -177.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.7 m -63.1 120.38 11.35 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.991 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -118.14 114.22 22.75 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -77.72 102.48 7.15 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -126.55 97.06 4.88 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.95 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.56 -112.97 3.77 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.319 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -83.38 -46.11 12.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.205 0.526 . . . . 0.0 111.816 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -97.88 170.73 8.75 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.936 0.874 . . . . 0.0 112.481 -172.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.1 113.77 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -125.35 157.95 35.47 Favored 'General case' 0 C--N 1.277 -2.587 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.402 ' SG ' HG11 ' A' ' 12' ' ' VAL . 65.6 m -80.88 111.1 17.04 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -80.4 124.41 28.87 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 92.4 m -97.91 112.63 24.48 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.326 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -95.3 133.44 39.2 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 176.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.51 155.33 26.13 Favored Glycine 0 C--N 1.287 -2.159 0 C-N-CA 117.506 -2.283 . . . . 0.0 114.436 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t0 . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 177.786 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.505 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 96.3 m . . . . . 0 N--CA 1.442 -0.842 0 CA-C-O 121.198 0.523 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -119.43 -35.76 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.445 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -74.49 131.91 41.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.413 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.15 111.58 10.53 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.2 mt -79.26 -30.61 43.17 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-O 121.392 0.615 . . . . 0.0 109.551 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.407 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . 163.02 -154.22 25.08 Favored Glycine 0 N--CA 1.404 -3.462 0 C-N-CA 120.502 -0.856 . . . . 0.0 110.997 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -128.65 158.19 39.23 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.94 139.96 31.94 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.863 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.17 114.2 2.49 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.36 2.04 . . . . 0.0 112.594 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 p -155.13 114.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -159.19 127.33 2.86 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.694 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.05 154.68 80.83 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.689 -1.379 . . . . 0.0 111.661 -3.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 51.3 t -117.41 137.59 52.39 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -103.04 157.13 17.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.16 -41.73 97.3 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.709 0.766 . . . . 0.0 110.562 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -75.1 -25.74 58.76 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.518 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.41 ' HA ' ' OG ' ' A' ' 22' ' ' SER . . . -76.51 -36.69 57.62 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.038 -178.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.452 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.5 t -64.9 -36.5 84.56 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -60.98 -47.77 84.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.849 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 19' ' ' ALA . 5.9 p -70.74 -43.48 68.75 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.288 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.1 t -63.54 -46.24 95.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.7 m -59.01 -38.05 78.31 Favored 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -64.02 -33.27 75.37 Favored 'General case' 0 N--CA 1.425 -1.685 0 C-N-CA 123.076 0.55 . . . . 0.0 111.14 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.83 -19.77 30.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -89.19 -38.1 14.52 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.748 -0.595 . . . . 0.0 111.066 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.407 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 57.4 m-85 -133.94 110.8 9.95 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -71.77 -8.29 53.34 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.699 0.762 . . . . 0.0 110.769 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -86.64 -6.23 58.92 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.306 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.38 132.16 39.3 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.766 -177.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 p -112.02 -21.25 11.63 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -132.73 141.45 48.56 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.792 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.87 147.23 18.98 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -138.52 119.49 14.36 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 118.371 1.085 . . . . 0.0 110.188 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 25.8 m -82.27 109.14 16.27 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.263 176.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -125.38 148.11 48.91 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.084 -177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 81.7 m-85 -73.9 103.0 4.26 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.647 0.736 . . . . 0.0 110.799 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -94.93 89.86 5.78 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.99 -98.69 2.45 Favored Glycine 0 N--CA 1.423 -2.179 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -176.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -108.15 -52.63 2.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.021 0.439 . . . . 0.0 110.414 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.95 170.73 9.22 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.343 -173.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 7.3 p -89.48 132.84 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-O 121.304 0.573 . . . . 0.0 110.312 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 11.6 m-70 -120.83 137.17 54.68 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.8 t -88.04 105.31 17.39 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -89.67 118.58 29.38 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.3 m -91.28 124.01 35.15 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.015 -176.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -108.01 138.81 43.61 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.505 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -167.87 -155.8 9.63 Favored Glycine 0 C--N 1.297 -1.611 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 C--N 1.301 -1.528 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.119 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 74.3 m . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -101.79 -24.03 14.11 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -76.66 139.66 40.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.516 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.63 130.28 41.16 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.736 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.4 mt -89.69 -23.73 21.77 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.645 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.59 -179.92 25.04 Favored Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 12.0 pt-20 -105.9 146.34 30.09 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.29 138.98 32.7 Favored Pre-proline 0 C--N 1.302 -1.466 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.74 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.76 131.46 13.46 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.641 2.227 . . . . 0.0 112.019 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -160.63 134.01 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 122.558 0.343 . . . . 0.0 110.386 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.471 ' CG ' ' HA ' ' A' ' 14' ' ' PRO . 33.8 t80 -155.7 140.9 12.37 Favored Pre-proline 0 N--CA 1.435 -1.191 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.471 ' HA ' ' CG ' ' A' ' 13' ' ' TYR . 4.5 Cg_exo -76.12 168.36 77.5 Favored 'Cis proline' 0 C--O 1.25 1.124 0 C-N-CA 123.867 -1.305 . . . . 0.0 111.948 -0.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -78.85 114.1 17.5 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.851 0.834 . . . . 0.0 110.858 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -138.32 136.59 36.56 Favored 'General case' 0 N--CA 1.394 -3.252 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.51 -47.39 82.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 124.065 0.853 . . . . 0.0 110.085 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -64.68 -38.22 90.24 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.386 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.72 -43.42 72.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.6 t -59.08 -51.62 69.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.214 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.39 -38.67 84.7 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.296 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.2 m -66.27 -48.6 69.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.643 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.25 -40.25 88.35 Favored 'Isoleucine or valine' 0 C--O 1.255 1.361 0 CA-C-O 121.033 0.444 . . . . 0.0 109.894 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 57.8 m -54.81 -46.24 74.5 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.65 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -57.17 -36.31 70.63 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 123.359 0.412 . . . . 0.0 111.913 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -73.12 -42.35 62.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.642 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -79.49 -39.43 32.13 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.969 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -134.52 102.63 5.38 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -62.46 -22.1 65.97 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -169.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -96.54 12.82 30.19 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.741 0.305 . . . . 0.0 111.466 -178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.73 127.77 33.53 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.015 0.436 . . . . 0.0 110.694 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.3 p -106.84 -20.9 13.19 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.988 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -156.51 157.38 35.33 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -140.23 150.18 21.38 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.692 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 10.0 tp10 -124.17 127.59 47.99 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 69.5 m -83.32 107.8 16.09 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.373 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -116.93 133.28 56.21 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 98.9 m-85 -81.64 131.08 35.26 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.826 0.346 . . . . 0.0 110.705 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -125.47 106.49 9.83 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.9 -97.85 1.15 Allowed Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -126.2 -2.91 6.94 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 111.682 0.252 . . . . 0.0 111.682 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -126.66 147.46 49.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 9.5 p -90.43 137.83 20.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 120.683 0.278 . . . . 0.0 110.594 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -125.71 151.86 46.07 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 2.2 m -97.69 126.77 43.2 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 177.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -84.75 110.4 18.77 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 171.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.3 m -89.53 124.9 34.94 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.823 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -96.09 148.9 22.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.61 171.19 30.55 Favored Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.617 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 C--N 1.289 -2.036 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.383 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.437 ' HA ' ' CG ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 120.851 0.358 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -120.44 137.23 54.45 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 98.3 m -88.26 16.29 6.47 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.431 0.634 . . . . 0.0 110.051 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -87.15 1.67 52.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.119 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 34.6 m80 -107.96 147.52 30.94 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -91.03 128.83 37.01 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.5 mt -91.5 -38.73 12.35 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.28 -151.62 14.07 Favored Glycine 0 N--CA 1.416 -2.658 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.855 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -131.67 151.04 51.93 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.572 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -122.03 137.23 27.1 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.77 94.73 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.123 1.882 . . . . 0.0 111.353 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.5 t -127.56 113.53 32.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -143.76 124.77 7.99 Favored Pre-proline 0 N--CA 1.434 -1.23 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.58 149.88 93.05 Favored 'Cis proline' 0 C--O 1.246 0.907 0 C-N-CA 123.421 -1.491 . . . . 0.0 110.429 -0.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.2 t -94.7 109.3 21.26 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.192 0.52 . . . . 0.0 110.564 -173.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.73 138.79 36.32 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 173.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -47.03 -49.24 21.5 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 124.35 1.031 . . . . 0.0 112.548 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -73.02 -37.67 66.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.945 0.403 . . . . 0.0 111.466 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.414 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -67.68 -39.38 84.48 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.8 t -59.2 -49.34 78.22 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.423 0.689 . . . . 0.0 109.461 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HG3' ' HA ' ' A' ' 33' ' ' LYS . 58.7 tttm -57.61 -34.87 69.73 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.256 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 m -76.54 -46.06 28.03 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.881 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 19' ' ' ALA . 73.3 t -68.04 -33.79 63.1 Favored 'Isoleucine or valine' 0 C--O 1.254 1.34 0 CA-C-O 121.297 0.57 . . . . 0.0 110.449 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.6 m -56.98 -38.72 73.42 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.304 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -71.7 -21.79 61.73 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.925 0.393 . . . . 0.0 111.409 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -73.45 -48.54 32.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -77.35 -47.17 20.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.961 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -116.8 107.97 15.29 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -69.58 -21.43 63.6 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -98.26 16.71 20.57 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.159 0.504 . . . . 0.0 110.415 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.48 142.8 31.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.611 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 2.0 p -115.41 -44.01 3.01 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.855 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HA ' ' HG3' ' A' ' 21' ' ' LYS . 82.3 tttt -120.46 153.35 36.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -141.05 140.08 10.1 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 107.161 -2.376 . . . . 0.0 107.161 174.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -144.52 144.19 31.21 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 118.02 0.91 . . . . 0.0 109.977 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.5 m -92.58 127.07 37.94 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.2 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -137.73 147.16 44.52 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.415 ' CE2' ' HB ' ' A' ' 43' ' ' VAL . 74.5 m-85 -86.15 126.69 34.42 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.187 0.518 . . . . 0.0 110.485 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.36 111.03 14.02 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.524 ' O ' ' HD2' ' A' ' 41' ' ' ARG . . . 81.31 -101.59 2.12 Favored Glycine 0 N--CA 1.413 -2.847 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 40' ' ' GLY . 12.7 mmm180 -125.72 -31.87 2.9 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -87.29 159.94 18.6 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.201 0.524 . . . . 0.0 111.206 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 38' ' ' TYR . 12.7 p -95.85 127.26 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.091 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -108.75 139.89 42.93 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.648 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 35.8 t -91.16 108.1 19.64 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -94.93 125.72 39.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.992 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.6 m -96.51 121.57 38.47 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.101 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.419 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 62.9 m-85 -105.24 141.25 37.11 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.611 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -178.96 -174.64 45.32 Favored Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.437 ' CG ' ' HA ' ' A' ' 1' ' ' ALA . 26.1 t70 -95.62 124.5 39.67 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -89.03 112.05 22.9 Favored 'General case' 0 N--CA 1.425 -1.685 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.737 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.4 p80 . . . . . 0 C--N 1.285 -2.235 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.452 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.444 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -76.02 151.54 37.15 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.0 m -97.19 85.9 3.81 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -119.99 9.16 11.15 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.413 ' HD1' HD23 ' A' ' 7' ' ' LEU . 63.2 t-80 -107.04 114.04 27.88 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -69.22 123.44 21.15 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.413 HD23 ' HD1' ' A' ' 5' ' ' HIS . 91.9 mt -96.95 -49.48 5.01 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.567 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.444 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -177.78 -179.33 47.87 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.5 127.99 56.29 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.082 0.468 . . . . 0.0 110.246 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.19 141.93 25.33 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.625 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.99 104.92 1.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.473 2.115 . . . . 0.0 111.104 176.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -123.25 103.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -136.24 122.81 14.04 Favored Pre-proline 0 C--N 1.304 -1.412 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.223 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.25 147.16 86.69 Favored 'Cis proline' 0 C--O 1.245 0.847 0 C-N-CA 123.66 -1.392 . . . . 0.0 111.826 1.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.4 t -68.31 120.17 14.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.477 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -141.54 140.82 33.53 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.98 -48.13 79.14 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.359 0.664 . . . . 0.0 111.109 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -62.47 -44.61 95.97 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.427 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.41 -45.16 94.61 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.566 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -54.67 -52.57 61.95 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.177 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 25.3 ttmm -59.71 -38.06 80.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 122.991 0.182 . . . . 0.0 110.938 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 t -72.37 -51.16 21.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.763 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.9 t -60.69 -37.98 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.584 0.354 . . . . 0.0 110.606 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.8 m -61.16 -37.99 84.86 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 21' ' ' LYS . 98.5 mttt -66.93 -35.25 79.58 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.713 0.768 . . . . 0.0 109.87 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.41 -35.39 70.97 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.474 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -84.32 -45.76 12.47 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.88 176.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.444 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 25.0 m-85 -126.28 130.42 50.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -72.95 -21.68 60.83 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.46 0.648 . . . . 0.0 110.916 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -94.5 -2.83 51.01 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.408 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . . . -83.82 126.73 33.24 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.397 0.617 . . . . 0.0 111.381 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.629 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 1.7 p -116.69 -28.86 6.25 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.44 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -124.32 135.18 53.16 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 122.07 -0.394 . . . . 0.0 110.77 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.94 136.04 9.17 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -147.28 131.51 17.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -175.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.6 m -91.21 137.16 32.58 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 120.985 0.421 . . . . 0.0 111.798 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -133.99 132.51 40.21 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.461 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 65.8 m-85 -88.57 136.23 33.1 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.328 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -127.46 90.09 3.07 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.54 -113.72 3.69 Favored Glycine 0 N--CA 1.432 -1.584 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -172.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -98.95 -33.46 10.83 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -76.21 150.98 36.99 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.938 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' A' ' 38' ' ' TYR . 7.8 p -146.58 133.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -126.28 160.34 30.6 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.691 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.5 t -97.74 119.92 37.19 Favored 'General case' 0 N--CA 1.41 -2.469 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -87.71 122.72 31.73 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.0 m -97.27 126.49 42.52 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.038 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -114.68 149.64 36.43 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.629 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -155.98 -170.13 20.96 Favored Glycine 0 C--N 1.288 -2.132 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -140.55 151.81 45.02 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 117.043 0.421 . . . . 0.0 109.871 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -112.32 119.13 37.25 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.815 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 . . . . . 0 C--O 1.247 0.924 0 C-N-CA 125.259 1.424 . . . . 0.0 112.577 172.76 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -121.43 146.52 46.82 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 121.896 -0.503 . . . . 0.0 110.071 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.0 m -86.24 71.89 10.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -144.67 15.13 1.58 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.523 0.678 . . . . 0.0 110.441 175.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 t60 -105.64 136.27 45.54 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -81.82 126.92 32.43 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.704 0.288 . . . . 0.0 110.483 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.419 HD13 ' HA3' ' A' ' 49' ' ' GLY . 85.7 mt -86.13 -44.49 12.2 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.7 -168.93 42.06 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 12.2 pt-20 -115.75 149.88 37.77 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 120.767 0.318 . . . . 0.0 110.506 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.19 138.11 18.85 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.5 141.91 22.94 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 121.887 1.724 . . . . 0.0 111.307 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 p -140.23 149.71 21.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -160.01 123.7 2.01 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.83 169.85 45.15 Favored 'Cis proline' 0 C--O 1.241 0.651 0 C-N-CA 124.557 -1.018 . . . . 0.0 111.364 -1.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.1 t -75.84 94.81 3.38 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -126.94 139.66 52.89 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 168.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.16 -45.78 75.71 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 123.555 0.534 . . . . 0.0 112.315 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -61.01 -39.36 89.44 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.583 0.552 . . . . 0.0 111.32 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -41.47 67.16 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.163 0.506 . . . . 0.0 110.061 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -60.73 -48.77 80.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.775 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.497 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 88.2 tttt -59.85 -41.61 91.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.779 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.9 m -59.56 -55.01 39.87 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.614 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.461 ' O ' ' HD2' ' A' ' 27' ' ' HIS . 13.0 p -65.76 -36.3 77.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.525 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.0 m -59.01 -39.5 82.09 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.804 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 30.4 mtpp -73.06 -27.59 61.83 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.703 0.287 . . . . 0.0 111.066 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -67.55 -37.6 82.92 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.208 0.528 . . . . 0.0 110.2 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.461 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 40.4 m-70 -77.73 -60.02 2.54 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.502 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 18.6 m-85 -120.23 106.45 11.93 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -175.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -56.57 -31.46 64.23 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -174.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -79.53 4.86 14.49 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.44 126.97 30.5 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.381 0.61 . . . . 0.0 109.989 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 p -124.16 -11.19 7.54 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.022 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 58.1 tptt -148.16 123.82 10.49 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.797 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.32 135.75 13.09 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -122.71 127.16 48.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 93.0 m -76.38 116.45 17.07 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.092 0.472 . . . . 0.0 111.759 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -110.19 98.86 8.02 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -78.61 103.02 8.28 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -113.28 89.23 3.03 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -174.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.53 -81.99 0.6 Allowed Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.585 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -85.09 -68.37 0.73 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -128.3 -179.17 4.87 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -172.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.24 126.21 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 121.876 0.846 . . . . 0.0 112.583 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -107.34 133.33 52.03 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 5.3 m -92.03 126.75 37.24 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.342 176.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -87.45 113.07 22.83 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 m -90.77 109.73 20.92 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.09 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.453 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 97.8 m-85 -89.79 139.46 30.55 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.419 ' HA3' HD13 ' A' ' 7' ' ' LEU . . . -134.04 168.1 23.46 Favored Glycine 0 N--CA 1.419 -2.478 0 C-N-CA 118.997 -1.573 . . . . 0.0 114.544 -175.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -109.86 113.02 25.41 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.223 -0.989 . . . . 0.0 110.36 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -88.0 127.74 35.39 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 . . . . . 0 C--N 1.298 -1.649 0 O-C-N 123.877 0.736 . . . . 0.0 109.563 -178.01 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.76 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -84.47 156.31 21.79 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.07 0.462 . . . . 0.0 111.202 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.1 m -87.44 78.74 8.59 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.722 -174.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -122.15 -1.11 9.3 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.545 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 5.4 t-160 -80.38 110.79 16.16 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 -178.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -66.67 104.88 1.39 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.56 -52.49 5.79 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.591 -177.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.52 -161.21 20.69 Favored Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -134.04 148.42 51.07 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.008 0.432 . . . . 0.0 110.741 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.556 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -129.12 151.82 78.33 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.194 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -93.06 131.68 0.88 Allowed 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 122.14 1.893 . . . . 0.0 112.878 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -160.65 127.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 123.125 0.57 . . . . 0.0 109.844 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -142.19 129.92 11.51 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.37 145.44 83.5 Favored 'Cis proline' 0 C--O 1.244 0.818 0 C-N-CA 123.344 -1.523 . . . . 0.0 110.63 -0.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 t -87.44 101.52 13.67 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.744 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -98.48 148.91 23.26 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.446 ' H ' ' CD ' ' A' ' 17' ' ' GLU . 1.9 mp0 -51.51 -54.57 25.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.211 0.604 . . . . 0.0 110.42 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.79 -42.07 99.55 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.256 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.85 95.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.418 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.9 t -61.04 -48.91 79.57 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 87.6 tttt -56.24 -42.17 76.88 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.557 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -66.36 -52.41 47.19 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.869 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.5 t -62.01 -37.7 78.97 Favored 'Isoleucine or valine' 0 C--O 1.257 1.472 0 CA-C-O 121.292 0.568 . . . . 0.0 111.018 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.0 m -59.32 -33.24 70.87 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 21' ' ' LYS . 52.9 mtmt -75.43 -18.96 59.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.062 0.392 . . . . 0.0 111.033 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -83.76 -40.54 18.67 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -79.43 -44.25 21.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.9 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -121.64 108.21 13.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -67.01 -18.87 65.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -90.84 -5.19 55.92 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.49 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.1 140.42 37.84 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 121.108 0.48 . . . . 0.0 110.191 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.447 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -139.45 4.9 2.21 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.509 -178.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -150.87 142.66 23.77 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.77 139.36 10.14 Favored Glycine 0 C--N 1.298 -1.575 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -135.9 137.58 41.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 61.6 m -85.12 129.71 34.75 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.628 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -126.11 130.15 50.5 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -93.38 115.96 28.52 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.355 0.597 . . . . 0.0 111.454 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -111.3 92.27 3.98 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.72 -113.57 4.26 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -101.3 -12.77 18.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.84 125.8 40.65 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.568 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.3 p -95.02 125.74 47.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -107.61 139.24 42.45 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 35.4 t -96.65 109.65 22.23 Favored 'General case' 0 C--N 1.279 -2.462 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -92.63 124.51 36.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.235 0.54 . . . . 0.0 110.367 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.8 m -94.35 122.52 36.98 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.721 -173.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 67.5 m-85 -113.62 136.62 52.63 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.34 178.91 26.56 Favored Glycine 0 N--CA 1.416 -2.676 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.293 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -140.94 123.65 16.12 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -67.77 109.1 3.21 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 69.0 m80 . . . . . 0 C--N 1.3 -1.546 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 173.513 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.502 ' H1 ' ' CG ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 120.417 0.151 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.41 ' CE1' ' HB2' ' A' ' 4' ' ' ASP . 11.5 t-160 -120.94 119.85 33.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.246 0.546 . . . . 0.0 111.25 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 m -87.21 107.62 18.56 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.41 ' HB2' ' CE1' ' A' ' 2' ' ' HIS . 24.2 t70 -131.16 -59.47 0.98 Allowed 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.628 -176.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -89.65 153.61 20.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.084 0.468 . . . . 0.0 110.923 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -77.46 136.61 38.38 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.614 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.2 mt -95.27 -19.12 20.26 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.51 -178.99 34.5 Favored Glycine 0 N--CA 1.405 -3.386 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.338 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -112.75 149.93 32.28 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.85 152.75 77.99 Favored Pre-proline 0 C--N 1.283 -2.289 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -83.65 142.71 10.44 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.268 1.978 . . . . 0.0 110.766 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p -151.92 136.81 10.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.29 0.567 . . . . 0.0 111.822 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -160.42 132.01 4.04 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.07 159.51 93.12 Favored 'Cis proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.31 -1.121 . . . . 0.0 112.044 -0.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.571 ' SG ' HG22 ' A' ' 43' ' ' VAL . 48.3 t -78.48 127.82 32.71 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 23.4 tptp -166.66 143.67 4.87 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -48.05 76.84 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.79 -36.9 84.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 117.947 0.34 . . . . 0.0 111.714 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.462 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -62.9 -50.5 70.62 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.9 t -63.85 -40.11 95.8 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.545 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -62.74 -32.02 73.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 19.0 t -77.45 -46.9 21.12 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 19' ' ' ALA . 78.7 t -52.41 -47.96 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.138 0.575 . . . . 0.0 110.11 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 58.0 m -55.59 -43.14 75.73 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HE2' ' HA ' ' A' ' 32' ' ' CYS . 94.7 mttt -75.87 -25.93 56.62 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.931 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 22' ' ' SER . 45.0 mt-10 -81.07 -19.07 44.51 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.889 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.428 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 50.7 m-70 -102.53 -39.53 7.06 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.31 174.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -121.2 115.04 22.29 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -66.43 -29.07 69.13 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -84.81 3.69 36.57 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.18 137.65 39.0 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.146 0.498 . . . . 0.0 110.684 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.405 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 5.6 p -124.42 -23.47 4.45 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.297 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -136.21 142.2 44.07 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -136.13 125.25 3.47 Favored Glycine 0 C--N 1.292 -1.909 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -115.39 135.67 53.88 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 117.652 0.726 . . . . 0.0 110.974 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.505 ' SG ' HG22 ' A' ' 43' ' ' VAL . 9.6 t -96.0 100.61 12.27 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -174.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.95 131.01 53.49 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.003 0.43 . . . . 0.0 111.876 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 74.7 m-85 -75.94 126.24 30.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.042 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -140.21 130.83 25.63 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.164 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.28 -116.17 5.12 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -120.06 0.23 10.69 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.084 0.468 . . . . 0.0 111.005 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -130.63 -169.91 2.24 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.11 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.571 HG22 ' SG ' ' A' ' 15' ' ' CYS . 11.8 p -114.42 138.32 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-O 120.899 0.381 . . . . 0.0 110.731 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -111.71 137.12 50.03 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.6 t -94.85 109.12 21.14 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.422 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 28.5 m170 -89.52 113.68 25.11 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 121.156 0.503 . . . . 0.0 110.65 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.4 m -94.24 109.68 21.47 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.151 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -97.07 132.82 42.49 Favored 'General case' 0 C--O 1.255 1.385 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -135.2 -176.23 14.25 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 119.125 -1.512 . . . . 0.0 113.433 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.502 ' CG ' ' H1 ' ' A' ' 1' ' ' ALA . 13.1 t70 -129.1 118.57 22.7 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -77.13 108.73 10.43 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 . . . . . 0 C--N 1.299 -1.589 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -174.248 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -84.99 149.64 25.46 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.922 -0.486 . . . . 0.0 111.565 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.1 m -87.72 77.5 8.63 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -125.74 -32.04 2.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.81 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.429 ' HD1' HD22 ' A' ' 7' ' ' LEU . 57.9 t-80 -70.69 124.12 23.51 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.478 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -70.63 105.96 3.33 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 124.238 0.961 . . . . 0.0 108.821 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.429 HD22 ' HD1' ' A' ' 5' ' ' HIS . 84.1 mt -77.65 -31.67 52.84 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.572 0.701 . . . . 0.0 109.155 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.68 -162.37 33.93 Favored Glycine 0 N--CA 1.412 -2.957 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -124.48 124.92 43.34 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 124.02 0.483 . . . . 0.0 109.699 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.13 138.05 21.24 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.914 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.31 103.26 1.71 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.157 1.904 . . . . 0.0 110.492 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 t -129.99 108.89 16.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -136.94 123.7 13.82 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.54 139.33 60.51 Favored 'Cis proline' 0 C--O 1.24 0.612 0 C-N-CA 123.466 -1.473 . . . . 0.0 110.715 -1.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 29.1 t -81.53 118.41 22.72 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.32 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -130.23 161.06 32.03 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.19 -65.51 0.66 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 124.434 1.094 . . . . 0.0 111.537 -172.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -64.64 -37.26 86.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.771 0.319 . . . . 0.0 110.96 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.407 ' O ' HG21 ' A' ' 23' ' ' VAL . . . -62.96 -43.19 99.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.948 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.8 t -68.9 -39.35 79.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.398 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.421 ' NZ ' ' HB3' ' A' ' 21' ' ' LYS . 8.0 mtpm? -56.06 -38.06 70.13 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 120.935 0.398 . . . . 0.0 110.036 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.4 m -67.89 -55.56 12.38 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.978 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 19' ' ' ALA . 80.0 t -59.42 -38.0 72.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.215 0.606 . . . . 0.0 111.567 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 80.7 m -61.46 -31.45 71.41 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -79.27 -10.99 59.95 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.597 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -93.77 -33.0 13.76 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.283 0.563 . . . . 0.0 109.888 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -92.42 -21.46 20.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.255 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -136.23 172.59 12.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -105.96 -47.44 3.86 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.074 0.464 . . . . 0.0 110.495 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -82.0 19.28 1.16 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.65 126.56 35.03 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.412 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.618 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 1.6 p -121.96 -27.41 4.61 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.849 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -131.28 131.4 43.82 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.63 130.11 8.33 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -134.46 133.94 41.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 118.042 0.921 . . . . 0.0 110.72 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 60.0 m -77.78 128.61 34.29 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.264 -174.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -101.55 99.85 10.2 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.31 105.62 17.78 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.073 0.463 . . . . 0.0 110.4 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -146.58 111.46 5.32 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.63 -138.54 14.32 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -98.56 -30.6 12.41 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 116.949 0.374 . . . . 0.0 110.078 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -84.41 176.91 8.37 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.366 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.46 119.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.517 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -95.36 160.07 14.7 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 14.5 t -132.61 122.4 24.66 Favored 'General case' 0 C--N 1.282 -2.355 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.788 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -90.06 134.57 34.17 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 121.454 0.645 . . . . 0.0 112.03 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.1 m -96.46 110.83 23.13 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.439 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -99.87 142.22 31.63 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.43 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.618 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -163.95 -163.66 17.38 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -121.55 113.48 19.86 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -108.19 165.46 11.47 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -169.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 8.7 t60 . . . . . 0 C--N 1.29 -2.019 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 178.616 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.875 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -101.76 144.09 30.88 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.48 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 99.1 m -84.07 71.35 10.56 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 122.563 1.173 . . . . 0.0 109.288 175.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -105.49 -28.22 10.94 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.541 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -85.32 121.96 28.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.729 -175.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -67.24 112.63 4.61 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.91 -29.59 17.39 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.705 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.82 175.74 39.64 Favored Glycine 0 N--CA 1.422 -2.297 0 C-N-CA 119.713 -1.232 . . . . 0.0 111.957 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -116.97 121.51 41.59 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 123.63 0.772 . . . . 0.0 109.567 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.65 133.14 20.74 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.43 114.61 4.02 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.242 1.961 . . . . 0.0 111.166 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -133.33 115.22 22.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -140.18 124.28 10.76 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -80.85 -179.69 26.06 Favored 'Cis proline' 0 C--N 1.352 0.76 0 C-N-CA 124.43 -1.071 . . . . 0.0 112.174 1.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.7 t -85.15 132.72 34.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.623 0.725 . . . . 0.0 112.392 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -149.04 132.04 16.22 Favored 'General case' 0 N--CA 1.402 -2.855 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 169.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER -52.39 -42.85 64.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -72.88 -35.55 67.18 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.27 -45.49 91.24 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.2 t -56.53 -53.18 60.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.738 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HE3' ' O ' ' A' ' 32' ' ' CYS . 87.8 tttt -61.17 -43.28 99.14 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.373 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -61.08 -46.57 90.11 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.542 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 19' ' ' ALA . 84.3 t -67.75 -39.82 82.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.583 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.5 m -57.8 -37.93 74.62 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.39 -15.32 60.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -81.6 -37.16 28.06 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -77.95 -48.99 15.02 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.772 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -130.99 117.73 19.61 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -176.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -78.46 0.37 26.16 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.781 0.801 . . . . 0.0 110.861 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -96.71 -1.83 45.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.654 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.4 127.49 44.37 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.153 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.434 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 16.7 p -109.24 -20.52 12.93 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -121.52 136.31 54.96 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.097 -173.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.51 122.51 2.4 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -124.43 134.17 53.16 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.864 0.364 . . . . 0.0 110.894 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 81.7 m -72.65 133.82 44.82 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -126.43 110.64 13.54 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.265 0.555 . . . . 0.0 110.805 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.42 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 73.7 m-85 -78.35 108.6 11.81 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.286 175.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -118.46 97.46 5.77 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.05 -89.64 0.98 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.994 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -126.16 -17.72 5.18 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -103.62 123.05 46.26 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.42 ' HB ' ' CD1' ' A' ' 38' ' ' TYR . 9.9 p -100.07 122.49 52.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.452 0.644 . . . . 0.0 109.434 174.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -125.37 161.27 27.39 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.1 t -95.85 121.9 38.07 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -94.14 119.0 32.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.36 126.46 36.45 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.572 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -117.95 140.75 49.28 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.073 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.48 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -173.37 -149.57 6.97 Favored Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -140.66 122.03 14.97 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -99.94 153.47 19.15 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 . . . . . 0 C--N 1.28 -2.439 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.962 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.663 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -74.32 113.13 11.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.565 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 84.1 m -56.92 121.84 10.87 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 124.071 0.948 . . . . 0.0 112.661 -176.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -152.17 -33.77 0.13 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.81 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -75.21 123.75 25.83 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.853 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -63.55 119.66 10.24 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.679 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.402 HD11 ' HB1' ' A' ' 31' ' ' ALA . 91.9 mt -96.7 -55.69 2.82 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.6 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.491 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -164.77 -172.91 32.82 Favored Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.095 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -118.28 131.48 56.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -175.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.25 138.92 23.21 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.123 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.23 94.25 0.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.185 1.924 . . . . 0.0 110.37 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.9 t -116.24 102.22 13.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 122.157 -0.339 . . . . 0.0 110.735 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 47.2 t80 -145.28 135.55 11.93 Favored Pre-proline 0 N--CA 1.432 -1.332 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 36.3 Cg_endo -65.12 151.49 76.43 Favored 'Cis proline' 0 C--O 1.249 1.074 0 C-N-CA 123.821 -1.325 . . . . 0.0 112.015 -1.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -81.56 112.29 18.64 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -174.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -125.66 146.27 49.8 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -69.22 -39.97 78.24 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -58.14 -37.08 73.94 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.404 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.4 -57.28 4.99 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.624 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.9 m -54.0 -46.41 71.76 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -66.09 -22.02 66.39 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 120.682 0.277 . . . . 0.0 110.9 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -88.99 -55.13 3.81 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.4 t -56.97 -38.07 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 C-N-CA 124.265 1.026 . . . . 0.0 111.782 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 90.1 m -63.35 -28.79 70.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -78.78 -22.43 46.36 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.335 0.588 . . . . 0.0 109.465 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -80.65 -39.73 26.81 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.691 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -75.7 -47.05 27.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.786 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.491 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 53.5 m-85 -125.43 117.99 24.87 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -70.77 -14.53 62.46 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.145 0.498 . . . . 0.0 111.127 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -91.36 -1.68 57.55 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.834 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.402 ' HB1' HD11 ' A' ' 7' ' ' LEU . . . -100.01 141.64 32.56 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.5 p -137.33 -5.52 1.82 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.318 0.58 . . . . 0.0 110.865 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -131.04 130.03 42.75 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -148.98 137.04 6.1 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 120.328 -0.939 . . . . 0.0 110.966 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -150.46 145.36 25.98 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.685 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 34.2 m -78.93 152.0 31.36 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -132.57 107.49 8.47 Favored 'General case' 0 N--CA 1.422 -1.826 0 C-N-CA 125.418 1.487 . . . . 0.0 108.604 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -84.33 103.49 13.54 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.586 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -148.91 113.2 5.25 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.976 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.09 -155.06 21.35 Favored Glycine 0 C--N 1.299 -1.522 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.403 ' HD2' ' OE2' ' A' ' 42' ' ' GLU . 27.8 ttm180 -79.47 -37.76 36.1 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.403 ' OE2' ' HD2' ' A' ' 41' ' ' ARG . 55.4 mm-40 -92.53 154.19 18.6 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.359 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.52 130.56 52.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -106.84 116.16 31.45 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 53.2 t -93.6 120.83 34.35 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.439 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 24.7 m170 -85.44 117.84 24.6 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.778 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.8 m -97.49 116.56 29.93 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.712 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -105.35 143.59 33.31 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.56 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.565 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -161.89 -146.97 4.83 Favored Glycine 0 N--CA 1.427 -1.906 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -140.2 133.76 30.18 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -136.14 115.2 12.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 58.4 m80 . . . . . 0 C--N 1.287 -2.122 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.163 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.462 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -87.2 130.5 34.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.405 0.621 . . . . 0.0 110.946 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.2 m -100.72 82.55 2.44 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.032 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -120.85 -51.89 2.12 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.528 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.0 m80 -91.88 150.06 21.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -82.64 115.76 21.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.991 -1.913 . . . . 0.0 108.237 -178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.8 mt -78.62 -30.0 46.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.11 179.34 40.05 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -99.93 158.55 15.73 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.69 125.57 26.72 Favored Pre-proline 0 C--N 1.287 -2.138 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.51 95.42 1.0 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.834 2.356 . . . . 0.0 114.31 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 m -137.13 116.86 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.45 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 28.2 t80 -154.17 127.8 4.39 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 42.4 Cg_endo -65.72 131.96 14.82 Favored 'Cis proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.698 0.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.8 t -80.87 139.6 35.84 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.579 -1.192 . . . . 0.0 111.953 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -131.9 150.83 52.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.376 1.07 . . . . 0.0 109.167 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.35 -50.81 70.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -64.61 -41.27 96.32 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.885 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.63 93.89 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 123.833 0.708 . . . . 0.0 110.096 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -59.01 -55.12 39.18 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.382 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.19 -24.02 65.82 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.305 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -68.78 -60.73 2.19 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.0 p -59.68 -35.55 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 123.858 0.724 . . . . 0.0 111.761 -175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.0 m -58.42 -45.51 88.31 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -82.3 -9.97 59.28 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.9 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -85.46 -42.05 14.83 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.62 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -80.89 -44.85 17.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.218 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -117.06 108.3 15.57 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -74.75 -10.07 59.16 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.415 0.626 . . . . 0.0 111.369 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -93.47 -2.33 54.6 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.106 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.5 140.8 35.71 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.136 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.5 p -115.41 -31.69 5.84 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.919 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -127.53 161.34 29.01 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 120.92 0.39 . . . . 0.0 110.679 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.62 110.95 0.5 Allowed Glycine 0 N--CA 1.42 -2.383 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -125.1 143.01 51.14 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.525 ' SG ' HG22 ' A' ' 43' ' ' VAL . 11.4 t -88.58 126.96 35.52 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.207 -174.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -139.37 161.26 37.89 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -71.34 124.64 25.01 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.058 0.456 . . . . 0.0 109.987 177.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -122.72 89.4 3.1 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.78 -106.74 2.39 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -103.49 -45.6 4.8 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.12 158.19 34.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.286 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.525 HG22 ' SG ' ' A' ' 36' ' ' CYS . 11.1 p -103.48 122.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.41 160.78 29.51 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.542 0.686 . . . . 0.0 112.217 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.68 126.5 32.94 Favored 'General case' 0 C--N 1.274 -2.683 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.508 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -110.94 125.97 54.24 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.307 0.575 . . . . 0.0 110.305 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.3 m -95.99 118.43 32.6 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.007 -175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -103.07 139.96 37.92 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -175.03 -163.79 28.7 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.096 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.76 114.27 18.55 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -86.57 140.27 30.03 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -174.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 . . . . . 0 C--N 1.292 -1.92 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.627 -179.756 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.43 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -120.0 121.66 39.42 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.1 m -135.99 132.51 36.41 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -117.42 -16.47 10.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -83.26 129.5 35.01 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.95 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -79.58 130.58 35.51 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.921 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.429 ' CD2' ' HB2' ' A' ' 51' ' ' TYR . 82.3 mt -94.93 -44.24 7.81 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.357 0.599 . . . . 0.0 109.997 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.02 -174.42 47.06 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -123.99 164.36 19.51 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.919 0.36 . . . . 0.0 110.681 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.63 140.59 30.47 Favored Pre-proline 0 C--N 1.308 -1.213 0 O-C-N 123.807 0.692 . . . . 0.0 109.706 177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.05 109.08 1.21 Allowed 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 123.027 2.485 . . . . 0.0 112.969 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 m -141.8 125.05 15.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 122.843 0.457 . . . . 0.0 110.399 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -156.4 130.73 4.95 Favored Pre-proline 0 C--N 1.308 -1.22 0 O-C-N 122.024 -0.423 . . . . 0.0 109.964 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.55 148.26 83.32 Favored 'Cis proline' 0 C--O 1.245 0.826 0 C-N-CA 123.601 -1.416 . . . . 0.0 111.024 -4.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -89.41 132.49 34.97 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.304 0.573 . . . . 0.0 111.801 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.575 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 3.0 mppt? -110.47 131.39 55.09 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 171.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.574 ' OE1' ' HG2' ' A' ' 18' ' ' LYS 0.302 0.0 OUTLIER -57.8 -43.98 86.0 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -177.954 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.574 ' HG2' ' OE1' ' A' ' 17' ' ' GLU . 47.5 mmtm -61.0 -41.72 97.04 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.734 0.302 . . . . 0.0 110.424 174.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.418 ' O ' HG21 ' A' ' 23' ' ' VAL . . . -63.58 -47.84 79.83 Favored 'General case' 0 C--O 1.201 -1.469 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.465 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.8 t -55.56 -46.35 77.18 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.629 0.771 . . . . 0.0 109.685 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.4 -40.19 95.69 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.131 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -67.12 -47.14 72.04 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 19' ' ' ALA . 83.3 t -58.47 -42.33 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 122.841 0.456 . . . . 0.0 109.972 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.8 m -59.65 -46.38 89.21 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.472 173.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.25 -23.15 67.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.467 0.544 . . . . 0.0 112.467 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -94.63 -32.68 13.3 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -84.98 -51.96 6.32 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.046 -0.409 . . . . 0.0 111.031 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -118.39 102.16 8.72 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -75.31 -4.18 37.69 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -93.08 -4.74 51.84 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.11 144.09 31.94 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.775 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.7 p -119.08 -20.64 7.97 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.155 0.503 . . . . 0.0 109.705 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -138.85 164.0 30.8 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.98 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.05 133.65 4.11 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -143.42 131.69 22.02 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 89.8 m -85.05 114.29 22.1 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.016 0.436 . . . . 0.0 109.828 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.43 154.04 27.64 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.98 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -84.7 99.56 10.91 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.342 0.592 . . . . 0.0 112.125 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -149.28 102.72 3.24 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.54 -152.25 16.85 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -88.17 -45.26 10.26 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.168 0.509 . . . . 0.0 109.818 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -110.25 158.14 18.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.97 127.38 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.509 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 13.4 m170 -106.53 141.18 38.25 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.622 -0.674 . . . . 0.0 112.173 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.8 t -79.27 109.16 13.35 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.719 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -94.26 123.12 37.46 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 66.3 m -94.84 121.78 36.79 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.917 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -102.2 131.46 48.72 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -153.28 179.94 29.26 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 119.297 -1.43 . . . . 0.0 113.259 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.65 107.65 19.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.429 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 72.1 t80 -120.92 136.13 55.02 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.381 -175.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 39.3 m80 . . . . . 0 C--N 1.31 -1.147 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.362 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.655 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -87.45 120.57 28.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.9 m -92.25 120.94 33.29 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.82 -175.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -114.19 -30.72 6.55 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 71.6 m80 -69.77 118.63 12.86 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.567 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -73.43 114.15 11.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.7 mt -92.84 -38.94 11.47 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.15 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.74 175.38 44.02 Favored Glycine 0 N--CA 1.423 -2.19 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -107.79 163.02 13.46 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 117.955 0.877 . . . . 0.0 108.979 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -131.8 144.46 53.36 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.63 113.06 2.78 Favored 'Trans proline' 0 C--O 1.249 1.06 0 C-N-CA 122.3 2.0 . . . . 0.0 111.428 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.1 t -137.52 123.37 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -150.24 127.57 5.54 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -69.01 134.45 28.1 Favored 'Cis proline' 0 C--N 1.356 0.952 0 C-N-CA 123.545 -1.44 . . . . 0.0 111.445 -1.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 9.0 t -79.11 103.13 8.84 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.308 -172.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.485 ' HG3' ' OE2' ' A' ' 17' ' ' GLU . 21.8 tptp -111.24 152.79 26.73 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.485 ' OE2' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -67.2 -39.54 86.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.488 0.585 . . . . 0.0 111.068 -178.078 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.81 -34.36 77.64 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.833 0.349 . . . . 0.0 110.392 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.37 83.08 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.3 m -60.99 -40.34 93.14 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -64.84 -17.69 64.48 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.254 0.549 . . . . 0.0 110.668 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -90.47 -56.18 3.3 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' A' ' 26' ' ' GLU . 66.0 t -62.04 -36.14 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 123.414 0.686 . . . . 0.0 112.67 -175.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 91.6 m -66.78 -27.31 67.48 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.842 -0.536 . . . . 0.0 112.299 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.93 -17.81 36.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.655 0.741 . . . . 0.0 109.73 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 9.0 tp10 -77.07 -45.2 27.9 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.447 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -81.44 -44.08 17.99 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.776 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -118.39 148.56 42.4 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -173.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -92.66 -21.63 19.91 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -99.99 -5.09 28.71 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.779 0.323 . . . . 0.0 111.328 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.78 123.46 26.73 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.023 0.439 . . . . 0.0 110.005 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.593 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 2.3 p -116.7 -9.47 11.29 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.473 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -144.4 152.88 41.3 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.68 130.39 2.94 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 177.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -134.38 146.32 49.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 117.231 0.515 . . . . 0.0 110.589 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.2 m -90.29 114.43 26.47 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -120.17 147.58 44.73 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.428 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 88.0 m-85 -93.28 143.51 26.19 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.047 0.451 . . . . 0.0 111.494 -173.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -131.56 89.51 2.72 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.12 -72.4 2.49 Favored Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.796 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -123.91 -59.71 1.49 Allowed 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.439 -0.448 . . . . 0.0 110.294 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -81.74 158.41 24.2 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.368 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.428 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 10.7 p -103.11 135.41 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.673 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -120.95 139.36 53.37 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.154 0.502 . . . . 0.0 109.924 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 41.3 t -88.42 114.69 25.3 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.988 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -102.77 126.11 49.77 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.129 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.3 m -94.77 126.7 40.26 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.397 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 71.7 m-85 -115.58 145.99 42.17 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.593 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -170.56 -147.81 5.72 Favored Glycine 0 C--N 1.287 -2.186 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -108.57 136.18 48.59 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -97.1 109.95 22.6 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 . . . . . 0 C--N 1.284 -2.24 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -178.759 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.495 0 CA-C-O 120.46 0.171 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -120.94 127.34 51.73 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 121.059 0.457 . . . . 0.0 110.246 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.5 m -85.64 86.28 7.37 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -123.97 -21.35 5.12 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.994 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -74.23 118.15 16.85 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.374 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -67.35 111.15 3.87 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.76 -42.05 18.44 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.581 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.92 -170.91 44.04 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -110.92 119.29 38.57 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 124.07 0.512 . . . . 0.0 109.809 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.1 127.28 26.99 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.31 110.99 3.21 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.25 1.967 . . . . 0.0 111.283 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.7 t -119.73 123.44 70.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -142.88 133.78 12.58 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.25 168.54 76.96 Favored 'Cis proline' 0 C--O 1.241 0.64 0 C-N-CA 123.705 -1.373 . . . . 0.0 112.154 -0.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -80.23 114.52 19.2 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.768 0.794 . . . . 0.0 111.237 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -144.05 138.93 28.67 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 174.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.44 -44.79 95.44 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.465 0.478 . . . . 0.0 110.332 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.88 -42.68 99.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.732 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.48 -49.4 69.2 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.097 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -55.6 -53.61 54.31 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 124.113 0.965 . . . . 0.0 110.55 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -63.49 -29.5 70.76 Favored 'General case' 0 CA--C 1.554 1.135 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.705 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -79.86 -45.47 18.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.548 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.21 -31.42 53.8 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 CA-C-O 121.242 0.544 . . . . 0.0 109.845 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.0 m -58.6 -29.0 66.12 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.694 173.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -85.4 -10.78 55.79 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -87.57 -30.86 20.22 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -86.32 -44.27 12.23 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.011 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.69 161.05 25.88 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -98.07 -40.03 8.63 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.633 0.254 . . . . 0.0 111.306 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -76.57 -2.58 33.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.74 112.48 7.88 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.14 0.495 . . . . 0.0 110.894 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.2 p -116.09 -1.55 12.43 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.261 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -155.71 150.25 26.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.57 129.68 2.66 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -122.59 142.17 50.92 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.637 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 85.3 m -71.06 116.01 10.86 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 123.686 0.616 . . . . 0.0 109.824 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.536 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 7.6 mm-40 -104.14 105.44 15.6 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -86.08 123.65 31.62 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.407 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -141.81 89.52 2.2 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.15 -115.34 6.04 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.115 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -82.66 -52.29 6.94 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 122.498 0.319 . . . . 0.0 111.537 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -89.0 114.73 25.94 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.63 123.62 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -120.25 152.92 37.07 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 36.4 m -96.17 119.58 34.9 Favored 'General case' 0 C--N 1.267 -2.997 0 CA-C-O 120.817 0.341 . . . . 0.0 110.998 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.536 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 15.3 m170 -83.54 110.84 18.55 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 170.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -84.82 122.36 29.04 Favored 'General case' 0 N--CA 1.412 -2.343 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.462 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.1 133.07 43.9 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.134 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -130.76 178.07 17.94 Favored Glycine 0 N--CA 1.413 -2.843 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.401 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -131.77 142.46 49.77 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 123.138 0.575 . . . . 0.0 109.725 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -128.47 109.25 11.23 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 . . . . . 0 C--N 1.301 -1.523 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.266 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 120.744 0.307 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -112.25 136.79 51.25 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.0 0.428 . . . . 0.0 110.845 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.1 m -95.24 27.59 3.21 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.963 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -106.02 -0.19 25.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.423 0.63 . . . . 0.0 110.025 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 35.5 t60 -108.18 125.91 52.18 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.936 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -81.15 119.75 23.98 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.337 0.655 . . . . 0.0 110.162 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.4 mt -94.88 -50.58 5.06 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.288 0.566 . . . . 0.0 110.395 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 28' ' ' TYR . . . -165.07 -170.58 30.21 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.264 -176.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -131.97 144.73 51.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -128.04 138.58 33.26 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.7 111.82 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.257 1.972 . . . . 0.0 110.948 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.73 120.55 52.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 122.116 -0.365 . . . . 0.0 110.643 -177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.464 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 61.0 t80 -158.4 120.07 1.95 Allowed Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.464 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 50.0 Cg_endo -65.71 150.61 77.8 Favored 'Cis proline' 0 C--N 1.356 0.968 0 C-N-CA 124.133 -1.195 . . . . 0.0 113.17 3.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.5 t -115.01 124.38 51.48 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.61 -174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -138.75 168.36 19.96 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -58.52 -57.11 14.38 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.815 0.697 . . . . 0.0 112.74 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.65 -37.31 85.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.431 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -51.86 63.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.273 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.3 t -61.87 -45.66 92.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.138 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.449 ' HG3' ' HA ' ' A' ' 33' ' ' LYS . 38.7 ttpt -64.78 -37.53 87.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -65.96 -57.59 7.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.435 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.6 m -62.77 -33.19 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.081 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.3 m -61.05 -33.67 73.67 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.483 ' HZ3' ' HB3' ' A' ' 25' ' ' LYS . 9.5 mtpm? -85.43 -9.43 57.53 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.817 0.342 . . . . 0.0 111.231 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.67 -37.71 10.69 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.582 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -72.24 -43.98 63.57 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.423 ' CZ ' ' HA3' ' A' ' 8' ' ' GLY . 46.6 m-85 -124.65 99.52 6.21 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -68.03 -2.95 8.65 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.316 0.579 . . . . 0.0 112.322 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.438 ' HB3' ' H ' ' A' ' 52' ' ' HIS . 56.0 m-70 -97.82 -9.09 27.06 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.585 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.11 162.41 26.68 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.342 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.8 p -119.6 -41.88 2.67 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.901 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.449 ' HA ' ' HG3' ' A' ' 21' ' ' LYS . 57.5 tttm -142.71 149.34 38.68 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.676 -176.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -116.69 165.02 12.29 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 174.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -151.47 130.69 12.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 118.03 0.915 . . . . 0.0 110.261 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.51 103.55 16.23 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.185 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -125.68 138.25 53.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.292 -172.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.549 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 88.8 m-85 -85.32 103.56 14.36 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 172.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -126.93 118.56 24.78 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.888 -172.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.51 -72.15 2.69 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -130.04 -67.4 0.75 Allowed 'General case' 0 C--N 1.311 -1.071 0 O-C-N 122.71 -0.288 . . . . 0.0 110.25 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -108.36 -172.52 2.08 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.191 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.549 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 7.3 p -88.35 140.18 16.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.545 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -129.28 146.87 51.1 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 39.3 t -95.33 102.27 14.06 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -85.96 130.23 34.6 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.4 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.0 m -100.54 123.68 45.07 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 123.388 0.43 . . . . 0.0 110.158 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 70.5 m-85 -114.03 151.87 31.82 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 122.551 0.341 . . . . 0.0 111.243 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.8 -150.95 22.62 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -139.55 156.45 46.89 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -81.49 109.08 15.62 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 172.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.438 ' H ' ' HB3' ' A' ' 30' ' ' HIS . 70.5 m80 . . . . . 0 C--N 1.295 -1.762 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.693 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.61 0.243 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -101.08 132.13 46.67 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 60.0 m -73.41 93.7 1.98 Allowed 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -116.63 -17.82 10.47 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.949 -167.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -76.43 114.74 15.47 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.393 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.33 118.56 10.86 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.893 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.5 mt -92.88 -57.6 2.6 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.844 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.483 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -163.24 -168.59 25.44 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.647 -176.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -124.33 125.0 43.61 Favored 'General case' 0 C--O 1.249 1.043 0 C-N-CA 123.636 0.774 . . . . 0.0 110.521 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -107.86 148.61 37.73 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.808 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -86.82 113.06 1.02 Allowed 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 121.955 1.77 . . . . 0.0 110.695 174.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 47.8 t -139.75 113.54 6.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -177.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -144.35 128.26 8.98 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.92 143.87 78.32 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 123.914 -1.286 . . . . 0.0 110.391 -2.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 16.2 t -96.15 134.76 38.84 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.225 -174.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -136.02 156.65 48.42 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -48.38 -51.14 27.91 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.492 1.117 . . . . 0.0 112.053 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -76.5 -35.65 58.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.005 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.43 92.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.565 0.221 . . . . 0.0 110.434 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.3 t -61.65 -47.33 85.85 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -55.11 -46.98 75.61 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.674 0.789 . . . . 0.0 110.493 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.8 t -67.62 -46.33 72.82 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.828 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.83 -31.41 41.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.172 0 CA-C-O 121.422 0.63 . . . . 0.0 110.715 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 60.2 m -60.16 -28.09 67.63 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.557 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -80.83 -15.07 57.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 0.0 111.371 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -85.53 -33.38 21.79 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -87.51 -43.17 12.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.939 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.483 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 87.6 m-85 -120.61 140.99 50.75 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.091 0.472 . . . . 0.0 110.645 -175.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -85.03 -27.56 26.3 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -91.42 6.92 43.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.39 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.33 159.92 29.19 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.531 0.681 . . . . 0.0 111.222 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.0 t -143.95 -48.45 0.28 Allowed 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.617 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -125.72 153.42 43.94 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -140.87 131.2 4.83 Favored Glycine 0 N--CA 1.423 -2.219 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -119.37 144.22 47.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 120.959 0.409 . . . . 0.0 110.972 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 59.8 m -100.26 117.48 34.56 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.502 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -113.81 105.73 13.62 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 120.926 0.393 . . . . 0.0 111.096 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.502 ' CD2' ' HB ' ' A' ' 43' ' ' VAL . 88.6 m-85 -81.32 99.67 8.78 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -118.81 105.3 11.39 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.84 -123.68 6.72 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.0 mtm180 -89.26 -32.83 17.2 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -96.44 165.23 12.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.322 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.502 ' HB ' ' CD2' ' A' ' 38' ' ' TYR . 7.4 p -124.12 130.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.43 -0.805 . . . . 0.0 108.926 174.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -101.54 117.26 34.55 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 37.2 t -88.19 104.15 16.44 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.536 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 66.7 m170 -83.68 110.95 18.7 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.053 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 65.4 m -88.77 112.67 23.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.143 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -102.82 148.36 25.73 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.96 -148.66 6.8 Favored Glycine 0 C--N 1.294 -1.752 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -139.19 145.41 39.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -125.56 165.62 18.17 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.446 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 . . . . . 0 C--N 1.289 -2.055 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.638 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.532 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.473 ' HB2' ' CE1' ' A' ' 5' ' ' HIS . 12.5 m170 -99.31 110.92 23.38 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 91.9 m -79.69 47.98 0.9 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.502 0.668 . . . . 0.0 110.943 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.34 -2.54 2.48 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.692 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.525 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 55.3 m80 -81.08 126.12 31.05 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -73.04 102.83 3.62 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.864 0.728 . . . . 0.0 109.993 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.8 mt -81.07 -35.14 32.14 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.079 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.29 -174.06 41.8 Favored Glycine 0 N--CA 1.427 -1.943 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -124.97 143.64 50.78 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 117.287 0.543 . . . . 0.0 110.855 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.61 142.07 33.47 Favored Pre-proline 0 C--N 1.297 -1.686 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.601 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.83 106.43 2.09 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.405 2.07 . . . . 0.0 111.438 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.4 t -128.02 103.73 10.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 O-C-N 121.859 -0.526 . . . . 0.0 109.866 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -142.35 132.21 12.34 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -74.65 167.86 78.88 Favored 'Cis proline' 0 C--O 1.237 0.474 0 C-N-CA 123.744 -1.357 . . . . 0.0 111.434 -2.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 t -83.67 131.65 34.93 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 122.018 0.913 . . . . 0.0 112.86 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -137.62 125.77 23.01 Favored 'General case' 0 N--CA 1.387 -3.622 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 170.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -41.41 70.0 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -176.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.74 -41.04 84.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.576 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.81 -47.01 82.55 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.038 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.5 t -54.96 -50.55 68.63 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.359 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.72 -41.23 99.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.164 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 27.4 t -61.78 -55.51 29.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.427 ' O ' ' HD2' ' A' ' 27' ' ' HIS . 98.2 t -55.35 -43.89 73.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 123.684 0.615 . . . . 0.0 110.511 -177.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.1 m -58.06 -42.21 84.99 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.845 0.684 . . . . 0.0 112.845 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 54.9 mtpt -75.34 -23.96 57.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.279 0.562 . . . . 0.0 111.431 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 22' ' ' SER . 45.1 mt-10 -77.89 -33.46 51.96 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.957 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.427 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 44.4 m-70 -85.27 -44.86 12.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.152 0.501 . . . . 0.0 110.285 175.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -116.7 107.16 14.33 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -64.62 -19.74 65.86 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -89.96 0.93 56.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 25' ' ' LYS . . . -78.07 138.14 38.61 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.095 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.5 p -134.82 1.0 3.0 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.722 0.772 . . . . 0.0 110.454 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 59.2 tptt -148.94 142.42 25.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.19 126.63 2.07 Favored Glycine 0 CA--C 1.481 -2.08 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.85 140.08 52.62 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.621 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 59.6 m -76.14 102.31 5.7 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.402 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 5.9 mm-40 -94.61 110.69 22.49 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.458 0.647 . . . . 0.0 109.762 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -77.61 103.93 7.84 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.839 -174.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -127.05 99.38 5.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.53 -149.72 21.34 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -175.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -95.95 -50.59 4.81 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.014 0.435 . . . . 0.0 110.603 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -78.64 103.08 8.34 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.6 0.714 . . . . 0.0 109.797 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.8 p -76.21 150.0 6.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.621 -175.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -123.51 151.52 42.72 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 39.3 m -96.87 126.29 41.91 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-O 120.72 0.295 . . . . 0.0 110.492 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.402 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 46.7 m170 -90.61 117.99 29.71 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.9 m -92.5 123.1 35.56 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.912 -174.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 67.3 m-85 -117.73 141.98 47.78 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.215 -177.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 5' ' ' HIS . . . -170.6 -168.68 32.73 Favored Glycine 0 C--N 1.289 -2.083 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -119.92 108.85 14.84 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -100.88 117.26 34.6 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 C--N 1.292 -1.917 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 179.848 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.605 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -105.88 144.79 32.12 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.3 m -113.34 97.61 6.58 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -144.53 -34.95 0.35 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.8 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -75.13 120.55 20.79 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -65.19 119.97 11.86 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.1 mt -94.15 -43.47 8.46 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.105 0.479 . . . . 0.0 110.043 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.417 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -177.53 -160.47 24.28 Favored Glycine 0 N--CA 1.419 -2.45 0 C-N-CA 119.49 -1.338 . . . . 0.0 112.98 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -131.69 131.22 42.92 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 123.677 0.791 . . . . 0.0 110.29 -171.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.56 143.96 44.82 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -89.09 111.1 0.53 Allowed 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 122.714 2.276 . . . . 0.0 112.558 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.4 t -132.12 104.05 7.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -138.21 124.01 12.62 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -74.58 147.45 89.42 Favored 'Cis proline' 0 C--N 1.347 0.466 0 C-N-CA 123.66 -1.392 . . . . 0.0 110.818 -2.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.5 t -91.23 142.17 28.01 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.367 0.603 . . . . 0.0 111.748 -174.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -137.03 152.77 50.48 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 172.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.25 -47.29 85.02 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.14 -40.44 86.74 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.076 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.11 -46.8 89.14 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.929 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t -59.3 -48.59 81.07 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 123.622 0.769 . . . . 0.0 109.712 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -55.77 -46.04 78.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.812 0.845 . . . . 0.0 110.182 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.3 t -64.66 -45.76 85.37 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.626 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.51 -38.6 83.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 CA-C-O 121.048 0.451 . . . . 0.0 110.322 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 83.2 m -58.92 -38.9 80.0 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.24 175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -64.04 -37.58 87.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.908 0.385 . . . . 0.0 110.621 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.28 -47.57 79.02 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.838 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -81.94 -39.48 23.66 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.417 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 63.1 m-85 -127.5 112.93 15.49 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -60.2 -37.33 79.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.872 0.367 . . . . 0.0 111.81 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -89.3 6.76 38.96 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.3 140.8 35.99 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.3 p -123.96 -28.75 3.73 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 121.013 0.435 . . . . 0.0 111.426 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -140.65 147.88 39.98 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.13 150.75 20.78 Favored Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -121.58 144.15 48.9 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 123.844 0.379 . . . . 0.0 110.197 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.5 m -84.83 102.1 12.8 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.473 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 8.4 mm-40 -92.14 109.38 20.74 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.135 0.493 . . . . 0.0 110.387 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -86.97 101.34 13.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.667 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -144.73 110.01 5.18 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.43 -159.48 28.47 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -88.93 -20.73 24.14 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.374 0.587 . . . . 0.0 110.692 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -91.94 146.39 23.78 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.11 124.4 67.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -98.3 123.75 42.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.927 -172.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 m -87.69 114.36 24.23 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.01 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.473 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 42.0 m170 -94.36 120.42 34.57 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 174.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.5 m -94.94 128.89 42.08 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.297 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -108.35 141.67 39.82 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.7 175.64 46.92 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 119.663 -1.256 . . . . 0.0 112.772 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -126.39 116.08 20.63 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.732 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -74.55 112.77 11.06 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.22 0.533 . . . . 0.0 111.452 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 . . . . . 0 C--N 1.294 -1.841 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.151 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.662 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -84.84 104.41 14.77 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.775 0.798 . . . . 0.0 110.832 178.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 88.1 m -113.5 96.94 6.15 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.013 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -117.83 -22.92 7.74 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.026 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 52.3 m80 -89.03 134.82 33.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.874 -176.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -66.58 131.14 45.36 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.855 0.36 . . . . 0.0 110.377 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.425 HD13 ' HB3' ' A' ' 31' ' ' ALA . 25.2 mt -103.04 -19.26 14.63 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.997 0.903 . . . . 0.0 108.849 175.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.07 -174.63 30.29 Favored Glycine 0 N--CA 1.409 -3.152 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -177.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -123.0 158.97 29.35 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.03 132.29 24.25 Favored Pre-proline 0 C--N 1.298 -1.633 0 O-C-N 123.318 0.386 . . . . 0.0 110.401 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HA ' ' NE2' ' A' ' 44' ' ' HIS . 58.8 Cg_endo -76.07 102.05 1.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.502 2.134 . . . . 0.0 112.752 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 m -143.95 140.75 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 123.357 0.663 . . . . 0.0 109.815 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.433 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 68.8 t80 -160.07 128.46 2.94 Favored Pre-proline 0 C--N 1.314 -0.96 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 8.9 Cg_exo -68.56 145.3 76.31 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 124.048 -1.23 . . . . 0.0 112.097 3.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.1 t -99.55 106.45 18.44 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -115.27 151.26 34.85 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.11 -41.55 68.42 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 124.049 0.843 . . . . 0.0 113.237 -175.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.6 -45.54 75.16 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.459 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.09 75.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.34 -51.12 69.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.878 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.27 -39.1 81.82 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.424 0.69 . . . . 0.0 111.149 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -70.12 -49.35 51.63 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.69 -40.9 80.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 123.39 0.676 . . . . 0.0 110.996 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 67.5 m -59.44 -44.07 92.99 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -72.61 -24.2 61.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.066 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -75.3 -47.72 26.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.397 177.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -79.99 -35.33 37.58 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.953 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -126.21 112.27 15.57 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -74.78 -18.21 60.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -92.17 8.81 36.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.098 0.475 . . . . 0.0 110.912 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.425 ' HB3' HD13 ' A' ' 7' ' ' LEU . . . -96.49 139.48 32.52 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.3 p -124.43 -20.07 5.28 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.103 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.58 134.78 35.99 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.55 -176.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.05 148.71 16.84 Favored Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.24 138.9 33.59 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.1 m -87.91 122.11 31.14 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -128.73 143.23 50.88 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.12 100.81 10.76 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -115.8 100.49 8.05 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 -102.57 2.55 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.06 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -98.09 -55.61 2.73 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.173 0.511 . . . . 0.0 110.245 -177.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -99.53 167.36 10.65 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.404 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.3 p -99.17 135.94 32.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.516 ' NE2' ' HA ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -138.09 160.26 39.86 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.807 -178.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.6 t -85.97 114.79 23.14 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.276 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -102.61 125.72 49.44 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 68.4 m -95.59 127.06 41.31 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.854 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 80.6 m-85 -112.06 147.97 34.89 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.326 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.62 -141.57 6.3 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -113.64 127.24 55.98 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -108.88 146.69 33.32 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.813 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 . . . . . 0 C--N 1.29 -2.001 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.42 176.559 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.574 0 CA-C-O 121.262 0.553 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -93.13 141.9 27.9 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.527 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 58.6 m -119.42 70.59 0.85 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -121.3 -43.23 2.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.912 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -83.9 135.6 34.43 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.084 -177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -85.99 116.41 24.19 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.9 mt -74.86 -33.47 62.12 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.609 0.718 . . . . 0.0 109.125 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.63 -178.3 37.57 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.94 143.13 38.59 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.08 132.9 24.25 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.15 140.97 18.15 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.503 2.135 . . . . 0.0 111.36 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.402 HG11 ' SG ' ' A' ' 45' ' ' CYS . 13.8 p -141.8 143.68 26.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 120.73 0.3 . . . . 0.0 110.688 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 84.3 t80 -148.43 123.34 5.0 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 2.0 Cg_endo -84.98 163.88 61.92 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.822 -1.324 . . . . 0.0 110.939 -2.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.21 92.36 3.83 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.1 0.952 . . . . 0.0 112.78 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -117.77 141.92 47.86 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 168.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.08 -43.22 91.8 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 118.218 0.463 . . . . 0.0 111.63 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.65 -48.69 80.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.234 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.43 -42.36 92.52 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.034 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.7 t -56.44 -54.76 41.92 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 124.115 0.966 . . . . 0.0 110.983 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -59.44 -38.24 80.18 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 121.168 0.508 . . . . 0.0 110.098 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.567 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 49.1 m -66.78 -54.62 20.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.592 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.6 t -60.65 -37.46 75.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-O 121.241 0.543 . . . . 0.0 110.457 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.8 t -56.19 -46.28 79.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.009 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 60.6 mtpt -72.82 -19.78 61.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.627 0.371 . . . . 0.0 111.689 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 22' ' ' SER . 24.6 mm-40 -74.92 -42.51 57.59 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -75.83 -45.54 35.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.246 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 54.3 m-85 -123.51 104.97 9.39 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -65.63 -24.15 66.98 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -175.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -84.02 0.03 49.8 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.28 123.86 23.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.427 0.632 . . . . 0.0 111.531 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.0 p -101.61 -29.09 12.14 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.999 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -136.37 128.84 30.34 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.847 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -133.89 118.45 2.06 Favored Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -135.13 140.44 45.44 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.056 -0.658 . . . . 0.0 112.735 -177.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.7 m -63.1 120.38 11.35 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.991 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -118.14 114.22 22.75 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -77.72 102.48 7.15 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -126.55 97.06 4.88 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.95 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.56 -112.97 3.77 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.319 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -83.38 -46.11 12.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.205 0.526 . . . . 0.0 111.816 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -97.88 170.73 8.75 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.936 0.874 . . . . 0.0 112.481 -172.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.1 113.77 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -125.35 157.95 35.47 Favored 'General case' 0 C--N 1.277 -2.587 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.402 ' SG ' HG11 ' A' ' 12' ' ' VAL . 65.6 m -80.88 111.1 17.04 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -80.4 124.41 28.87 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 92.4 m -97.91 112.63 24.48 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.326 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -95.3 133.44 39.2 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 176.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.51 155.33 26.13 Favored Glycine 0 C--N 1.287 -2.159 0 C-N-CA 117.506 -2.283 . . . . 0.0 114.436 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -101.65 118.41 36.88 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -137.7 140.65 40.87 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.513 -174.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 . . . . . 0 C--N 1.296 -1.736 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 171.984 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.03 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.443 ' CD2' ' HB2' ' A' ' 4' ' ' ASP . 15.2 p-80 -87.7 172.9 9.35 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 123.326 0.391 . . . . 0.0 110.064 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.505 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 96.3 m -85.0 94.93 8.93 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.198 0.523 . . . . 0.0 110.987 178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.443 ' HB2' ' CD2' ' A' ' 2' ' ' HIS . 29.9 t70 -119.43 -35.76 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.445 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -74.49 131.91 41.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.413 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.15 111.58 10.53 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.2 mt -79.26 -30.61 43.17 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-O 121.392 0.615 . . . . 0.0 109.551 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.407 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . 163.02 -154.22 25.08 Favored Glycine 0 N--CA 1.404 -3.462 0 C-N-CA 120.502 -0.856 . . . . 0.0 110.997 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -128.65 158.19 39.23 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.94 139.96 31.94 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.863 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.17 114.2 2.49 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.36 2.04 . . . . 0.0 112.594 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 p -155.13 114.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -159.19 127.33 2.86 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.694 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.05 154.68 80.83 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.689 -1.379 . . . . 0.0 111.661 -3.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 51.3 t -117.41 137.59 52.39 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -103.04 157.13 17.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.16 -41.73 97.3 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.709 0.766 . . . . 0.0 110.562 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -75.1 -25.74 58.76 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.518 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.41 ' HA ' ' OG ' ' A' ' 22' ' ' SER . . . -76.51 -36.69 57.62 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.038 -178.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.452 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.5 t -64.9 -36.5 84.56 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -60.98 -47.77 84.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.849 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 19' ' ' ALA . 5.9 p -70.74 -43.48 68.75 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.288 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 88.1 t -63.54 -46.24 95.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.7 m -59.01 -38.05 78.31 Favored 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -64.02 -33.27 75.37 Favored 'General case' 0 N--CA 1.425 -1.685 0 C-N-CA 123.076 0.55 . . . . 0.0 111.14 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.83 -19.77 30.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -89.19 -38.1 14.52 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.748 -0.595 . . . . 0.0 111.066 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.407 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 57.4 m-85 -133.94 110.8 9.95 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -71.77 -8.29 53.34 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.699 0.762 . . . . 0.0 110.769 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -86.64 -6.23 58.92 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.306 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.38 132.16 39.3 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.766 -177.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 p -112.02 -21.25 11.63 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -132.73 141.45 48.56 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.792 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.87 147.23 18.98 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -138.52 119.49 14.36 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 118.371 1.085 . . . . 0.0 110.188 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 25.8 m -82.27 109.14 16.27 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.263 176.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -125.38 148.11 48.91 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.084 -177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 81.7 m-85 -73.9 103.0 4.26 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.647 0.736 . . . . 0.0 110.799 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -94.93 89.86 5.78 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.99 -98.69 2.45 Favored Glycine 0 N--CA 1.423 -2.179 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -176.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -108.15 -52.63 2.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.021 0.439 . . . . 0.0 110.414 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.95 170.73 9.22 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.343 -173.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 7.3 p -89.48 132.84 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-O 121.304 0.573 . . . . 0.0 110.312 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 11.6 m-70 -120.83 137.17 54.68 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.8 t -88.04 105.31 17.39 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -89.67 118.58 29.38 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.3 m -91.28 124.01 35.15 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.015 -176.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -108.01 138.81 43.61 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.505 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -167.87 -155.8 9.63 Favored Glycine 0 C--N 1.297 -1.611 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -120.19 133.26 55.53 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -140.8 134.05 29.62 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 . . . . . 0 C--N 1.303 -1.416 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.993 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.462 0.172 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -111.65 -178.4 3.43 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 74.3 m -68.6 38.02 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -101.79 -24.03 14.11 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -76.66 139.66 40.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.516 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.63 130.28 41.16 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.736 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.4 mt -89.69 -23.73 21.77 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.645 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.59 -179.92 25.04 Favored Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 12.0 pt-20 -105.9 146.34 30.09 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.29 138.98 32.7 Favored Pre-proline 0 C--N 1.302 -1.466 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.74 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.76 131.46 13.46 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.641 2.227 . . . . 0.0 112.019 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -160.63 134.01 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 122.558 0.343 . . . . 0.0 110.386 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.471 ' CG ' ' HA ' ' A' ' 14' ' ' PRO . 33.8 t80 -155.7 140.9 12.37 Favored Pre-proline 0 N--CA 1.435 -1.191 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.471 ' HA ' ' CG ' ' A' ' 13' ' ' TYR . 4.5 Cg_exo -76.12 168.36 77.5 Favored 'Cis proline' 0 C--O 1.25 1.124 0 C-N-CA 123.867 -1.305 . . . . 0.0 111.948 -0.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -78.85 114.1 17.5 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.851 0.834 . . . . 0.0 110.858 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -138.32 136.59 36.56 Favored 'General case' 0 N--CA 1.394 -3.252 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.51 -47.39 82.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 124.065 0.853 . . . . 0.0 110.085 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -64.68 -38.22 90.24 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.386 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.72 -43.42 72.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.6 t -59.08 -51.62 69.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.214 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.39 -38.67 84.7 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.296 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.2 m -66.27 -48.6 69.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.643 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.25 -40.25 88.35 Favored 'Isoleucine or valine' 0 C--O 1.255 1.361 0 CA-C-O 121.033 0.444 . . . . 0.0 109.894 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 57.8 m -54.81 -46.24 74.5 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.65 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -57.17 -36.31 70.63 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 123.359 0.412 . . . . 0.0 111.913 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -73.12 -42.35 62.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.642 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -79.49 -39.43 32.13 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.969 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -134.52 102.63 5.38 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -62.46 -22.1 65.97 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -169.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -96.54 12.82 30.19 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.741 0.305 . . . . 0.0 111.466 -178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.73 127.77 33.53 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.015 0.436 . . . . 0.0 110.694 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.3 p -106.84 -20.9 13.19 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.988 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -156.51 157.38 35.33 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -140.23 150.18 21.38 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.692 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 45' ' ' CYS . 10.0 tp10 -124.17 127.59 47.99 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 69.5 m -83.32 107.8 16.09 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.373 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -116.93 133.28 56.21 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 98.9 m-85 -81.64 131.08 35.26 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.826 0.346 . . . . 0.0 110.705 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -125.47 106.49 9.83 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.9 -97.85 1.15 Allowed Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -126.2 -2.91 6.94 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 111.682 0.252 . . . . 0.0 111.682 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -126.66 147.46 49.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 9.5 p -90.43 137.83 20.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 120.683 0.278 . . . . 0.0 110.594 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -125.71 151.86 46.07 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 2.2 m -97.69 126.77 43.2 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 177.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -84.75 110.4 18.77 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 171.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.3 m -89.53 124.9 34.94 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.823 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -96.09 148.9 22.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.61 171.19 30.55 Favored Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.617 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -127.58 113.99 16.81 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.22 170.6 8.55 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.209 -172.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 36.8 m80 . . . . . 0 C--N 1.318 -0.791 0 C-N-CA 125.489 1.516 . . . . 0.0 108.548 -175.212 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 98.3 m . . . . . 0 C--O 1.225 -0.236 0 CA-C-O 121.431 0.634 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -87.15 1.67 52.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.119 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 34.6 m80 -107.96 147.52 30.94 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -91.03 128.83 37.01 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.5 mt -91.5 -38.73 12.35 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.28 -151.62 14.07 Favored Glycine 0 N--CA 1.416 -2.658 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.855 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -131.67 151.04 51.93 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -122.03 137.23 27.1 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.77 94.73 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.123 1.882 . . . . 0.0 111.353 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.5 t -127.56 113.53 32.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -143.76 124.77 7.99 Favored Pre-proline 0 N--CA 1.434 -1.23 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.58 149.88 93.05 Favored 'Cis proline' 0 C--O 1.246 0.907 0 C-N-CA 123.421 -1.491 . . . . 0.0 110.429 -0.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.2 t -94.7 109.3 21.26 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.192 0.52 . . . . 0.0 110.564 -173.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.73 138.79 36.32 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 173.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -47.03 -49.24 21.5 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 124.35 1.031 . . . . 0.0 112.548 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -73.02 -37.67 66.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.945 0.403 . . . . 0.0 111.466 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -67.68 -39.38 84.48 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.8 t -59.2 -49.34 78.22 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.423 0.689 . . . . 0.0 109.461 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HG3' ' HA ' ' A' ' 33' ' ' LYS . 58.7 tttm -57.61 -34.87 69.73 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.256 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 m -76.54 -46.06 28.03 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.881 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 19' ' ' ALA . 73.3 t -68.04 -33.79 63.1 Favored 'Isoleucine or valine' 0 C--O 1.254 1.34 0 CA-C-O 121.297 0.57 . . . . 0.0 110.449 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.6 m -56.98 -38.72 73.42 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.304 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 51.5 mtpt -71.7 -21.79 61.73 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.925 0.393 . . . . 0.0 111.409 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -73.45 -48.54 32.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -77.35 -47.17 20.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.961 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -116.8 107.97 15.29 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -69.58 -21.43 63.6 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -98.26 16.71 20.57 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.159 0.504 . . . . 0.0 110.415 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.48 142.8 31.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.622 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 2.0 p -115.41 -44.01 3.01 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.855 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.471 ' HA ' ' HG3' ' A' ' 21' ' ' LYS . 82.3 tttt -120.46 153.35 36.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.411 ' N ' ' HG2' ' A' ' 33' ' ' LYS . . . -141.05 140.08 10.1 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 107.161 -2.376 . . . . 0.0 107.161 174.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -144.52 144.19 31.21 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 118.02 0.91 . . . . 0.0 109.977 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.5 m -92.58 127.07 37.94 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.2 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -137.73 147.16 44.52 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.424 ' CE2' ' HB ' ' A' ' 43' ' ' VAL . 74.5 m-85 -86.15 126.69 34.42 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.187 0.518 . . . . 0.0 110.485 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.36 111.03 14.02 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.531 ' O ' ' HD2' ' A' ' 41' ' ' ARG . . . 81.31 -101.59 2.12 Favored Glycine 0 N--CA 1.413 -2.847 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.531 ' HD2' ' O ' ' A' ' 40' ' ' GLY . 12.7 mmm180 -125.72 -31.87 2.9 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -87.29 159.94 18.6 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.201 0.524 . . . . 0.0 111.206 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.424 ' HB ' ' CE2' ' A' ' 38' ' ' TYR . 12.7 p -95.85 127.26 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.091 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -108.75 139.89 42.93 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.648 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 35.8 t -91.16 108.1 19.64 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -94.93 125.72 39.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.992 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.6 m -96.51 121.57 38.47 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.101 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.456 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 62.9 m-85 -105.24 141.25 37.11 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.622 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -178.96 -174.64 45.32 Favored Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--N 1.286 -2.195 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.676 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.435 -1.21 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -119.99 9.16 11.15 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -107.04 114.04 27.88 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -69.22 123.44 21.15 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.9 mt -96.95 -49.48 5.01 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.567 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.421 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -177.78 -179.33 47.87 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.5 127.99 56.29 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.082 0.468 . . . . 0.0 110.246 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.19 141.93 25.33 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.625 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.99 104.92 1.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.473 2.115 . . . . 0.0 111.104 176.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -123.25 103.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -136.24 122.81 14.04 Favored Pre-proline 0 C--N 1.304 -1.412 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.223 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.25 147.16 86.69 Favored 'Cis proline' 0 C--O 1.245 0.847 0 C-N-CA 123.66 -1.392 . . . . 0.0 111.826 1.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.4 t -68.31 120.17 14.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.477 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -141.54 140.82 33.53 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 17' ' ' GLU . 1.5 mp0 -56.98 -48.13 79.14 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.359 0.664 . . . . 0.0 111.109 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -62.47 -44.61 95.97 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.427 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.41 -45.16 94.61 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.566 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -54.67 -52.57 61.95 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.177 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 25.3 ttmm -59.71 -38.06 80.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 122.991 0.182 . . . . 0.0 110.938 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 t -72.37 -51.16 21.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.763 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.9 t -60.69 -37.98 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.584 0.354 . . . . 0.0 110.606 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.8 m -61.16 -37.99 84.86 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 21' ' ' LYS . 98.5 mttt -66.93 -35.25 79.58 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.713 0.768 . . . . 0.0 109.87 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.41 -35.39 70.97 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.474 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -84.32 -45.76 12.47 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.88 176.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 25.0 m-85 -126.28 130.42 50.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -72.95 -21.68 60.83 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.46 0.648 . . . . 0.0 110.916 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -94.5 -2.83 51.01 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.408 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . . . -83.82 126.73 33.24 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.397 0.617 . . . . 0.0 111.381 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.64 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 1.7 p -116.69 -28.86 6.25 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.44 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -124.32 135.18 53.16 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 122.07 -0.394 . . . . 0.0 110.77 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.94 136.04 9.17 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -147.28 131.51 17.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -175.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.6 m -91.21 137.16 32.58 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 120.985 0.421 . . . . 0.0 111.798 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -133.99 132.51 40.21 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.453 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 65.8 m-85 -88.57 136.23 33.1 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.328 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -127.46 90.09 3.07 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.54 -113.72 3.69 Favored Glycine 0 N--CA 1.432 -1.584 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -172.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -98.95 -33.46 10.83 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -76.21 150.98 36.99 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.938 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.453 ' HB ' ' CD1' ' A' ' 38' ' ' TYR . 7.8 p -146.58 133.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -126.28 160.34 30.6 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.691 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.5 t -97.74 119.92 37.19 Favored 'General case' 0 N--CA 1.41 -2.469 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -87.71 122.72 31.73 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.0 m -97.27 126.49 42.52 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.038 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -114.68 149.64 36.43 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.64 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -155.98 -170.13 20.96 Favored Glycine 0 C--N 1.288 -2.132 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 C--N 1.3 -1.564 0 CA-C-N 117.043 0.421 . . . . 0.0 109.871 176.874 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.0 m . . . . . 0 C--O 1.242 0.695 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -144.67 15.13 1.58 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.523 0.678 . . . . 0.0 110.441 175.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 14.0 t60 -105.64 136.27 45.54 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -81.82 126.92 32.43 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.704 0.288 . . . . 0.0 110.483 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.468 HD11 ' HA3' ' A' ' 49' ' ' GLY . 85.7 mt -86.13 -44.49 12.2 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.7 -168.93 42.06 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 12.2 pt-20 -115.75 149.88 37.77 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 120.767 0.318 . . . . 0.0 110.506 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.19 138.11 18.85 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.5 141.91 22.94 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 121.887 1.724 . . . . 0.0 111.307 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 p -140.23 149.71 21.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -160.01 123.7 2.01 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.83 169.85 45.15 Favored 'Cis proline' 0 C--O 1.241 0.651 0 C-N-CA 124.557 -1.018 . . . . 0.0 111.364 -1.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.1 t -75.84 94.81 3.38 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -126.94 139.66 52.89 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 168.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.16 -45.78 75.71 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 123.555 0.534 . . . . 0.0 112.315 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -61.01 -39.36 89.44 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.583 0.552 . . . . 0.0 111.32 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -41.47 67.16 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.163 0.506 . . . . 0.0 110.061 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -60.73 -48.77 80.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.775 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 88.2 tttt -59.85 -41.61 91.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.779 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.9 m -59.56 -55.01 39.87 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.614 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 p -65.76 -36.3 77.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.525 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.0 m -59.01 -39.5 82.09 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.804 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 30.4 mtpp -73.06 -27.59 61.83 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.703 0.287 . . . . 0.0 111.066 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -67.55 -37.6 82.92 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.208 0.528 . . . . 0.0 110.2 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -77.73 -60.02 2.54 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.502 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 18.6 m-85 -120.23 106.45 11.93 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -175.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -56.57 -31.46 64.23 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -174.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -79.53 4.86 14.49 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.44 126.97 30.5 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.381 0.61 . . . . 0.0 109.989 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 p -124.16 -11.19 7.54 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.022 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 58.1 tptt -148.16 123.82 10.49 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.797 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.32 135.75 13.09 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -122.71 127.16 48.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 93.0 m -76.38 116.45 17.07 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.092 0.472 . . . . 0.0 111.759 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -110.19 98.86 8.02 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -78.61 103.02 8.28 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -113.28 89.23 3.03 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -174.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.53 -81.99 0.6 Allowed Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.585 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -85.09 -68.37 0.73 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -128.3 -179.17 4.87 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -172.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.24 126.21 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 121.876 0.846 . . . . 0.0 112.583 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -107.34 133.33 52.03 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 5.3 m -92.03 126.75 37.24 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.342 176.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -87.45 113.07 22.83 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 m -90.77 109.73 20.92 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.09 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 97.8 m-85 -89.79 139.46 30.55 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -134.04 168.1 23.46 Favored Glycine 0 N--CA 1.419 -2.478 0 C-N-CA 118.997 -1.573 . . . . 0.0 114.544 -175.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--N 1.303 -1.437 0 CA-C-N 114.223 -0.989 . . . . 0.0 110.36 -178.753 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.439 -0.988 0 CA-C-O 120.924 0.392 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -122.15 -1.11 9.3 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.547 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -80.38 110.79 16.16 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 -178.509 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -66.67 104.88 1.39 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.56 -52.49 5.79 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.591 -177.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.52 -161.21 20.69 Favored Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -134.04 148.42 51.07 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.008 0.432 . . . . 0.0 110.741 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.566 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -129.12 151.82 78.33 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.194 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -93.06 131.68 0.88 Allowed 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 122.14 1.893 . . . . 0.0 112.878 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -160.65 127.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 123.125 0.57 . . . . 0.0 109.844 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -142.19 129.92 11.51 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.37 145.44 83.5 Favored 'Cis proline' 0 C--O 1.244 0.818 0 C-N-CA 123.344 -1.523 . . . . 0.0 110.63 -0.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 t -87.44 101.52 13.67 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.744 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -98.48 148.91 23.26 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.529 ' H ' ' CD ' ' A' ' 17' ' ' GLU . 1.9 mp0 -51.51 -54.57 25.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.211 0.604 . . . . 0.0 110.42 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.79 -42.07 99.55 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.256 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.85 95.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.418 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.9 t -61.04 -48.91 79.57 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 32' ' ' CYS . 87.6 tttt -56.24 -42.17 76.88 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.557 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -66.36 -52.41 47.19 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.869 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.5 t -62.01 -37.7 78.97 Favored 'Isoleucine or valine' 0 C--O 1.257 1.472 0 CA-C-O 121.292 0.568 . . . . 0.0 111.018 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.0 m -59.32 -33.24 70.87 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 21' ' ' LYS . 52.9 mtmt -75.43 -18.96 59.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.062 0.392 . . . . 0.0 111.033 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -83.76 -40.54 18.67 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -79.43 -44.25 21.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.9 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -121.64 108.21 13.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -67.01 -18.87 65.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -90.84 -5.19 55.92 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.49 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.1 140.42 37.84 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 121.108 0.48 . . . . 0.0 110.191 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.46 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -139.45 4.9 2.21 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.509 -178.513 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 60.0 tttm -150.87 142.66 23.77 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.77 139.36 10.14 Favored Glycine 0 C--N 1.298 -1.575 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -135.9 137.58 41.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 61.6 m -85.12 129.71 34.75 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.628 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -126.11 130.15 50.5 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -93.38 115.96 28.52 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.355 0.597 . . . . 0.0 111.454 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -111.3 92.27 3.98 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.72 -113.57 4.26 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -101.3 -12.77 18.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.84 125.8 40.65 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.568 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.3 p -95.02 125.74 47.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -107.61 139.24 42.45 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 35.4 t -96.65 109.65 22.23 Favored 'General case' 0 C--N 1.279 -2.462 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -92.63 124.51 36.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.235 0.54 . . . . 0.0 110.367 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.8 m -94.35 122.52 36.98 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.721 -173.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 67.5 m-85 -113.62 136.62 52.63 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.34 178.91 26.56 Favored Glycine 0 N--CA 1.416 -2.676 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.293 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.0 t70 . . . . . 0 C--N 1.288 -2.075 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 175.242 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.439 -0.999 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -131.16 -59.47 0.98 Allowed 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.628 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -89.65 153.61 20.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.084 0.468 . . . . 0.0 110.923 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -77.46 136.61 38.38 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.614 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.47 HD11 ' HA3' ' A' ' 49' ' ' GLY . 95.2 mt -95.27 -19.12 20.26 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.51 -178.99 34.5 Favored Glycine 0 N--CA 1.405 -3.386 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.338 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -112.75 149.93 32.28 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.85 152.75 77.99 Favored Pre-proline 0 C--N 1.283 -2.289 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -83.65 142.71 10.44 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.268 1.978 . . . . 0.0 110.766 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p -151.92 136.81 10.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.29 0.567 . . . . 0.0 111.822 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -160.42 132.01 4.04 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.07 159.51 93.12 Favored 'Cis proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.31 -1.121 . . . . 0.0 112.044 -0.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.582 ' SG ' HG21 ' A' ' 43' ' ' VAL . 48.3 t -78.48 127.82 32.71 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.488 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 23.4 tptp -166.66 143.67 4.87 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -48.05 76.84 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.79 -36.9 84.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 117.947 0.34 . . . . 0.0 111.714 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -62.9 -50.5 70.62 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.9 t -63.85 -40.11 95.8 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.545 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -62.74 -32.02 73.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 19.0 t -77.45 -46.9 21.12 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 19' ' ' ALA . 78.7 t -52.41 -47.96 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.138 0.575 . . . . 0.0 110.11 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 58.0 m -55.59 -43.14 75.73 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 32' ' ' CYS . 94.7 mttt -75.87 -25.93 56.62 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.931 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 22' ' ' SER . 45.0 mt-10 -81.07 -19.07 44.51 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.889 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -102.53 -39.53 7.06 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.31 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -121.2 115.04 22.29 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -66.43 -29.07 69.13 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -84.81 3.69 36.57 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.18 137.65 39.0 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.146 0.498 . . . . 0.0 110.684 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.448 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 5.6 p -124.42 -23.47 4.45 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.297 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -136.21 142.2 44.07 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -136.13 125.25 3.47 Favored Glycine 0 C--N 1.292 -1.909 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -115.39 135.67 53.88 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 117.652 0.726 . . . . 0.0 110.974 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.508 ' SG ' HG21 ' A' ' 43' ' ' VAL . 9.6 t -96.0 100.61 12.27 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -174.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.95 131.01 53.49 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.003 0.43 . . . . 0.0 111.876 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 74.7 m-85 -75.94 126.24 30.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.042 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -140.21 130.83 25.63 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.164 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.28 -116.17 5.12 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -120.06 0.23 10.69 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.084 0.468 . . . . 0.0 111.005 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -130.63 -169.91 2.24 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.11 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.582 HG21 ' SG ' ' A' ' 15' ' ' CYS . 11.8 p -114.42 138.32 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-O 120.899 0.381 . . . . 0.0 110.731 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -111.71 137.12 50.03 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.6 t -94.85 109.12 21.14 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.433 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 28.5 m170 -89.52 113.68 25.11 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 121.156 0.503 . . . . 0.0 110.65 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.4 m -94.24 109.68 21.47 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.151 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -97.07 132.82 42.49 Favored 'General case' 0 C--O 1.255 1.385 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.47 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -135.2 -176.23 14.25 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 119.125 -1.512 . . . . 0.0 113.433 -176.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--N 1.3 -1.58 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.617 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 N--CA 1.439 -0.984 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -125.74 -32.04 2.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.81 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -70.69 124.12 23.51 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.478 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -70.63 105.96 3.33 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 124.238 0.961 . . . . 0.0 108.821 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.1 mt -77.65 -31.67 52.84 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.572 0.701 . . . . 0.0 109.155 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.68 -162.37 33.93 Favored Glycine 0 N--CA 1.412 -2.957 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 9.6 pt-20 -124.48 124.92 43.34 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 124.02 0.483 . . . . 0.0 109.699 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.13 138.05 21.24 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.914 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.31 103.26 1.71 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.157 1.904 . . . . 0.0 110.492 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 15' ' ' CYS . 19.4 t -129.99 108.89 16.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -136.94 123.7 13.82 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.54 139.33 60.51 Favored 'Cis proline' 0 C--O 1.24 0.612 0 C-N-CA 123.466 -1.473 . . . . 0.0 110.715 -1.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.45 ' HA ' HG12 ' A' ' 12' ' ' VAL . 29.1 t -81.53 118.41 22.72 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.32 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -130.23 161.06 32.03 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.19 -65.51 0.66 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 124.434 1.094 . . . . 0.0 111.537 -172.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -64.64 -37.26 86.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.771 0.319 . . . . 0.0 110.96 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -62.96 -43.19 99.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.948 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.8 t -68.9 -39.35 79.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.398 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 21' ' ' LYS . 8.0 mtpm? -56.06 -38.06 70.13 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 120.935 0.398 . . . . 0.0 110.036 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 40.4 m -67.89 -55.56 12.38 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.978 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 19' ' ' ALA . 80.0 t -59.42 -38.0 72.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.215 0.606 . . . . 0.0 111.567 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.416 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 80.7 m -61.46 -31.45 71.41 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -79.27 -10.99 59.95 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.597 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 22' ' ' SER . 8.6 mm-40 -93.77 -33.0 13.76 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.283 0.563 . . . . 0.0 109.888 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -92.42 -21.46 20.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.255 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -136.23 172.59 12.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -105.96 -47.44 3.86 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.074 0.464 . . . . 0.0 110.495 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -82.0 19.28 1.16 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 24' ' ' CYS . . . -87.65 126.56 35.03 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.412 -175.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.632 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 1.6 p -121.96 -27.41 4.61 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.849 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 35' ' ' GLU . 46.2 tptt -131.28 131.4 43.82 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.63 130.11 8.33 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 7.9 tp10 -134.46 133.94 41.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 118.042 0.921 . . . . 0.0 110.72 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 60.0 m -77.78 128.61 34.29 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.264 -174.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -101.55 99.85 10.2 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.31 105.62 17.78 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.073 0.463 . . . . 0.0 110.4 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -146.58 111.46 5.32 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.63 -138.54 14.32 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -98.56 -30.6 12.41 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 116.949 0.374 . . . . 0.0 110.078 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -84.41 176.91 8.37 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.366 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.46 119.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.517 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -95.36 160.07 14.7 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 14.5 t -132.61 122.4 24.66 Favored 'General case' 0 C--N 1.282 -2.355 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.788 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -90.06 134.57 34.17 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 121.454 0.645 . . . . 0.0 112.03 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.1 m -96.46 110.83 23.13 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.439 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -99.87 142.22 31.63 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.43 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.632 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -163.95 -163.66 17.38 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 t70 . . . . . 0 C--N 1.295 -1.783 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 174.443 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.49 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 99.1 m . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 122.563 1.173 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -105.49 -28.22 10.94 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.541 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -85.32 121.96 28.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.729 -175.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -67.24 112.63 4.61 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.91 -29.59 17.39 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.705 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.407 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . 170.82 175.74 39.64 Favored Glycine 0 N--CA 1.422 -2.297 0 C-N-CA 119.713 -1.232 . . . . 0.0 111.957 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -116.97 121.51 41.59 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 123.63 0.772 . . . . 0.0 109.567 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.65 133.14 20.74 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.43 114.61 4.02 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.242 1.961 . . . . 0.0 111.166 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -133.33 115.22 22.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -140.18 124.28 10.76 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -80.85 -179.69 26.06 Favored 'Cis proline' 0 C--N 1.352 0.76 0 C-N-CA 124.43 -1.071 . . . . 0.0 112.174 1.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.7 t -85.15 132.72 34.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.623 0.725 . . . . 0.0 112.392 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.45 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 17.5 tptm -149.04 132.04 16.22 Favored 'General case' 0 N--CA 1.402 -2.855 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 169.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER -52.39 -42.85 64.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.763 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -72.88 -35.55 67.18 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.27 -45.49 91.24 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.2 t -56.53 -53.18 60.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.738 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 32' ' ' CYS . 87.8 tttt -61.17 -43.28 99.14 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.373 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -61.08 -46.57 90.11 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.542 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 19' ' ' ALA . 84.3 t -67.75 -39.82 82.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.583 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.5 m -57.8 -37.93 74.62 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.39 -15.32 60.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -81.6 -37.16 28.06 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -77.95 -48.99 15.02 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.772 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.407 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 29.2 m-85 -130.99 117.73 19.61 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -78.46 0.37 26.16 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.781 0.801 . . . . 0.0 110.861 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -96.71 -1.83 45.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.654 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.4 127.49 44.37 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.153 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.445 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 16.7 p -109.24 -20.52 12.93 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 61.6 tttp -121.52 136.31 54.96 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.097 -173.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.51 122.51 2.4 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -124.43 134.17 53.16 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.864 0.364 . . . . 0.0 110.894 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 81.7 m -72.65 133.82 44.82 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -126.43 110.64 13.54 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.265 0.555 . . . . 0.0 110.805 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.417 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 73.7 m-85 -78.35 108.6 11.81 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.286 175.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -118.46 97.46 5.77 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.05 -89.64 0.98 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.994 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -126.16 -17.72 5.18 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -103.62 123.05 46.26 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.417 ' HB ' ' CD1' ' A' ' 38' ' ' TYR . 9.9 p -100.07 122.49 52.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.452 0.644 . . . . 0.0 109.434 174.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -125.37 161.27 27.39 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.1 t -95.85 121.9 38.07 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -94.14 119.0 32.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.36 126.46 36.45 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.572 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.416 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 86.4 m-85 -117.95 140.75 49.28 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.073 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.49 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -173.37 -149.57 6.97 Favored Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--N 1.301 -1.543 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.527 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.577 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 84.1 m . . . . . 0 N--CA 1.44 -0.946 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -152.17 -33.77 0.13 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.81 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -75.21 123.75 25.83 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.853 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -63.55 119.66 10.24 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.679 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 31' ' ' ALA . 91.9 mt -96.7 -55.69 2.82 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.6 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.498 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -164.77 -172.91 32.82 Favored Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.095 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -118.28 131.48 56.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -175.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.25 138.92 23.21 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.123 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.23 94.25 0.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.185 1.924 . . . . 0.0 110.37 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.9 t -116.24 102.22 13.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 122.157 -0.339 . . . . 0.0 110.735 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.432 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 47.2 t80 -145.28 135.55 11.93 Favored Pre-proline 0 N--CA 1.432 -1.332 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 36.3 Cg_endo -65.12 151.49 76.43 Favored 'Cis proline' 0 C--O 1.249 1.074 0 C-N-CA 123.821 -1.325 . . . . 0.0 112.015 -1.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -81.56 112.29 18.64 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -174.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -125.66 146.27 49.8 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -69.22 -39.97 78.24 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -58.14 -37.08 73.94 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.404 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.4 -57.28 4.99 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.624 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.9 m -54.0 -46.41 71.76 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -66.09 -22.02 66.39 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 120.682 0.277 . . . . 0.0 110.9 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -88.99 -55.13 3.81 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.4 t -56.97 -38.07 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 C-N-CA 124.265 1.026 . . . . 0.0 111.782 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 90.1 m -63.35 -28.79 70.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -78.78 -22.43 46.36 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.335 0.588 . . . . 0.0 109.465 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -80.65 -39.73 26.81 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.691 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -75.7 -47.05 27.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.786 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.498 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 53.5 m-85 -125.43 117.99 24.87 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -70.77 -14.53 62.46 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.145 0.498 . . . . 0.0 111.127 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -91.36 -1.68 57.55 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.834 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HB2' HD12 ' A' ' 7' ' ' LEU . . . -100.01 141.64 32.56 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.5 p -137.33 -5.52 1.82 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.318 0.58 . . . . 0.0 110.865 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -131.04 130.03 42.75 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -148.98 137.04 6.1 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 120.328 -0.939 . . . . 0.0 110.966 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -150.46 145.36 25.98 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.685 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 34.2 m -78.93 152.0 31.36 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -132.57 107.49 8.47 Favored 'General case' 0 N--CA 1.422 -1.826 0 C-N-CA 125.418 1.487 . . . . 0.0 108.604 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -84.33 103.49 13.54 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.586 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -148.91 113.2 5.25 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.976 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.09 -155.06 21.35 Favored Glycine 0 C--N 1.299 -1.522 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.414 ' HD2' ' OE2' ' A' ' 42' ' ' GLU . 27.8 ttm180 -79.47 -37.76 36.1 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.414 ' OE2' ' HD2' ' A' ' 41' ' ' ARG . 55.4 mm-40 -92.53 154.19 18.6 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.359 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.52 130.56 52.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -106.84 116.16 31.45 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 53.2 t -93.6 120.83 34.35 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.45 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 24.7 m170 -85.44 117.84 24.6 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.778 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.8 m -97.49 116.56 29.93 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.712 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -105.35 143.59 33.31 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.56 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.577 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -161.89 -146.97 4.83 Favored Glycine 0 N--CA 1.427 -1.906 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 C--N 1.299 -1.617 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.009 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.43 -1.456 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -120.85 -51.89 2.12 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.528 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.0 m80 -91.88 150.06 21.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -82.64 115.76 21.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.991 -1.913 . . . . 0.0 108.237 -178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.8 mt -78.62 -30.0 46.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.11 179.34 40.05 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -99.93 158.55 15.73 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.69 125.57 26.72 Favored Pre-proline 0 C--N 1.287 -2.138 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.51 95.42 1.0 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.834 2.356 . . . . 0.0 114.31 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 m -137.13 116.86 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 28.2 t80 -154.17 127.8 4.39 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.422 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 42.4 Cg_endo -65.72 131.96 14.82 Favored 'Cis proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.698 0.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.8 t -80.87 139.6 35.84 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.579 -1.192 . . . . 0.0 111.953 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -131.9 150.83 52.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.376 1.07 . . . . 0.0 109.167 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.35 -50.81 70.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -64.61 -41.27 96.32 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.885 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.63 93.89 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 123.833 0.708 . . . . 0.0 110.096 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -59.01 -55.12 39.18 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.382 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.19 -24.02 65.82 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.305 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -68.78 -60.73 2.19 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.0 p -59.68 -35.55 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 123.858 0.724 . . . . 0.0 111.761 -175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.0 m -58.42 -45.51 88.31 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -82.3 -9.97 59.28 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.9 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -85.46 -42.05 14.83 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.62 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -80.89 -44.85 17.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.218 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -117.06 108.3 15.57 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -74.75 -10.07 59.16 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.415 0.626 . . . . 0.0 111.369 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -93.47 -2.33 54.6 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.106 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.5 140.8 35.71 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.136 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.407 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 5.5 p -115.41 -31.69 5.84 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.919 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -127.53 161.34 29.01 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 120.92 0.39 . . . . 0.0 110.679 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.62 110.95 0.5 Allowed Glycine 0 N--CA 1.42 -2.383 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -125.1 143.01 51.14 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.525 ' SG ' HG22 ' A' ' 43' ' ' VAL . 11.4 t -88.58 126.96 35.52 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.207 -174.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -139.37 161.26 37.89 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -71.34 124.64 25.01 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.058 0.456 . . . . 0.0 109.987 177.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -122.72 89.4 3.1 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.78 -106.74 2.39 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -103.49 -45.6 4.8 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.12 158.19 34.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.286 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.525 HG22 ' SG ' ' A' ' 36' ' ' CYS . 11.1 p -103.48 122.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.41 160.78 29.51 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.542 0.686 . . . . 0.0 112.217 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.68 126.5 32.94 Favored 'General case' 0 C--N 1.274 -2.683 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.508 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -110.94 125.97 54.24 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.307 0.575 . . . . 0.0 110.305 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.3 m -95.99 118.43 32.6 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.007 -175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -103.07 139.96 37.92 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.407 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -175.03 -163.79 28.7 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.096 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 t70 . . . . . 0 C--N 1.307 -1.279 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.529 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.1 m . . . . . 0 N--CA 1.441 -0.877 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -117.42 -16.47 10.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -83.26 129.5 35.01 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.95 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -79.58 130.58 35.51 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.921 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.469 HD11 ' HA3' ' A' ' 49' ' ' GLY . 82.3 mt -94.93 -44.24 7.81 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.357 0.599 . . . . 0.0 109.997 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.02 -174.42 47.06 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -123.99 164.36 19.51 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.919 0.36 . . . . 0.0 110.681 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.63 140.59 30.47 Favored Pre-proline 0 C--N 1.308 -1.213 0 O-C-N 123.807 0.692 . . . . 0.0 109.706 177.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.05 109.08 1.21 Allowed 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 123.027 2.485 . . . . 0.0 112.969 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 m -141.8 125.05 15.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 122.843 0.457 . . . . 0.0 110.399 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -156.4 130.73 4.95 Favored Pre-proline 0 C--N 1.308 -1.22 0 O-C-N 122.024 -0.423 . . . . 0.0 109.964 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.55 148.26 83.32 Favored 'Cis proline' 0 C--O 1.245 0.826 0 C-N-CA 123.601 -1.416 . . . . 0.0 111.024 -4.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -89.41 132.49 34.97 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.304 0.573 . . . . 0.0 111.801 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.467 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 3.0 mppt? -110.47 131.39 55.09 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 171.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.576 ' OE1' ' HG2' ' A' ' 18' ' ' LYS 0.302 0.0 OUTLIER -57.8 -43.98 86.0 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -177.954 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.576 ' HG2' ' OE1' ' A' ' 17' ' ' GLU . 47.5 mmtm -61.0 -41.72 97.04 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.734 0.302 . . . . 0.0 110.424 174.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.421 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.58 -47.84 79.83 Favored 'General case' 0 C--O 1.201 -1.469 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.465 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.8 t -55.56 -46.35 77.18 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.629 0.771 . . . . 0.0 109.685 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.4 -40.19 95.69 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.131 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -67.12 -47.14 72.04 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 19' ' ' ALA . 83.3 t -58.47 -42.33 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 122.841 0.456 . . . . 0.0 109.972 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.8 m -59.65 -46.38 89.21 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.472 173.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.25 -23.15 67.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.467 0.544 . . . . 0.0 112.467 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -94.63 -32.68 13.3 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -84.98 -51.96 6.32 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.046 -0.409 . . . . 0.0 111.031 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -118.39 102.16 8.72 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -75.31 -4.18 37.69 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -93.08 -4.74 51.84 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.11 144.09 31.94 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.775 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.7 p -119.08 -20.64 7.97 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.155 0.503 . . . . 0.0 109.705 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -138.85 164.0 30.8 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.98 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.05 133.65 4.11 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -143.42 131.69 22.02 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 89.8 m -85.05 114.29 22.1 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.016 0.436 . . . . 0.0 109.828 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.43 154.04 27.64 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.98 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -84.7 99.56 10.91 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.342 0.592 . . . . 0.0 112.125 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -149.28 102.72 3.24 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.54 -152.25 16.85 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -88.17 -45.26 10.26 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.168 0.509 . . . . 0.0 109.818 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -110.25 158.14 18.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' A' ' 36' ' ' CYS . 7.4 p -69.97 127.38 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 13.4 m170 -106.53 141.18 38.25 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.622 -0.674 . . . . 0.0 112.173 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.8 t -79.27 109.16 13.35 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.719 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -94.26 123.12 37.46 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 66.3 m -94.84 121.78 36.79 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.917 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -102.2 131.46 48.72 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.469 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -153.28 179.94 29.26 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 119.297 -1.43 . . . . 0.0 113.259 -177.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 C--N 1.302 -1.486 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.75 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 3.9 m . . . . . 0 N--CA 1.434 -1.267 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -114.19 -30.72 6.55 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 71.6 m80 -69.77 118.63 12.86 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.567 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -73.43 114.15 11.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.7 mt -92.84 -38.94 11.47 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.15 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.74 175.38 44.02 Favored Glycine 0 N--CA 1.423 -2.19 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -107.79 163.02 13.46 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 117.955 0.877 . . . . 0.0 108.979 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.577 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -131.8 144.46 53.36 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.63 113.06 2.78 Favored 'Trans proline' 0 C--O 1.249 1.06 0 C-N-CA 122.3 2.0 . . . . 0.0 111.428 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.1 t -137.52 123.37 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -150.24 127.57 5.54 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -69.01 134.45 28.1 Favored 'Cis proline' 0 C--N 1.356 0.952 0 C-N-CA 123.545 -1.44 . . . . 0.0 111.445 -1.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 9.0 t -79.11 103.13 8.84 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.308 -172.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.495 ' HG3' ' OE2' ' A' ' 17' ' ' GLU . 21.8 tptp -111.24 152.79 26.73 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.495 ' OE2' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -67.2 -39.54 86.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.488 0.585 . . . . 0.0 111.068 -178.078 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.81 -34.36 77.64 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.833 0.349 . . . . 0.0 110.392 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.37 83.08 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.3 m -60.99 -40.34 93.14 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -64.84 -17.69 64.48 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.254 0.549 . . . . 0.0 110.668 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -90.47 -56.18 3.3 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 26' ' ' GLU . 66.0 t -62.04 -36.14 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 123.414 0.686 . . . . 0.0 112.67 -175.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 91.6 m -66.78 -27.31 67.48 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.842 -0.536 . . . . 0.0 112.299 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.93 -17.81 36.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.655 0.741 . . . . 0.0 109.73 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 9.0 tp10 -77.07 -45.2 27.9 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.447 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -81.44 -44.08 17.99 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.776 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -118.39 148.56 42.4 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -173.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -92.66 -21.63 19.91 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -99.99 -5.09 28.71 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.779 0.323 . . . . 0.0 111.328 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.78 123.46 26.73 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.023 0.439 . . . . 0.0 110.005 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.602 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 2.3 p -116.7 -9.47 11.29 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.473 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 3' ' ' CYS . 87.9 tttt -144.4 152.88 41.3 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -153.68 130.39 2.94 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -134.38 146.32 49.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 117.231 0.515 . . . . 0.0 110.589 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.2 m -90.29 114.43 26.47 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -120.17 147.58 44.73 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.431 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 88.0 m-85 -93.28 143.51 26.19 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.047 0.451 . . . . 0.0 111.494 -173.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -131.56 89.51 2.72 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.12 -72.4 2.49 Favored Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.796 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -123.91 -59.71 1.49 Allowed 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.439 -0.448 . . . . 0.0 110.294 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -81.74 158.41 24.2 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.368 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.431 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 10.7 p -103.11 135.41 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.673 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -120.95 139.36 53.37 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.154 0.502 . . . . 0.0 109.924 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 41.3 t -88.42 114.69 25.3 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.988 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.405 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 40.2 m170 -102.77 126.11 49.77 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.129 -177.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.3 m -94.77 126.7 40.26 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.397 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 71.7 m-85 -115.58 145.99 42.17 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.602 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -170.56 -147.81 5.72 Favored Glycine 0 C--N 1.287 -2.186 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--N 1.296 -1.72 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.115 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.431 -1.403 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -123.97 -21.35 5.12 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.994 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -74.23 118.15 16.85 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.374 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -67.35 111.15 3.87 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.76 -42.05 18.44 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.581 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.92 -170.91 44.04 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -110.92 119.29 38.57 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 124.07 0.512 . . . . 0.0 109.809 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.1 127.28 26.99 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.31 110.99 3.21 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.25 1.967 . . . . 0.0 111.283 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.7 t -119.73 123.44 70.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -142.88 133.78 12.58 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.25 168.54 76.96 Favored 'Cis proline' 0 C--O 1.241 0.64 0 C-N-CA 123.705 -1.373 . . . . 0.0 112.154 -0.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -80.23 114.52 19.2 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.768 0.794 . . . . 0.0 111.237 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -144.05 138.93 28.67 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 174.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.44 -44.79 95.44 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.465 0.478 . . . . 0.0 110.332 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.88 -42.68 99.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.732 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.48 -49.4 69.2 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.097 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -55.6 -53.61 54.31 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 124.113 0.965 . . . . 0.0 110.55 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -63.49 -29.5 70.76 Favored 'General case' 0 CA--C 1.554 1.135 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.705 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -79.86 -45.47 18.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.548 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.21 -31.42 53.8 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 CA-C-O 121.242 0.544 . . . . 0.0 109.845 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.0 m -58.6 -29.0 66.12 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.694 173.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -85.4 -10.78 55.79 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -87.57 -30.86 20.22 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -86.32 -44.27 12.23 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.011 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.69 161.05 25.88 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -98.07 -40.03 8.63 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.633 0.254 . . . . 0.0 111.306 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -76.57 -2.58 33.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.74 112.48 7.88 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.14 0.495 . . . . 0.0 110.894 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.2 p -116.09 -1.55 12.43 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.261 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 64.6 tttp -155.71 150.25 26.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.57 129.68 2.66 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -122.59 142.17 50.92 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.637 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 85.3 m -71.06 116.01 10.86 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 123.686 0.616 . . . . 0.0 109.824 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.537 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 7.6 mm-40 -104.14 105.44 15.6 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -86.08 123.65 31.62 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.407 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -141.81 89.52 2.2 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.15 -115.34 6.04 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.115 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -82.66 -52.29 6.94 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 122.498 0.319 . . . . 0.0 111.537 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -89.0 114.73 25.94 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.63 123.62 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -120.25 152.92 37.07 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 36.4 m -96.17 119.58 34.9 Favored 'General case' 0 C--N 1.267 -2.997 0 CA-C-O 120.817 0.341 . . . . 0.0 110.998 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.537 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 15.3 m170 -83.54 110.84 18.55 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 170.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -84.82 122.36 29.04 Favored 'General case' 0 N--CA 1.412 -2.343 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.462 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.41 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 97.3 m-85 -99.1 133.07 43.9 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.134 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -130.76 178.07 17.94 Favored Glycine 0 N--CA 1.413 -2.843 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.401 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.5 t70 . . . . . 0 C--N 1.298 -1.667 0 C-N-CA 123.138 0.575 . . . . 0.0 109.725 -176.608 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.1 m . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 120.905 0.383 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -106.02 -0.19 25.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.423 0.63 . . . . 0.0 110.025 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 35.5 t60 -108.18 125.91 52.18 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.936 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -81.15 119.75 23.98 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.337 0.655 . . . . 0.0 110.162 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.4 mt -94.88 -50.58 5.06 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.288 0.566 . . . . 0.0 110.395 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.426 ' HA3' ' CZ ' ' A' ' 28' ' ' TYR . . . -165.07 -170.58 30.21 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.264 -176.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -131.97 144.73 51.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -128.04 138.58 33.26 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.7 111.82 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.257 1.972 . . . . 0.0 110.948 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.412 ' CG2' HG21 ' A' ' 23' ' ' VAL . 40.7 t -128.73 120.55 52.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 122.116 -0.365 . . . . 0.0 110.643 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.43 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 61.0 t80 -158.4 120.07 1.95 Allowed Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 50.0 Cg_endo -65.71 150.61 77.8 Favored 'Cis proline' 0 C--N 1.356 0.968 0 C-N-CA 124.133 -1.195 . . . . 0.0 113.17 3.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.5 t -115.01 124.38 51.48 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.61 -174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -138.75 168.36 19.96 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -58.52 -57.11 14.38 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.815 0.697 . . . . 0.0 112.74 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.65 -37.31 85.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.431 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -51.86 63.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.273 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.3 t -61.87 -45.66 92.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.138 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HG3' ' HA ' ' A' ' 33' ' ' LYS . 38.7 ttpt -64.78 -37.53 87.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -65.96 -57.59 7.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.435 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.412 HG21 ' CG2' ' A' ' 12' ' ' VAL . 33.6 m -62.77 -33.19 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.081 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.3 m -61.05 -33.67 73.67 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -85.43 -9.43 57.53 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.817 0.342 . . . . 0.0 111.231 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.67 -37.71 10.69 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.582 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -72.24 -43.98 63.57 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.426 ' CZ ' ' HA3' ' A' ' 8' ' ' GLY . 46.6 m-85 -124.65 99.52 6.21 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -68.03 -2.95 8.65 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.316 0.579 . . . . 0.0 112.322 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -97.82 -9.09 27.06 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.585 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.11 162.41 26.68 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.342 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.8 p -119.6 -41.88 2.67 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.901 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.482 ' HA ' ' HG3' ' A' ' 21' ' ' LYS . 57.5 tttm -142.71 149.34 38.68 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.676 -176.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -116.69 165.02 12.29 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 174.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -151.47 130.69 12.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 118.03 0.915 . . . . 0.0 110.261 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.51 103.55 16.23 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.185 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -125.68 138.25 53.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.292 -172.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.56 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 88.8 m-85 -85.32 103.56 14.36 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 172.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -126.93 118.56 24.78 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.888 -172.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.51 -72.15 2.69 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -130.04 -67.4 0.75 Allowed 'General case' 0 C--N 1.311 -1.071 0 O-C-N 122.71 -0.288 . . . . 0.0 110.25 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -108.36 -172.52 2.08 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.191 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.56 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 7.3 p -88.35 140.18 16.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.545 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -129.28 146.87 51.1 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 39.3 t -95.33 102.27 14.06 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -85.96 130.23 34.6 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.4 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.0 m -100.54 123.68 45.07 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 123.388 0.43 . . . . 0.0 110.158 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 70.5 m-85 -114.03 151.87 31.82 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 122.551 0.341 . . . . 0.0 111.243 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.8 -150.95 22.62 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 C--N 1.299 -1.618 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.082 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -116.63 -17.82 10.47 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.949 -167.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -76.43 114.74 15.47 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.393 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.33 118.56 10.86 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.893 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.5 mt -92.88 -57.6 2.6 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.844 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.493 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -163.24 -168.59 25.44 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.647 -176.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -124.33 125.0 43.61 Favored 'General case' 0 C--O 1.249 1.043 0 C-N-CA 123.636 0.774 . . . . 0.0 110.521 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -107.86 148.61 37.73 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.808 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -86.82 113.06 1.02 Allowed 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 121.955 1.77 . . . . 0.0 110.695 174.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 47.8 t -139.75 113.54 6.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -177.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -144.35 128.26 8.98 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.92 143.87 78.32 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 123.914 -1.286 . . . . 0.0 110.391 -2.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 16.2 t -96.15 134.76 38.84 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.225 -174.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -136.02 156.65 48.42 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -48.38 -51.14 27.91 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.492 1.117 . . . . 0.0 112.053 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -76.5 -35.65 58.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.005 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.43 92.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.565 0.221 . . . . 0.0 110.434 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.3 t -61.65 -47.33 85.85 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -55.11 -46.98 75.61 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.674 0.789 . . . . 0.0 110.493 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.8 t -67.62 -46.33 72.82 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.828 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.83 -31.41 41.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.172 0 CA-C-O 121.422 0.63 . . . . 0.0 110.715 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 60.2 m -60.16 -28.09 67.63 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.557 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -80.83 -15.07 57.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 0.0 111.371 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -85.53 -33.38 21.79 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -87.51 -43.17 12.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.939 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.493 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 87.6 m-85 -120.61 140.99 50.75 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.091 0.472 . . . . 0.0 110.645 -175.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -85.03 -27.56 26.3 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -91.42 6.92 43.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.39 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.33 159.92 29.19 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.531 0.681 . . . . 0.0 111.222 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.0 t -143.95 -48.45 0.28 Allowed 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.617 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -125.72 153.42 43.94 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -140.87 131.2 4.83 Favored Glycine 0 N--CA 1.423 -2.219 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -119.37 144.22 47.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 120.959 0.409 . . . . 0.0 110.972 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 59.8 m -100.26 117.48 34.56 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.502 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -113.81 105.73 13.62 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 120.926 0.393 . . . . 0.0 111.096 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.498 ' CD2' ' HB ' ' A' ' 43' ' ' VAL . 88.6 m-85 -81.32 99.67 8.78 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -118.81 105.3 11.39 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.84 -123.68 6.72 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.0 mtm180 -89.26 -32.83 17.2 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -96.44 165.23 12.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.322 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.498 ' HB ' ' CD2' ' A' ' 38' ' ' TYR . 7.4 p -124.12 130.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.43 -0.805 . . . . 0.0 108.926 174.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -101.54 117.26 34.55 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.543 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 37.2 t -88.19 104.15 16.44 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.544 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 5.6 m-70 -83.68 110.95 18.7 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.053 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 65.4 m -88.77 112.67 23.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.143 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -102.82 148.36 25.73 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.96 -148.66 6.8 Favored Glycine 0 C--N 1.294 -1.752 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 . . . . . 0 C--N 1.304 -1.388 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.883 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 91.9 m . . . . . 0 C--O 1.233 0.23 0 CA-C-O 121.502 0.668 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.34 -2.54 2.48 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.692 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 55.3 m80 -81.08 126.12 31.05 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -73.04 102.83 3.62 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.864 0.728 . . . . 0.0 109.993 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.8 mt -81.07 -35.14 32.14 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.079 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.29 -174.06 41.8 Favored Glycine 0 N--CA 1.427 -1.943 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -124.97 143.64 50.78 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 117.287 0.543 . . . . 0.0 110.855 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.61 142.07 33.47 Favored Pre-proline 0 C--N 1.297 -1.686 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.601 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.83 106.43 2.09 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.405 2.07 . . . . 0.0 111.438 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.4 t -128.02 103.73 10.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 O-C-N 121.859 -0.526 . . . . 0.0 109.866 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -142.35 132.21 12.34 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -74.65 167.86 78.88 Favored 'Cis proline' 0 C--O 1.237 0.474 0 C-N-CA 123.744 -1.357 . . . . 0.0 111.434 -2.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 t -83.67 131.65 34.93 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 122.018 0.913 . . . . 0.0 112.86 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 56.2 tptt -137.62 125.77 23.01 Favored 'General case' 0 N--CA 1.387 -3.622 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 170.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -41.41 70.0 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -176.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.74 -41.04 84.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.576 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . . . -63.81 -47.01 82.55 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.038 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.5 t -54.96 -50.55 68.63 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.359 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.72 -41.23 99.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.164 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 27.4 t -61.78 -55.51 29.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 19' ' ' ALA . 98.2 t -55.35 -43.89 73.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 123.684 0.615 . . . . 0.0 110.511 -177.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.1 m -58.06 -42.21 84.99 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.845 0.684 . . . . 0.0 112.845 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 54.9 mtpt -75.34 -23.96 57.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.279 0.562 . . . . 0.0 111.431 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 22' ' ' SER . 45.1 mt-10 -77.89 -33.46 51.96 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.957 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -85.27 -44.86 12.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.152 0.501 . . . . 0.0 110.285 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -116.7 107.16 14.33 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -64.62 -19.74 65.86 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -89.96 0.93 56.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.452 ' O ' ' HG2' ' A' ' 25' ' ' LYS . . . -78.07 138.14 38.61 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.095 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.41 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 2.5 p -134.82 1.0 3.0 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.722 0.772 . . . . 0.0 110.454 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 59.2 tptt -148.94 142.42 25.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.19 126.63 2.07 Favored Glycine 0 CA--C 1.481 -2.08 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.85 140.08 52.62 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.621 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.43 ' HB3' HG21 ' A' ' 43' ' ' VAL . 59.6 m -76.14 102.31 5.7 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 5.9 mm-40 -94.61 110.69 22.49 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.458 0.647 . . . . 0.0 109.762 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -77.61 103.93 7.84 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.839 -174.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -127.05 99.38 5.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.53 -149.72 21.34 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -175.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -95.95 -50.59 4.81 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.014 0.435 . . . . 0.0 110.603 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -78.64 103.08 8.34 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.6 0.714 . . . . 0.0 109.797 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 36' ' ' CYS . 14.8 p -76.21 150.0 6.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.621 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -123.51 151.52 42.72 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 39.3 m -96.87 126.29 41.91 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-O 120.72 0.295 . . . . 0.0 110.492 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.408 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 46.7 m170 -90.61 117.99 29.71 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.9 m -92.5 123.1 35.56 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.912 -174.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 67.3 m-85 -117.73 141.98 47.78 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.215 -177.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 5' ' ' HIS . . . -170.6 -168.68 32.73 Favored Glycine 0 C--N 1.289 -2.083 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 C--N 1.293 -1.865 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.267 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.432 -1.362 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -144.53 -34.95 0.35 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.8 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -75.13 120.55 20.79 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -65.19 119.97 11.86 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.1 mt -94.15 -43.47 8.46 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.105 0.479 . . . . 0.0 110.043 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.427 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -177.53 -160.47 24.28 Favored Glycine 0 N--CA 1.419 -2.45 0 C-N-CA 119.49 -1.338 . . . . 0.0 112.98 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -131.69 131.22 42.92 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 123.677 0.791 . . . . 0.0 110.29 -171.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.56 143.96 44.82 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -89.09 111.1 0.53 Allowed 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 122.714 2.276 . . . . 0.0 112.558 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.4 t -132.12 104.05 7.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -138.21 124.01 12.62 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -74.58 147.45 89.42 Favored 'Cis proline' 0 C--N 1.347 0.466 0 C-N-CA 123.66 -1.392 . . . . 0.0 110.818 -2.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.5 t -91.23 142.17 28.01 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.367 0.603 . . . . 0.0 111.748 -174.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -137.03 152.77 50.48 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 172.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.25 -47.29 85.02 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.14 -40.44 86.74 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.076 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -61.11 -46.8 89.14 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.929 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t -59.3 -48.59 81.07 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 123.622 0.769 . . . . 0.0 109.712 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -55.77 -46.04 78.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.812 0.845 . . . . 0.0 110.182 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.3 t -64.66 -45.76 85.37 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.626 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 19' ' ' ALA . 94.5 t -64.51 -38.6 83.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 CA-C-O 121.048 0.451 . . . . 0.0 110.322 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 83.2 m -58.92 -38.9 80.0 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.24 175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -64.04 -37.58 87.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.908 0.385 . . . . 0.0 110.621 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.28 -47.57 79.02 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.838 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -81.94 -39.48 23.66 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 63.1 m-85 -127.5 112.93 15.49 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -60.2 -37.33 79.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.872 0.367 . . . . 0.0 111.81 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -89.3 6.76 38.96 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . . . -80.3 140.8 35.99 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.3 p -123.96 -28.75 3.73 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 121.013 0.435 . . . . 0.0 111.426 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -140.65 147.88 39.98 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.13 150.75 20.78 Favored Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -121.58 144.15 48.9 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 123.844 0.379 . . . . 0.0 110.197 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.5 m -84.83 102.1 12.8 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.486 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 8.4 mm-40 -92.14 109.38 20.74 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.135 0.493 . . . . 0.0 110.387 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -86.97 101.34 13.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.667 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -144.73 110.01 5.18 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.43 -159.48 28.47 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -88.93 -20.73 24.14 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.374 0.587 . . . . 0.0 110.692 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -91.94 146.39 23.78 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.11 124.4 67.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -98.3 123.75 42.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.927 -172.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 m -87.69 114.36 24.23 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.01 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.486 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 42.0 m170 -94.36 120.42 34.57 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 174.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.5 m -94.94 128.89 42.08 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.297 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -108.35 141.67 39.82 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.7 175.64 46.92 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 119.663 -1.256 . . . . 0.0 112.772 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 C--N 1.3 -1.548 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.732 -176.431 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 88.1 m . . . . . 0 N--CA 1.417 -2.096 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -117.83 -22.92 7.74 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.026 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 52.3 m80 -89.03 134.82 33.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.874 -176.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -66.58 131.14 45.36 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.855 0.36 . . . . 0.0 110.377 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' A' ' 31' ' ' ALA . 25.2 mt -103.04 -19.26 14.63 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.997 0.903 . . . . 0.0 108.849 175.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.07 -174.63 30.29 Favored Glycine 0 N--CA 1.409 -3.152 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -177.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -123.0 158.97 29.35 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.03 132.29 24.25 Favored Pre-proline 0 C--N 1.298 -1.633 0 O-C-N 123.318 0.386 . . . . 0.0 110.401 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HA ' ' NE2' ' A' ' 44' ' ' HIS . 58.8 Cg_endo -76.07 102.05 1.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.502 2.134 . . . . 0.0 112.752 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 m -143.95 140.75 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 123.357 0.663 . . . . 0.0 109.815 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.433 ' CD2' ' HA ' ' A' ' 14' ' ' PRO . 68.8 t80 -160.07 128.46 2.94 Favored Pre-proline 0 C--N 1.314 -0.96 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.433 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 8.9 Cg_exo -68.56 145.3 76.31 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 124.048 -1.23 . . . . 0.0 112.097 3.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.1 t -99.55 106.45 18.44 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -115.27 151.26 34.85 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.11 -41.55 68.42 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 124.049 0.843 . . . . 0.0 113.237 -175.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.6 -45.54 75.16 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.459 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.09 75.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.34 -51.12 69.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.878 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.27 -39.1 81.82 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.424 0.69 . . . . 0.0 111.149 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -70.12 -49.35 51.63 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.69 -40.9 80.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 123.39 0.676 . . . . 0.0 110.996 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 67.5 m -59.44 -44.07 92.99 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -72.61 -24.2 61.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.066 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -75.3 -47.72 26.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.397 177.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -79.99 -35.33 37.58 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.953 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -126.21 112.27 15.57 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -74.78 -18.21 60.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -92.17 8.81 36.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.098 0.475 . . . . 0.0 110.912 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB2' HD12 ' A' ' 7' ' ' LEU . . . -96.49 139.48 32.52 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.3 p -124.43 -20.07 5.28 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.103 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.58 134.78 35.99 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.55 -176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.05 148.71 16.84 Favored Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.24 138.9 33.59 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.1 m -87.91 122.11 31.14 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -128.73 143.23 50.88 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.12 100.81 10.76 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -115.8 100.49 8.05 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 -102.57 2.55 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.06 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -98.09 -55.61 2.73 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.173 0.511 . . . . 0.0 110.245 -177.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -99.53 167.36 10.65 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.404 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.3 p -99.17 135.94 32.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.522 ' NE2' ' HA ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -138.09 160.26 39.86 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.807 -178.699 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.6 t -85.97 114.79 23.14 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.276 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -102.61 125.72 49.44 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 68.4 m -95.59 127.06 41.31 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.854 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 80.6 m-85 -112.06 147.97 34.89 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.326 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.62 -141.57 6.3 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 C--N 1.306 -1.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.11 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.422 -1.855 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -121.3 -43.23 2.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.912 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -83.9 135.6 34.43 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.084 -177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -85.99 116.41 24.19 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.416 HD11 ' HA3' ' A' ' 49' ' ' GLY . 89.9 mt -74.86 -33.47 62.12 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.609 0.718 . . . . 0.0 109.125 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.63 -178.3 37.57 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.94 143.13 38.59 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.08 132.9 24.25 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.15 140.97 18.15 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.503 2.135 . . . . 0.0 111.36 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.443 HG11 ' SG ' ' A' ' 45' ' ' CYS . 13.8 p -141.8 143.68 26.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 120.73 0.3 . . . . 0.0 110.688 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 84.3 t80 -148.43 123.34 5.0 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 2.0 Cg_endo -84.98 163.88 61.92 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.822 -1.324 . . . . 0.0 110.939 -2.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.21 92.36 3.83 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.1 0.952 . . . . 0.0 112.78 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -117.77 141.92 47.86 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 168.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.08 -43.22 91.8 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 118.218 0.463 . . . . 0.0 111.63 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.65 -48.69 80.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.234 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.43 -42.36 92.52 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.034 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.7 t -56.44 -54.76 41.92 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 124.115 0.966 . . . . 0.0 110.983 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -59.44 -38.24 80.18 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 121.168 0.508 . . . . 0.0 110.098 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.578 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 49.1 m -66.78 -54.62 20.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.592 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.6 t -60.65 -37.46 75.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-O 121.241 0.543 . . . . 0.0 110.457 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.8 t -56.19 -46.28 79.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.009 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 60.6 mtpt -72.82 -19.78 61.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.627 0.371 . . . . 0.0 111.689 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 22' ' ' SER . 24.6 mm-40 -74.92 -42.51 57.59 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -75.83 -45.54 35.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.246 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 54.3 m-85 -123.51 104.97 9.39 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -65.63 -24.15 66.98 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -175.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -84.02 0.03 49.8 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.28 123.86 23.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.427 0.632 . . . . 0.0 111.531 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.0 p -101.61 -29.09 12.14 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.999 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -136.37 128.84 30.34 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.847 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -133.89 118.45 2.06 Favored Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -135.13 140.44 45.44 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.056 -0.658 . . . . 0.0 112.735 -177.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.7 m -63.1 120.38 11.35 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.991 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -118.14 114.22 22.75 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -77.72 102.48 7.15 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -126.55 97.06 4.88 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.95 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.56 -112.97 3.77 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.319 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -83.38 -46.11 12.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.205 0.526 . . . . 0.0 111.816 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -97.88 170.73 8.75 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.936 0.874 . . . . 0.0 112.481 -172.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.1 113.77 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -125.35 157.95 35.47 Favored 'General case' 0 C--N 1.277 -2.587 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.443 ' SG ' HG11 ' A' ' 12' ' ' VAL . 65.6 m -80.88 111.1 17.04 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.404 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 31.2 m170 -80.4 124.41 28.87 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 92.4 m -97.91 112.63 24.48 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.326 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -95.3 133.44 39.2 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 176.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.416 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -154.51 155.33 26.13 Favored Glycine 0 C--N 1.287 -2.159 0 C-N-CA 117.506 -2.283 . . . . 0.0 114.436 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t0 . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 177.786 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.51 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 96.3 m . . . . . 0 N--CA 1.442 -0.842 0 CA-C-O 121.198 0.523 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -119.43 -35.76 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.445 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -74.49 131.91 41.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.413 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.15 111.58 10.53 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.416 HD11 ' HA3' ' A' ' 49' ' ' GLY . 80.2 mt -79.26 -30.61 43.17 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-O 121.392 0.615 . . . . 0.0 109.551 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.407 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . 163.02 -154.22 25.08 Favored Glycine 0 N--CA 1.404 -3.462 0 C-N-CA 120.502 -0.856 . . . . 0.0 110.997 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -128.65 158.19 39.23 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HB1' HG12 ' A' ' 23' ' ' VAL . . . -135.94 139.96 31.94 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.863 176.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.17 114.2 2.49 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.36 2.04 . . . . 0.0 112.594 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 p -155.13 114.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -159.19 127.33 2.86 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.694 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.05 154.68 80.83 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.689 -1.379 . . . . 0.0 111.661 -3.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 51.3 t -117.41 137.59 52.39 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 19' ' ' ALA . 13.8 mptt -103.04 157.13 17.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.16 -41.73 97.3 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.709 0.766 . . . . 0.0 110.562 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -75.1 -25.74 58.76 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.518 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.403 ' HB3' ' H ' ' A' ' 16' ' ' LYS . . . -76.51 -36.69 57.62 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.038 -178.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.5 t -64.9 -36.5 84.56 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -60.98 -47.77 84.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.849 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.9 p -70.74 -43.48 68.75 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.288 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.413 HG12 ' HB1' ' A' ' 10' ' ' ALA . 88.1 t -63.54 -46.24 95.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.7 m -59.01 -38.05 78.31 Favored 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -64.02 -33.27 75.37 Favored 'General case' 0 N--CA 1.425 -1.685 0 C-N-CA 123.076 0.55 . . . . 0.0 111.14 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.83 -19.77 30.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -89.19 -38.1 14.52 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.748 -0.595 . . . . 0.0 111.066 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.407 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 57.4 m-85 -133.94 110.8 9.95 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -71.77 -8.29 53.34 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.699 0.762 . . . . 0.0 110.769 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -86.64 -6.23 58.92 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.306 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.38 132.16 39.3 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.766 -177.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 p -112.02 -21.25 11.63 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -132.73 141.45 48.56 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.792 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.87 147.23 18.98 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -138.52 119.49 14.36 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 118.371 1.085 . . . . 0.0 110.188 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 25.8 m -82.27 109.14 16.27 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.263 176.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -125.38 148.11 48.91 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.084 -177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 81.7 m-85 -73.9 103.0 4.26 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.647 0.736 . . . . 0.0 110.799 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -94.93 89.86 5.78 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.99 -98.69 2.45 Favored Glycine 0 N--CA 1.423 -2.179 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -176.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -108.15 -52.63 2.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.021 0.439 . . . . 0.0 110.414 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.95 170.73 9.22 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.343 -173.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 7.3 p -89.48 132.84 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-O 121.304 0.573 . . . . 0.0 110.312 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 11.6 m-70 -120.83 137.17 54.68 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.8 t -88.04 105.31 17.39 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -89.67 118.58 29.38 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.3 m -91.28 124.01 35.15 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.015 -176.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -108.01 138.81 43.61 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.51 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -167.87 -155.8 9.63 Favored Glycine 0 C--N 1.297 -1.611 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 C--N 1.301 -1.528 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.119 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 74.3 m . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -101.79 -24.03 14.11 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -76.66 139.66 40.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.516 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.63 130.28 41.16 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.736 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.4 mt -89.69 -23.73 21.77 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.645 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.59 -179.92 25.04 Favored Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 12.0 pt-20 -105.9 146.34 30.09 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.29 138.98 32.7 Favored Pre-proline 0 C--N 1.302 -1.466 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.74 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.76 131.46 13.46 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.641 2.227 . . . . 0.0 112.019 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -160.63 134.01 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 122.558 0.343 . . . . 0.0 110.386 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.471 ' CG ' ' HA ' ' A' ' 14' ' ' PRO . 33.8 t80 -155.7 140.9 12.37 Favored Pre-proline 0 N--CA 1.435 -1.191 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.471 ' HA ' ' CG ' ' A' ' 13' ' ' TYR . 4.5 Cg_exo -76.12 168.36 77.5 Favored 'Cis proline' 0 C--O 1.25 1.124 0 C-N-CA 123.867 -1.305 . . . . 0.0 111.948 -0.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -78.85 114.1 17.5 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.851 0.834 . . . . 0.0 110.858 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 42.3 tptt -138.32 136.59 36.56 Favored 'General case' 0 N--CA 1.394 -3.252 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 175.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.51 -47.39 82.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 124.065 0.853 . . . . 0.0 110.085 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -64.68 -38.22 90.24 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.386 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.72 -43.42 72.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.6 t -59.08 -51.62 69.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.214 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.39 -38.67 84.7 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.296 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.2 m -66.27 -48.6 69.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.643 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.25 -40.25 88.35 Favored 'Isoleucine or valine' 0 C--O 1.255 1.361 0 CA-C-O 121.033 0.444 . . . . 0.0 109.894 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 57.8 m -54.81 -46.24 74.5 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.65 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 29' ' ' HIS . 96.5 mttt -57.17 -36.31 70.63 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 123.359 0.412 . . . . 0.0 111.913 177.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -73.12 -42.35 62.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.642 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -79.49 -39.43 32.13 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.969 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -134.52 102.63 5.38 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 72.6 m-70 -62.46 -22.1 65.97 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -169.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -96.54 12.82 30.19 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.741 0.305 . . . . 0.0 111.466 -178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.73 127.77 33.53 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.015 0.436 . . . . 0.0 110.694 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.3 p -106.84 -20.9 13.19 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.988 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -156.51 157.38 35.33 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -140.23 150.18 21.38 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.692 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -124.17 127.59 47.99 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 69.5 m -83.32 107.8 16.09 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.373 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -116.93 133.28 56.21 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 98.9 m-85 -81.64 131.08 35.26 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.826 0.346 . . . . 0.0 110.705 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -125.47 106.49 9.83 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.9 -97.85 1.15 Allowed Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -126.2 -2.91 6.94 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 111.682 0.252 . . . . 0.0 111.682 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -126.66 147.46 49.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 9.5 p -90.43 137.83 20.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 120.683 0.278 . . . . 0.0 110.594 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -125.71 151.86 46.07 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 2.2 m -97.69 126.77 43.2 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 177.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -84.75 110.4 18.77 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 171.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.3 m -89.53 124.9 34.94 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.823 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -96.09 148.9 22.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.61 171.19 30.55 Favored Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.617 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 C--N 1.289 -2.036 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.383 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.437 ' HA ' ' CG ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 120.851 0.358 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -120.44 137.23 54.45 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 98.3 m -88.26 16.29 6.47 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.431 0.634 . . . . 0.0 110.051 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -87.15 1.67 52.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.119 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 34.6 m80 -107.96 147.52 30.94 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -91.03 128.83 37.01 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.5 mt -91.5 -38.73 12.35 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.28 -151.62 14.07 Favored Glycine 0 N--CA 1.416 -2.658 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.855 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -131.67 151.04 51.93 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -122.03 137.23 27.1 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.77 94.73 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.123 1.882 . . . . 0.0 111.353 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.5 t -127.56 113.53 32.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -143.76 124.77 7.99 Favored Pre-proline 0 N--CA 1.434 -1.23 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.58 149.88 93.05 Favored 'Cis proline' 0 C--O 1.246 0.907 0 C-N-CA 123.421 -1.491 . . . . 0.0 110.429 -0.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.2 t -94.7 109.3 21.26 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.192 0.52 . . . . 0.0 110.564 -173.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.73 138.79 36.32 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 173.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -47.03 -49.24 21.5 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 124.35 1.031 . . . . 0.0 112.548 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -73.02 -37.67 66.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.945 0.403 . . . . 0.0 111.466 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -67.68 -39.38 84.48 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.8 t -59.2 -49.34 78.22 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.423 0.689 . . . . 0.0 109.461 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HG3' ' HA ' ' A' ' 33' ' ' LYS . 58.7 tttm -57.61 -34.87 69.73 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.256 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 m -76.54 -46.06 28.03 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.881 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 19' ' ' ALA . 73.3 t -68.04 -33.79 63.1 Favored 'Isoleucine or valine' 0 C--O 1.254 1.34 0 CA-C-O 121.297 0.57 . . . . 0.0 110.449 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.6 m -56.98 -38.72 73.42 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.304 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 51.5 mtpt -71.7 -21.79 61.73 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.925 0.393 . . . . 0.0 111.409 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -73.45 -48.54 32.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -77.35 -47.17 20.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.961 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -116.8 107.97 15.29 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -69.58 -21.43 63.6 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -98.26 16.71 20.57 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.159 0.504 . . . . 0.0 110.415 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.48 142.8 31.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.622 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 2.0 p -115.41 -44.01 3.01 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.855 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.471 ' HA ' ' HG3' ' A' ' 21' ' ' LYS . 82.3 tttt -120.46 153.35 36.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.411 ' N ' ' HG2' ' A' ' 33' ' ' LYS . . . -141.05 140.08 10.1 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 107.161 -2.376 . . . . 0.0 107.161 174.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -144.52 144.19 31.21 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 118.02 0.91 . . . . 0.0 109.977 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.5 m -92.58 127.07 37.94 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.2 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -137.73 147.16 44.52 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.424 ' CE2' ' HB ' ' A' ' 43' ' ' VAL . 74.5 m-85 -86.15 126.69 34.42 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.187 0.518 . . . . 0.0 110.485 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.36 111.03 14.02 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.531 ' O ' ' HD2' ' A' ' 41' ' ' ARG . . . 81.31 -101.59 2.12 Favored Glycine 0 N--CA 1.413 -2.847 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.531 ' HD2' ' O ' ' A' ' 40' ' ' GLY . 12.7 mmm180 -125.72 -31.87 2.9 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -87.29 159.94 18.6 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.201 0.524 . . . . 0.0 111.206 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.424 ' HB ' ' CE2' ' A' ' 38' ' ' TYR . 12.7 p -95.85 127.26 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.091 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -108.75 139.89 42.93 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.648 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 35.8 t -91.16 108.1 19.64 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -94.93 125.72 39.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.992 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.6 m -96.51 121.57 38.47 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.101 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.456 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 62.9 m-85 -105.24 141.25 37.11 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.622 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -178.96 -174.64 45.32 Favored Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.437 ' CG ' ' HA ' ' A' ' 1' ' ' ALA . 26.1 t70 -95.62 124.5 39.67 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -89.03 112.05 22.9 Favored 'General case' 0 N--CA 1.425 -1.685 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.737 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.4 p80 . . . . . 0 C--N 1.285 -2.235 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.452 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.444 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -76.02 151.54 37.15 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.0 m -97.19 85.9 3.81 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -119.99 9.16 11.15 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -107.04 114.04 27.88 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -69.22 123.44 21.15 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.9 mt -96.95 -49.48 5.01 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.567 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.421 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -177.78 -179.33 47.87 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.5 127.99 56.29 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.082 0.468 . . . . 0.0 110.246 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.19 141.93 25.33 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.625 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.99 104.92 1.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.473 2.115 . . . . 0.0 111.104 176.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -123.25 103.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -136.24 122.81 14.04 Favored Pre-proline 0 C--N 1.304 -1.412 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.223 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.25 147.16 86.69 Favored 'Cis proline' 0 C--O 1.245 0.847 0 C-N-CA 123.66 -1.392 . . . . 0.0 111.826 1.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.4 t -68.31 120.17 14.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.477 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -141.54 140.82 33.53 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 17' ' ' GLU . 1.5 mp0 -56.98 -48.13 79.14 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.359 0.664 . . . . 0.0 111.109 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -62.47 -44.61 95.97 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.427 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.41 -45.16 94.61 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.566 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -54.67 -52.57 61.95 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.177 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 25.3 ttmm -59.71 -38.06 80.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 122.991 0.182 . . . . 0.0 110.938 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 t -72.37 -51.16 21.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.763 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.9 t -60.69 -37.98 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.584 0.354 . . . . 0.0 110.606 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.8 m -61.16 -37.99 84.86 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 21' ' ' LYS . 98.5 mttt -66.93 -35.25 79.58 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.713 0.768 . . . . 0.0 109.87 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.41 -35.39 70.97 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.474 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -84.32 -45.76 12.47 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.88 176.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 25.0 m-85 -126.28 130.42 50.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -72.95 -21.68 60.83 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.46 0.648 . . . . 0.0 110.916 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -94.5 -2.83 51.01 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.408 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . . . -83.82 126.73 33.24 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.397 0.617 . . . . 0.0 111.381 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.64 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 1.7 p -116.69 -28.86 6.25 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.44 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -124.32 135.18 53.16 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 122.07 -0.394 . . . . 0.0 110.77 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.94 136.04 9.17 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -147.28 131.51 17.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -175.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.6 m -91.21 137.16 32.58 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 120.985 0.421 . . . . 0.0 111.798 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -133.99 132.51 40.21 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.453 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 65.8 m-85 -88.57 136.23 33.1 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.328 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -127.46 90.09 3.07 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.54 -113.72 3.69 Favored Glycine 0 N--CA 1.432 -1.584 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -172.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -98.95 -33.46 10.83 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -76.21 150.98 36.99 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.938 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.453 ' HB ' ' CD1' ' A' ' 38' ' ' TYR . 7.8 p -146.58 133.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -126.28 160.34 30.6 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.691 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.5 t -97.74 119.92 37.19 Favored 'General case' 0 N--CA 1.41 -2.469 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -87.71 122.72 31.73 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.0 m -97.27 126.49 42.52 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.038 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -114.68 149.64 36.43 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.64 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -155.98 -170.13 20.96 Favored Glycine 0 C--N 1.288 -2.132 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -140.55 151.81 45.02 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 117.043 0.421 . . . . 0.0 109.871 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -112.32 119.13 37.25 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.815 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 . . . . . 0 C--O 1.247 0.924 0 C-N-CA 125.259 1.424 . . . . 0.0 112.577 172.76 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -121.43 146.52 46.82 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 121.896 -0.503 . . . . 0.0 110.071 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.0 m -86.24 71.89 10.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -144.67 15.13 1.58 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.523 0.678 . . . . 0.0 110.441 175.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 66.5 t-80 -105.64 136.27 45.54 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -81.82 126.92 32.43 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.704 0.288 . . . . 0.0 110.483 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.468 HD11 ' HA3' ' A' ' 49' ' ' GLY . 85.7 mt -86.13 -44.49 12.2 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.7 -168.93 42.06 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 12.2 pt-20 -115.75 149.88 37.77 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 120.767 0.318 . . . . 0.0 110.506 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.19 138.11 18.85 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.5 141.91 22.94 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 121.887 1.724 . . . . 0.0 111.307 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 p -140.23 149.71 21.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -160.01 123.7 2.01 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.83 169.85 45.15 Favored 'Cis proline' 0 C--O 1.241 0.651 0 C-N-CA 124.557 -1.018 . . . . 0.0 111.364 -1.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.1 t -75.84 94.81 3.38 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -126.94 139.66 52.89 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 168.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.16 -45.78 75.71 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 123.555 0.534 . . . . 0.0 112.315 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -61.01 -39.36 89.44 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.583 0.552 . . . . 0.0 111.32 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -41.47 67.16 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.163 0.506 . . . . 0.0 110.061 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -60.73 -48.77 80.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.775 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 88.2 tttt -59.85 -41.61 91.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.779 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.9 m -59.56 -55.01 39.87 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.614 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 p -65.76 -36.3 77.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.525 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.0 m -59.01 -39.5 82.09 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.804 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 30.4 mtpp -73.06 -27.59 61.83 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.703 0.287 . . . . 0.0 111.066 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -67.55 -37.6 82.92 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.208 0.528 . . . . 0.0 110.2 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -77.73 -60.02 2.54 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.502 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 18.6 m-85 -120.23 106.45 11.93 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -175.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -56.57 -31.46 64.23 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -174.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -79.53 4.86 14.49 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.44 126.97 30.5 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.381 0.61 . . . . 0.0 109.989 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 p -124.16 -11.19 7.54 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.022 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 58.1 tptt -148.16 123.82 10.49 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.797 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.32 135.75 13.09 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -122.71 127.16 48.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 93.0 m -76.38 116.45 17.07 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.092 0.472 . . . . 0.0 111.759 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -110.19 98.86 8.02 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -78.61 103.02 8.28 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -113.28 89.23 3.03 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -174.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.53 -81.99 0.6 Allowed Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.585 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -85.09 -68.37 0.73 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -128.3 -179.17 4.87 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -172.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.24 126.21 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 121.876 0.846 . . . . 0.0 112.583 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -107.34 133.33 52.03 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 5.3 m -92.03 126.75 37.24 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.342 176.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -87.45 113.07 22.83 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 m -90.77 109.73 20.92 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.09 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 97.8 m-85 -89.79 139.46 30.55 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -134.04 168.1 23.46 Favored Glycine 0 N--CA 1.419 -2.478 0 C-N-CA 118.997 -1.573 . . . . 0.0 114.544 -175.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -109.86 113.02 25.41 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.223 -0.989 . . . . 0.0 110.36 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -88.0 127.74 35.39 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 . . . . . 0 C--N 1.298 -1.649 0 O-C-N 123.877 0.736 . . . . 0.0 109.563 -178.01 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.76 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -84.47 156.31 21.79 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.07 0.462 . . . . 0.0 111.202 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.1 m -87.44 78.74 8.59 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.722 -174.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -122.15 -1.11 9.3 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.547 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -80.38 110.79 16.16 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 -178.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -66.67 104.88 1.39 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.56 -52.49 5.79 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.591 -177.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.52 -161.21 20.69 Favored Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -134.04 148.42 51.07 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.008 0.432 . . . . 0.0 110.741 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.566 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -129.12 151.82 78.33 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.194 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -93.06 131.68 0.88 Allowed 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 122.14 1.893 . . . . 0.0 112.878 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -160.65 127.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 123.125 0.57 . . . . 0.0 109.844 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -142.19 129.92 11.51 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.37 145.44 83.5 Favored 'Cis proline' 0 C--O 1.244 0.818 0 C-N-CA 123.344 -1.523 . . . . 0.0 110.63 -0.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 t -87.44 101.52 13.67 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.744 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -98.48 148.91 23.26 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.529 ' H ' ' CD ' ' A' ' 17' ' ' GLU . 1.9 mp0 -51.51 -54.57 25.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.211 0.604 . . . . 0.0 110.42 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.79 -42.07 99.55 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.256 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.85 95.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.418 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.9 t -61.04 -48.91 79.57 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 32' ' ' CYS . 87.6 tttt -56.24 -42.17 76.88 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.557 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -66.36 -52.41 47.19 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.869 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.5 t -62.01 -37.7 78.97 Favored 'Isoleucine or valine' 0 C--O 1.257 1.472 0 CA-C-O 121.292 0.568 . . . . 0.0 111.018 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.0 m -59.32 -33.24 70.87 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 21' ' ' LYS . 52.9 mtmt -75.43 -18.96 59.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.062 0.392 . . . . 0.0 111.033 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -83.76 -40.54 18.67 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -79.43 -44.25 21.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.9 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -121.64 108.21 13.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -67.01 -18.87 65.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -90.84 -5.19 55.92 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.49 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.1 140.42 37.84 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 121.108 0.48 . . . . 0.0 110.191 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.46 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -139.45 4.9 2.21 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.509 -178.513 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 60.0 tttm -150.87 142.66 23.77 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.77 139.36 10.14 Favored Glycine 0 C--N 1.298 -1.575 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -135.9 137.58 41.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 61.6 m -85.12 129.71 34.75 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.628 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -126.11 130.15 50.5 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -93.38 115.96 28.52 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.355 0.597 . . . . 0.0 111.454 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -111.3 92.27 3.98 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.72 -113.57 4.26 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -101.3 -12.77 18.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.84 125.8 40.65 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.568 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.3 p -95.02 125.74 47.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -107.61 139.24 42.45 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 35.4 t -96.65 109.65 22.23 Favored 'General case' 0 C--N 1.279 -2.462 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -92.63 124.51 36.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.235 0.54 . . . . 0.0 110.367 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.8 m -94.35 122.52 36.98 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.721 -173.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 67.5 m-85 -113.62 136.62 52.63 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.34 178.91 26.56 Favored Glycine 0 N--CA 1.416 -2.676 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.293 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -140.94 123.65 16.12 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -67.77 109.1 3.21 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 69.0 m80 . . . . . 0 C--N 1.3 -1.546 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 173.513 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 120.417 0.151 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -120.94 119.85 33.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.246 0.546 . . . . 0.0 111.25 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 m -87.21 107.62 18.56 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -131.16 -59.47 0.98 Allowed 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.628 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -89.65 153.61 20.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.084 0.468 . . . . 0.0 110.923 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -77.46 136.61 38.38 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.614 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.47 HD11 ' HA3' ' A' ' 49' ' ' GLY . 95.2 mt -95.27 -19.12 20.26 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.51 -178.99 34.5 Favored Glycine 0 N--CA 1.405 -3.386 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.338 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -112.75 149.93 32.28 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.85 152.75 77.99 Favored Pre-proline 0 C--N 1.283 -2.289 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -83.65 142.71 10.44 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.268 1.978 . . . . 0.0 110.766 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p -151.92 136.81 10.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.29 0.567 . . . . 0.0 111.822 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -160.42 132.01 4.04 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.07 159.51 93.12 Favored 'Cis proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.31 -1.121 . . . . 0.0 112.044 -0.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.582 ' SG ' HG21 ' A' ' 43' ' ' VAL . 48.3 t -78.48 127.82 32.71 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.488 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 23.4 tptp -166.66 143.67 4.87 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -48.05 76.84 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.79 -36.9 84.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 117.947 0.34 . . . . 0.0 111.714 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -62.9 -50.5 70.62 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.9 t -63.85 -40.11 95.8 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.545 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -62.74 -32.02 73.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 19.0 t -77.45 -46.9 21.12 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 19' ' ' ALA . 78.7 t -52.41 -47.96 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.138 0.575 . . . . 0.0 110.11 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 58.0 m -55.59 -43.14 75.73 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 32' ' ' CYS . 94.7 mttt -75.87 -25.93 56.62 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.931 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 22' ' ' SER . 45.0 mt-10 -81.07 -19.07 44.51 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.889 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -102.53 -39.53 7.06 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.31 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -121.2 115.04 22.29 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -66.43 -29.07 69.13 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -84.81 3.69 36.57 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.18 137.65 39.0 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.146 0.498 . . . . 0.0 110.684 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.448 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 5.6 p -124.42 -23.47 4.45 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.297 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -136.21 142.2 44.07 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -136.13 125.25 3.47 Favored Glycine 0 C--N 1.292 -1.909 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -115.39 135.67 53.88 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 117.652 0.726 . . . . 0.0 110.974 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.508 ' SG ' HG21 ' A' ' 43' ' ' VAL . 9.6 t -96.0 100.61 12.27 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -174.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.95 131.01 53.49 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.003 0.43 . . . . 0.0 111.876 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 74.7 m-85 -75.94 126.24 30.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.042 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -140.21 130.83 25.63 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.164 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.28 -116.17 5.12 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -120.06 0.23 10.69 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.084 0.468 . . . . 0.0 111.005 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -130.63 -169.91 2.24 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.11 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.582 HG21 ' SG ' ' A' ' 15' ' ' CYS . 11.8 p -114.42 138.32 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-O 120.899 0.381 . . . . 0.0 110.731 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -111.71 137.12 50.03 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.6 t -94.85 109.12 21.14 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.433 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 28.5 m170 -89.52 113.68 25.11 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 121.156 0.503 . . . . 0.0 110.65 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.4 m -94.24 109.68 21.47 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.151 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -97.07 132.82 42.49 Favored 'General case' 0 C--O 1.255 1.385 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.47 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -135.2 -176.23 14.25 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 119.125 -1.512 . . . . 0.0 113.433 -176.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -129.1 118.57 22.7 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -77.13 108.73 10.43 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 . . . . . 0 C--N 1.299 -1.589 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -174.248 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -84.99 149.64 25.46 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.922 -0.486 . . . . 0.0 111.565 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.1 m -87.72 77.5 8.63 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -125.74 -32.04 2.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.81 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -70.69 124.12 23.51 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.478 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -70.63 105.96 3.33 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 124.238 0.961 . . . . 0.0 108.821 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.1 mt -77.65 -31.67 52.84 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.572 0.701 . . . . 0.0 109.155 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.68 -162.37 33.93 Favored Glycine 0 N--CA 1.412 -2.957 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 9.6 pt-20 -124.48 124.92 43.34 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 124.02 0.483 . . . . 0.0 109.699 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.13 138.05 21.24 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.914 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.31 103.26 1.71 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.157 1.904 . . . . 0.0 110.492 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 15' ' ' CYS . 19.4 t -129.99 108.89 16.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -136.94 123.7 13.82 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.54 139.33 60.51 Favored 'Cis proline' 0 C--O 1.24 0.612 0 C-N-CA 123.466 -1.473 . . . . 0.0 110.715 -1.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.45 ' HA ' HG12 ' A' ' 12' ' ' VAL . 29.1 t -81.53 118.41 22.72 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.32 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -130.23 161.06 32.03 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.19 -65.51 0.66 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 124.434 1.094 . . . . 0.0 111.537 -172.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -64.64 -37.26 86.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.771 0.319 . . . . 0.0 110.96 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -62.96 -43.19 99.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.948 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.8 t -68.9 -39.35 79.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.398 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 21' ' ' LYS . 8.0 mtpm? -56.06 -38.06 70.13 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 120.935 0.398 . . . . 0.0 110.036 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 40.4 m -67.89 -55.56 12.38 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.978 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 19' ' ' ALA . 80.0 t -59.42 -38.0 72.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.215 0.606 . . . . 0.0 111.567 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.416 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 80.7 m -61.46 -31.45 71.41 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -79.27 -10.99 59.95 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.597 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 22' ' ' SER . 8.6 mm-40 -93.77 -33.0 13.76 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.283 0.563 . . . . 0.0 109.888 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -92.42 -21.46 20.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.255 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -136.23 172.59 12.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -105.96 -47.44 3.86 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.074 0.464 . . . . 0.0 110.495 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -82.0 19.28 1.16 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 24' ' ' CYS . . . -87.65 126.56 35.03 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.412 -175.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.632 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 1.6 p -121.96 -27.41 4.61 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.849 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 35' ' ' GLU . 46.2 tptt -131.28 131.4 43.82 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.63 130.11 8.33 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 7.9 tp10 -134.46 133.94 41.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 118.042 0.921 . . . . 0.0 110.72 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 60.0 m -77.78 128.61 34.29 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.264 -174.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -101.55 99.85 10.2 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.31 105.62 17.78 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.073 0.463 . . . . 0.0 110.4 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -146.58 111.46 5.32 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.63 -138.54 14.32 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -98.56 -30.6 12.41 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 116.949 0.374 . . . . 0.0 110.078 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -84.41 176.91 8.37 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.366 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.46 119.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.517 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -95.36 160.07 14.7 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 14.5 t -132.61 122.4 24.66 Favored 'General case' 0 C--N 1.282 -2.355 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.788 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -90.06 134.57 34.17 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 121.454 0.645 . . . . 0.0 112.03 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.1 m -96.46 110.83 23.13 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.439 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -99.87 142.22 31.63 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.43 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.632 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -163.95 -163.66 17.38 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -121.55 113.48 19.86 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -108.19 165.46 11.47 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -169.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 8.7 t60 . . . . . 0 C--N 1.29 -2.019 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 178.616 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.875 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -101.76 144.09 30.88 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.49 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 99.1 m -84.07 71.35 10.56 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 122.563 1.173 . . . . 0.0 109.288 175.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -105.49 -28.22 10.94 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.541 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -85.32 121.96 28.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.729 -175.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -67.24 112.63 4.61 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.91 -29.59 17.39 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.705 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.407 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . 170.82 175.74 39.64 Favored Glycine 0 N--CA 1.422 -2.297 0 C-N-CA 119.713 -1.232 . . . . 0.0 111.957 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -116.97 121.51 41.59 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 123.63 0.772 . . . . 0.0 109.567 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.65 133.14 20.74 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.43 114.61 4.02 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.242 1.961 . . . . 0.0 111.166 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -133.33 115.22 22.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -140.18 124.28 10.76 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -80.85 -179.69 26.06 Favored 'Cis proline' 0 C--N 1.352 0.76 0 C-N-CA 124.43 -1.071 . . . . 0.0 112.174 1.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.7 t -85.15 132.72 34.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.623 0.725 . . . . 0.0 112.392 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.45 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 17.5 tptm -149.04 132.04 16.22 Favored 'General case' 0 N--CA 1.402 -2.855 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 169.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER -52.39 -42.85 64.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.763 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -72.88 -35.55 67.18 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.27 -45.49 91.24 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.2 t -56.53 -53.18 60.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.738 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 32' ' ' CYS . 87.8 tttt -61.17 -43.28 99.14 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.373 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -61.08 -46.57 90.11 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.542 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 19' ' ' ALA . 84.3 t -67.75 -39.82 82.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.583 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.5 m -57.8 -37.93 74.62 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.39 -15.32 60.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -81.6 -37.16 28.06 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -77.95 -48.99 15.02 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.772 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.407 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 29.2 m-85 -130.99 117.73 19.61 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -78.46 0.37 26.16 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.781 0.801 . . . . 0.0 110.861 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -96.71 -1.83 45.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.654 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.4 127.49 44.37 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.153 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.445 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 16.7 p -109.24 -20.52 12.93 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 61.6 tttp -121.52 136.31 54.96 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.097 -173.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.51 122.51 2.4 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -124.43 134.17 53.16 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.864 0.364 . . . . 0.0 110.894 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 81.7 m -72.65 133.82 44.82 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -126.43 110.64 13.54 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.265 0.555 . . . . 0.0 110.805 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.417 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 73.7 m-85 -78.35 108.6 11.81 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.286 175.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -118.46 97.46 5.77 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.05 -89.64 0.98 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.994 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -126.16 -17.72 5.18 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -103.62 123.05 46.26 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.417 ' HB ' ' CD1' ' A' ' 38' ' ' TYR . 9.9 p -100.07 122.49 52.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.452 0.644 . . . . 0.0 109.434 174.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -125.37 161.27 27.39 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.1 t -95.85 121.9 38.07 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -94.14 119.0 32.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.36 126.46 36.45 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.572 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.416 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 86.4 m-85 -117.95 140.75 49.28 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.073 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.49 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -173.37 -149.57 6.97 Favored Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -140.66 122.03 14.97 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -99.94 153.47 19.15 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 45.8 m80 . . . . . 0 C--N 1.28 -2.439 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.962 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.663 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -74.32 113.13 11.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.577 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 84.1 m -56.92 121.84 10.87 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 124.071 0.948 . . . . 0.0 112.661 -176.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -152.17 -33.77 0.13 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.81 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -75.21 123.75 25.83 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.853 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -63.55 119.66 10.24 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.679 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 31' ' ' ALA . 91.9 mt -96.7 -55.69 2.82 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.6 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.498 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -164.77 -172.91 32.82 Favored Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.095 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -118.28 131.48 56.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -175.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.25 138.92 23.21 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.123 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.23 94.25 0.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.185 1.924 . . . . 0.0 110.37 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.9 t -116.24 102.22 13.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 122.157 -0.339 . . . . 0.0 110.735 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.432 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 47.2 t80 -145.28 135.55 11.93 Favored Pre-proline 0 N--CA 1.432 -1.332 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 36.3 Cg_endo -65.12 151.49 76.43 Favored 'Cis proline' 0 C--O 1.249 1.074 0 C-N-CA 123.821 -1.325 . . . . 0.0 112.015 -1.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -81.56 112.29 18.64 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -174.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -125.66 146.27 49.8 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -69.22 -39.97 78.24 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -58.14 -37.08 73.94 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.404 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.4 -57.28 4.99 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.624 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.9 m -54.0 -46.41 71.76 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -66.09 -22.02 66.39 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 120.682 0.277 . . . . 0.0 110.9 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -88.99 -55.13 3.81 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.4 t -56.97 -38.07 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 C-N-CA 124.265 1.026 . . . . 0.0 111.782 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 90.1 m -63.35 -28.79 70.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -78.78 -22.43 46.36 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.335 0.588 . . . . 0.0 109.465 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -80.65 -39.73 26.81 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.691 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -75.7 -47.05 27.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.786 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.498 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 53.5 m-85 -125.43 117.99 24.87 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -70.77 -14.53 62.46 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.145 0.498 . . . . 0.0 111.127 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -91.36 -1.68 57.55 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.834 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HB2' HD12 ' A' ' 7' ' ' LEU . . . -100.01 141.64 32.56 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.5 p -137.33 -5.52 1.82 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.318 0.58 . . . . 0.0 110.865 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -131.04 130.03 42.75 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -148.98 137.04 6.1 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 120.328 -0.939 . . . . 0.0 110.966 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -150.46 145.36 25.98 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.685 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 34.2 m -78.93 152.0 31.36 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -132.57 107.49 8.47 Favored 'General case' 0 N--CA 1.422 -1.826 0 C-N-CA 125.418 1.487 . . . . 0.0 108.604 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -84.33 103.49 13.54 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.586 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -148.91 113.2 5.25 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.976 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.09 -155.06 21.35 Favored Glycine 0 C--N 1.299 -1.522 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.414 ' HD2' ' OE2' ' A' ' 42' ' ' GLU . 27.8 ttm180 -79.47 -37.76 36.1 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.414 ' OE2' ' HD2' ' A' ' 41' ' ' ARG . 55.4 mm-40 -92.53 154.19 18.6 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.359 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.52 130.56 52.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -106.84 116.16 31.45 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 53.2 t -93.6 120.83 34.35 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.45 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 24.7 m170 -85.44 117.84 24.6 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.778 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.8 m -97.49 116.56 29.93 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.712 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -105.35 143.59 33.31 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.56 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.577 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -161.89 -146.97 4.83 Favored Glycine 0 N--CA 1.427 -1.906 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -140.2 133.76 30.18 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -136.14 115.2 12.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 58.4 m80 . . . . . 0 C--N 1.287 -2.122 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.163 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.462 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -87.2 130.5 34.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.405 0.621 . . . . 0.0 110.946 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.2 m -100.72 82.55 2.44 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.032 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -120.85 -51.89 2.12 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.528 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.0 m80 -91.88 150.06 21.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -82.64 115.76 21.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.991 -1.913 . . . . 0.0 108.237 -178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.8 mt -78.62 -30.0 46.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.11 179.34 40.05 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -99.93 158.55 15.73 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.69 125.57 26.72 Favored Pre-proline 0 C--N 1.287 -2.138 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.51 95.42 1.0 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.834 2.356 . . . . 0.0 114.31 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 m -137.13 116.86 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 28.2 t80 -154.17 127.8 4.39 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.422 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 42.4 Cg_endo -65.72 131.96 14.82 Favored 'Cis proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.698 0.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.8 t -80.87 139.6 35.84 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.579 -1.192 . . . . 0.0 111.953 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -131.9 150.83 52.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.376 1.07 . . . . 0.0 109.167 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.35 -50.81 70.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -64.61 -41.27 96.32 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.885 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.63 93.89 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 123.833 0.708 . . . . 0.0 110.096 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -59.01 -55.12 39.18 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.382 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.19 -24.02 65.82 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.305 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -68.78 -60.73 2.19 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.0 p -59.68 -35.55 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 123.858 0.724 . . . . 0.0 111.761 -175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.0 m -58.42 -45.51 88.31 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -82.3 -9.97 59.28 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.9 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -85.46 -42.05 14.83 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.62 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -80.89 -44.85 17.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.218 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -117.06 108.3 15.57 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -74.75 -10.07 59.16 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.415 0.626 . . . . 0.0 111.369 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -93.47 -2.33 54.6 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.106 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.5 140.8 35.71 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.136 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.407 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 5.5 p -115.41 -31.69 5.84 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.919 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -127.53 161.34 29.01 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 120.92 0.39 . . . . 0.0 110.679 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.62 110.95 0.5 Allowed Glycine 0 N--CA 1.42 -2.383 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -125.1 143.01 51.14 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.525 ' SG ' HG22 ' A' ' 43' ' ' VAL . 11.4 t -88.58 126.96 35.52 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.207 -174.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -139.37 161.26 37.89 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -71.34 124.64 25.01 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.058 0.456 . . . . 0.0 109.987 177.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -122.72 89.4 3.1 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.78 -106.74 2.39 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -103.49 -45.6 4.8 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.12 158.19 34.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.286 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.525 HG22 ' SG ' ' A' ' 36' ' ' CYS . 11.1 p -103.48 122.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.41 160.78 29.51 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.542 0.686 . . . . 0.0 112.217 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.68 126.5 32.94 Favored 'General case' 0 C--N 1.274 -2.683 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.508 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -110.94 125.97 54.24 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.307 0.575 . . . . 0.0 110.305 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.3 m -95.99 118.43 32.6 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.007 -175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -103.07 139.96 37.92 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.407 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -175.03 -163.79 28.7 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.096 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.76 114.27 18.55 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -86.57 140.27 30.03 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -174.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 . . . . . 0 C--N 1.292 -1.92 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.627 -179.756 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.43 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -120.0 121.66 39.42 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.1 m -135.99 132.51 36.41 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -117.42 -16.47 10.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -83.26 129.5 35.01 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.95 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -79.58 130.58 35.51 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.921 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.469 HD11 ' HA3' ' A' ' 49' ' ' GLY . 82.3 mt -94.93 -44.24 7.81 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.357 0.599 . . . . 0.0 109.997 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.02 -174.42 47.06 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -123.99 164.36 19.51 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.919 0.36 . . . . 0.0 110.681 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.63 140.59 30.47 Favored Pre-proline 0 C--N 1.308 -1.213 0 O-C-N 123.807 0.692 . . . . 0.0 109.706 177.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.05 109.08 1.21 Allowed 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 123.027 2.485 . . . . 0.0 112.969 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 m -141.8 125.05 15.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 122.843 0.457 . . . . 0.0 110.399 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -156.4 130.73 4.95 Favored Pre-proline 0 C--N 1.308 -1.22 0 O-C-N 122.024 -0.423 . . . . 0.0 109.964 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.55 148.26 83.32 Favored 'Cis proline' 0 C--O 1.245 0.826 0 C-N-CA 123.601 -1.416 . . . . 0.0 111.024 -4.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -89.41 132.49 34.97 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.304 0.573 . . . . 0.0 111.801 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.467 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 3.0 mppt? -110.47 131.39 55.09 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 171.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.576 ' OE1' ' HG2' ' A' ' 18' ' ' LYS 0.302 0.0 OUTLIER -57.8 -43.98 86.0 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -177.954 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.576 ' HG2' ' OE1' ' A' ' 17' ' ' GLU . 47.5 mmtm -61.0 -41.72 97.04 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.734 0.302 . . . . 0.0 110.424 174.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.421 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.58 -47.84 79.83 Favored 'General case' 0 C--O 1.201 -1.469 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.465 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.8 t -55.56 -46.35 77.18 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.629 0.771 . . . . 0.0 109.685 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.4 -40.19 95.69 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.131 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -67.12 -47.14 72.04 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 19' ' ' ALA . 83.3 t -58.47 -42.33 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 122.841 0.456 . . . . 0.0 109.972 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.8 m -59.65 -46.38 89.21 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.472 173.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.25 -23.15 67.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.467 0.544 . . . . 0.0 112.467 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -94.63 -32.68 13.3 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -84.98 -51.96 6.32 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.046 -0.409 . . . . 0.0 111.031 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -118.39 102.16 8.72 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -75.31 -4.18 37.69 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -93.08 -4.74 51.84 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.11 144.09 31.94 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.775 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.7 p -119.08 -20.64 7.97 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.155 0.503 . . . . 0.0 109.705 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -138.85 164.0 30.8 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.98 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.05 133.65 4.11 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -143.42 131.69 22.02 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 89.8 m -85.05 114.29 22.1 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.016 0.436 . . . . 0.0 109.828 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.43 154.04 27.64 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.98 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -84.7 99.56 10.91 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.342 0.592 . . . . 0.0 112.125 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -149.28 102.72 3.24 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.54 -152.25 16.85 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -88.17 -45.26 10.26 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.168 0.509 . . . . 0.0 109.818 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -110.25 158.14 18.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' A' ' 36' ' ' CYS . 7.4 p -69.97 127.38 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 13.4 m170 -106.53 141.18 38.25 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.622 -0.674 . . . . 0.0 112.173 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.8 t -79.27 109.16 13.35 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.719 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -94.26 123.12 37.46 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 66.3 m -94.84 121.78 36.79 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.917 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -102.2 131.46 48.72 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.469 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -153.28 179.94 29.26 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 119.297 -1.43 . . . . 0.0 113.259 -177.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.65 107.65 19.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.435 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 72.1 t80 -120.92 136.13 55.02 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.381 -175.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 39.3 m80 . . . . . 0 C--N 1.31 -1.147 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.362 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.655 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -87.45 120.57 28.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 3.9 m -92.25 120.94 33.29 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.82 -175.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -114.19 -30.72 6.55 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 71.6 m80 -69.77 118.63 12.86 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.567 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -73.43 114.15 11.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.7 mt -92.84 -38.94 11.47 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.15 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.74 175.38 44.02 Favored Glycine 0 N--CA 1.423 -2.19 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -107.79 163.02 13.46 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 117.955 0.877 . . . . 0.0 108.979 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.577 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -131.8 144.46 53.36 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.63 113.06 2.78 Favored 'Trans proline' 0 C--O 1.249 1.06 0 C-N-CA 122.3 2.0 . . . . 0.0 111.428 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.1 t -137.52 123.37 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -150.24 127.57 5.54 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -69.01 134.45 28.1 Favored 'Cis proline' 0 C--N 1.356 0.952 0 C-N-CA 123.545 -1.44 . . . . 0.0 111.445 -1.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 9.0 t -79.11 103.13 8.84 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.308 -172.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.495 ' HG3' ' OE2' ' A' ' 17' ' ' GLU . 21.8 tptp -111.24 152.79 26.73 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.495 ' OE2' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -67.2 -39.54 86.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.488 0.585 . . . . 0.0 111.068 -178.078 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.81 -34.36 77.64 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.833 0.349 . . . . 0.0 110.392 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.37 83.08 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.3 m -60.99 -40.34 93.14 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -64.84 -17.69 64.48 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.254 0.549 . . . . 0.0 110.668 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -90.47 -56.18 3.3 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 26' ' ' GLU . 66.0 t -62.04 -36.14 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 123.414 0.686 . . . . 0.0 112.67 -175.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 91.6 m -66.78 -27.31 67.48 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.842 -0.536 . . . . 0.0 112.299 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.93 -17.81 36.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.655 0.741 . . . . 0.0 109.73 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 9.0 tp10 -77.07 -45.2 27.9 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.447 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -81.44 -44.08 17.99 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.776 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -118.39 148.56 42.4 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -173.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -92.66 -21.63 19.91 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -99.99 -5.09 28.71 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.779 0.323 . . . . 0.0 111.328 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.78 123.46 26.73 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.023 0.439 . . . . 0.0 110.005 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.602 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 2.3 p -116.7 -9.47 11.29 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.473 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 3' ' ' CYS . 87.9 tttt -144.4 152.88 41.3 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -153.68 130.39 2.94 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -134.38 146.32 49.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 117.231 0.515 . . . . 0.0 110.589 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.2 m -90.29 114.43 26.47 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -120.17 147.58 44.73 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.431 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 88.0 m-85 -93.28 143.51 26.19 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.047 0.451 . . . . 0.0 111.494 -173.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -131.56 89.51 2.72 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.12 -72.4 2.49 Favored Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.796 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -123.91 -59.71 1.49 Allowed 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.439 -0.448 . . . . 0.0 110.294 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -81.74 158.41 24.2 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.368 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.431 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 10.7 p -103.11 135.41 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.673 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -120.95 139.36 53.37 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.154 0.502 . . . . 0.0 109.924 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 41.3 t -88.42 114.69 25.3 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.988 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.405 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 40.2 m170 -102.77 126.11 49.77 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.129 -177.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.3 m -94.77 126.7 40.26 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.397 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 71.7 m-85 -115.58 145.99 42.17 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.602 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -170.56 -147.81 5.72 Favored Glycine 0 C--N 1.287 -2.186 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -108.57 136.18 48.59 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -97.1 109.95 22.6 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 . . . . . 0 C--N 1.284 -2.24 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -178.759 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.495 0 CA-C-O 120.46 0.171 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -120.94 127.34 51.73 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 121.059 0.457 . . . . 0.0 110.246 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.5 m -85.64 86.28 7.37 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -123.97 -21.35 5.12 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.994 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -74.23 118.15 16.85 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.374 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -67.35 111.15 3.87 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.76 -42.05 18.44 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.581 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.92 -170.91 44.04 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -110.92 119.29 38.57 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 124.07 0.512 . . . . 0.0 109.809 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.1 127.28 26.99 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.31 110.99 3.21 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.25 1.967 . . . . 0.0 111.283 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.7 t -119.73 123.44 70.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -142.88 133.78 12.58 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.25 168.54 76.96 Favored 'Cis proline' 0 C--O 1.241 0.64 0 C-N-CA 123.705 -1.373 . . . . 0.0 112.154 -0.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -80.23 114.52 19.2 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.768 0.794 . . . . 0.0 111.237 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -144.05 138.93 28.67 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 174.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.44 -44.79 95.44 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.465 0.478 . . . . 0.0 110.332 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.88 -42.68 99.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.732 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.48 -49.4 69.2 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.097 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -55.6 -53.61 54.31 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 124.113 0.965 . . . . 0.0 110.55 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -63.49 -29.5 70.76 Favored 'General case' 0 CA--C 1.554 1.135 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.705 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -79.86 -45.47 18.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.548 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.21 -31.42 53.8 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 CA-C-O 121.242 0.544 . . . . 0.0 109.845 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.0 m -58.6 -29.0 66.12 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.694 173.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -85.4 -10.78 55.79 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -87.57 -30.86 20.22 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -86.32 -44.27 12.23 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.011 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.69 161.05 25.88 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -98.07 -40.03 8.63 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.633 0.254 . . . . 0.0 111.306 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -76.57 -2.58 33.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.74 112.48 7.88 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.14 0.495 . . . . 0.0 110.894 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.2 p -116.09 -1.55 12.43 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.261 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 64.6 tttp -155.71 150.25 26.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.57 129.68 2.66 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -122.59 142.17 50.92 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.637 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 85.3 m -71.06 116.01 10.86 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 123.686 0.616 . . . . 0.0 109.824 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.537 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 7.6 mm-40 -104.14 105.44 15.6 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -86.08 123.65 31.62 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.407 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -141.81 89.52 2.2 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.15 -115.34 6.04 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.115 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -82.66 -52.29 6.94 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 122.498 0.319 . . . . 0.0 111.537 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -89.0 114.73 25.94 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.63 123.62 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -120.25 152.92 37.07 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 36.4 m -96.17 119.58 34.9 Favored 'General case' 0 C--N 1.267 -2.997 0 CA-C-O 120.817 0.341 . . . . 0.0 110.998 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.537 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 15.3 m170 -83.54 110.84 18.55 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 170.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -84.82 122.36 29.04 Favored 'General case' 0 N--CA 1.412 -2.343 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.462 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.41 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 97.3 m-85 -99.1 133.07 43.9 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.134 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -130.76 178.07 17.94 Favored Glycine 0 N--CA 1.413 -2.843 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.401 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -131.77 142.46 49.77 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 123.138 0.575 . . . . 0.0 109.725 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -128.47 109.25 11.23 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 . . . . . 0 C--N 1.301 -1.523 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.266 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 120.744 0.307 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -112.25 136.79 51.25 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.0 0.428 . . . . 0.0 110.845 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.1 m -95.24 27.59 3.21 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.963 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -106.02 -0.19 25.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.423 0.63 . . . . 0.0 110.025 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 35.5 t60 -108.18 125.91 52.18 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.936 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -81.15 119.75 23.98 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.337 0.655 . . . . 0.0 110.162 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.4 mt -94.88 -50.58 5.06 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.288 0.566 . . . . 0.0 110.395 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.426 ' HA3' ' CZ ' ' A' ' 28' ' ' TYR . . . -165.07 -170.58 30.21 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.264 -176.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -131.97 144.73 51.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -128.04 138.58 33.26 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.7 111.82 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.257 1.972 . . . . 0.0 110.948 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.412 ' CG2' HG21 ' A' ' 23' ' ' VAL . 40.7 t -128.73 120.55 52.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 122.116 -0.365 . . . . 0.0 110.643 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.43 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 61.0 t80 -158.4 120.07 1.95 Allowed Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 50.0 Cg_endo -65.71 150.61 77.8 Favored 'Cis proline' 0 C--N 1.356 0.968 0 C-N-CA 124.133 -1.195 . . . . 0.0 113.17 3.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.5 t -115.01 124.38 51.48 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.61 -174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -138.75 168.36 19.96 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -58.52 -57.11 14.38 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.815 0.697 . . . . 0.0 112.74 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.65 -37.31 85.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.431 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -51.86 63.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.273 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.3 t -61.87 -45.66 92.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.138 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HG3' ' HA ' ' A' ' 33' ' ' LYS . 38.7 ttpt -64.78 -37.53 87.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -65.96 -57.59 7.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.435 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.412 HG21 ' CG2' ' A' ' 12' ' ' VAL . 33.6 m -62.77 -33.19 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.081 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.3 m -61.05 -33.67 73.67 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -85.43 -9.43 57.53 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.817 0.342 . . . . 0.0 111.231 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.67 -37.71 10.69 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.582 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -72.24 -43.98 63.57 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.426 ' CZ ' ' HA3' ' A' ' 8' ' ' GLY . 46.6 m-85 -124.65 99.52 6.21 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -68.03 -2.95 8.65 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.316 0.579 . . . . 0.0 112.322 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.466 ' HB3' ' H ' ' A' ' 52' ' ' HIS . 56.0 m-70 -97.82 -9.09 27.06 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.585 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.11 162.41 26.68 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.342 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.8 p -119.6 -41.88 2.67 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.901 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.482 ' HA ' ' HG3' ' A' ' 21' ' ' LYS . 57.5 tttm -142.71 149.34 38.68 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.676 -176.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -116.69 165.02 12.29 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 174.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -151.47 130.69 12.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 118.03 0.915 . . . . 0.0 110.261 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.51 103.55 16.23 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.185 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -125.68 138.25 53.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.292 -172.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.56 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 88.8 m-85 -85.32 103.56 14.36 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 172.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -126.93 118.56 24.78 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.888 -172.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.51 -72.15 2.69 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -130.04 -67.4 0.75 Allowed 'General case' 0 C--N 1.311 -1.071 0 O-C-N 122.71 -0.288 . . . . 0.0 110.25 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -108.36 -172.52 2.08 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.191 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.56 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 7.3 p -88.35 140.18 16.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.545 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -129.28 146.87 51.1 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 39.3 t -95.33 102.27 14.06 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -85.96 130.23 34.6 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.4 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.0 m -100.54 123.68 45.07 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 123.388 0.43 . . . . 0.0 110.158 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 70.5 m-85 -114.03 151.87 31.82 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 122.551 0.341 . . . . 0.0 111.243 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.8 -150.95 22.62 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -139.55 156.45 46.89 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -81.49 109.08 15.62 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 172.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.466 ' H ' ' HB3' ' A' ' 30' ' ' HIS . 70.5 m80 . . . . . 0 C--N 1.295 -1.762 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.693 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.61 0.243 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -101.08 132.13 46.67 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 60.0 m -73.41 93.7 1.98 Allowed 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -116.63 -17.82 10.47 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.949 -167.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -76.43 114.74 15.47 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.393 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.33 118.56 10.86 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.893 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.5 mt -92.88 -57.6 2.6 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.844 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.493 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -163.24 -168.59 25.44 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.647 -176.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -124.33 125.0 43.61 Favored 'General case' 0 C--O 1.249 1.043 0 C-N-CA 123.636 0.774 . . . . 0.0 110.521 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -107.86 148.61 37.73 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.808 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -86.82 113.06 1.02 Allowed 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 121.955 1.77 . . . . 0.0 110.695 174.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 47.8 t -139.75 113.54 6.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -177.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -144.35 128.26 8.98 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.92 143.87 78.32 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 123.914 -1.286 . . . . 0.0 110.391 -2.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 16.2 t -96.15 134.76 38.84 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.225 -174.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -136.02 156.65 48.42 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -48.38 -51.14 27.91 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.492 1.117 . . . . 0.0 112.053 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -76.5 -35.65 58.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.005 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.43 92.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.565 0.221 . . . . 0.0 110.434 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.3 t -61.65 -47.33 85.85 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -55.11 -46.98 75.61 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.674 0.789 . . . . 0.0 110.493 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.8 t -67.62 -46.33 72.82 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.828 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.83 -31.41 41.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.172 0 CA-C-O 121.422 0.63 . . . . 0.0 110.715 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 60.2 m -60.16 -28.09 67.63 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.557 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -80.83 -15.07 57.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 0.0 111.371 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -85.53 -33.38 21.79 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -87.51 -43.17 12.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.939 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.493 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 87.6 m-85 -120.61 140.99 50.75 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.091 0.472 . . . . 0.0 110.645 -175.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -85.03 -27.56 26.3 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -91.42 6.92 43.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.39 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.33 159.92 29.19 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.531 0.681 . . . . 0.0 111.222 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.0 t -143.95 -48.45 0.28 Allowed 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.617 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -125.72 153.42 43.94 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -140.87 131.2 4.83 Favored Glycine 0 N--CA 1.423 -2.219 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -119.37 144.22 47.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 120.959 0.409 . . . . 0.0 110.972 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 59.8 m -100.26 117.48 34.56 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.502 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -113.81 105.73 13.62 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 120.926 0.393 . . . . 0.0 111.096 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.498 ' CD2' ' HB ' ' A' ' 43' ' ' VAL . 88.6 m-85 -81.32 99.67 8.78 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -118.81 105.3 11.39 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.84 -123.68 6.72 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.0 mtm180 -89.26 -32.83 17.2 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -96.44 165.23 12.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.322 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.498 ' HB ' ' CD2' ' A' ' 38' ' ' TYR . 7.4 p -124.12 130.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.43 -0.805 . . . . 0.0 108.926 174.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -101.54 117.26 34.55 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.543 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 37.2 t -88.19 104.15 16.44 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.544 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 5.6 m-70 -83.68 110.95 18.7 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.053 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 65.4 m -88.77 112.67 23.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.143 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -102.82 148.36 25.73 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.96 -148.66 6.8 Favored Glycine 0 C--N 1.294 -1.752 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -139.19 145.41 39.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -125.56 165.62 18.17 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.446 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 . . . . . 0 C--N 1.289 -2.055 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.638 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.532 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.485 ' HB2' ' CE1' ' A' ' 5' ' ' HIS . 12.5 m170 -99.31 110.92 23.38 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 91.9 m -79.69 47.98 0.9 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.502 0.668 . . . . 0.0 110.943 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.34 -2.54 2.48 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.692 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 55.3 m80 -81.08 126.12 31.05 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -73.04 102.83 3.62 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.864 0.728 . . . . 0.0 109.993 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.8 mt -81.07 -35.14 32.14 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.079 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.29 -174.06 41.8 Favored Glycine 0 N--CA 1.427 -1.943 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -124.97 143.64 50.78 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 117.287 0.543 . . . . 0.0 110.855 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.61 142.07 33.47 Favored Pre-proline 0 C--N 1.297 -1.686 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.601 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.83 106.43 2.09 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.405 2.07 . . . . 0.0 111.438 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.4 t -128.02 103.73 10.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 O-C-N 121.859 -0.526 . . . . 0.0 109.866 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -142.35 132.21 12.34 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -74.65 167.86 78.88 Favored 'Cis proline' 0 C--O 1.237 0.474 0 C-N-CA 123.744 -1.357 . . . . 0.0 111.434 -2.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 t -83.67 131.65 34.93 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 122.018 0.913 . . . . 0.0 112.86 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 56.2 tptt -137.62 125.77 23.01 Favored 'General case' 0 N--CA 1.387 -3.622 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 170.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -41.41 70.0 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -176.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.74 -41.04 84.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.576 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . . . -63.81 -47.01 82.55 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.038 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.5 t -54.96 -50.55 68.63 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.359 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.72 -41.23 99.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.164 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 27.4 t -61.78 -55.51 29.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 19' ' ' ALA . 98.2 t -55.35 -43.89 73.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 123.684 0.615 . . . . 0.0 110.511 -177.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.1 m -58.06 -42.21 84.99 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.845 0.684 . . . . 0.0 112.845 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 54.9 mtpt -75.34 -23.96 57.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.279 0.562 . . . . 0.0 111.431 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 22' ' ' SER . 45.1 mt-10 -77.89 -33.46 51.96 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.957 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -85.27 -44.86 12.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.152 0.501 . . . . 0.0 110.285 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -116.7 107.16 14.33 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -64.62 -19.74 65.86 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -89.96 0.93 56.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.452 ' O ' ' HG2' ' A' ' 25' ' ' LYS . . . -78.07 138.14 38.61 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.095 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.41 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 2.5 p -134.82 1.0 3.0 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.722 0.772 . . . . 0.0 110.454 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 59.2 tptt -148.94 142.42 25.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.19 126.63 2.07 Favored Glycine 0 CA--C 1.481 -2.08 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.85 140.08 52.62 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.621 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.43 ' HB3' HG21 ' A' ' 43' ' ' VAL . 59.6 m -76.14 102.31 5.7 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 5.9 mm-40 -94.61 110.69 22.49 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.458 0.647 . . . . 0.0 109.762 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -77.61 103.93 7.84 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.839 -174.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -127.05 99.38 5.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.53 -149.72 21.34 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -175.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -95.95 -50.59 4.81 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.014 0.435 . . . . 0.0 110.603 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -78.64 103.08 8.34 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.6 0.714 . . . . 0.0 109.797 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 36' ' ' CYS . 14.8 p -76.21 150.0 6.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.621 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -123.51 151.52 42.72 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 39.3 m -96.87 126.29 41.91 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-O 120.72 0.295 . . . . 0.0 110.492 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.408 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 46.7 m170 -90.61 117.99 29.71 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.9 m -92.5 123.1 35.56 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.912 -174.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 67.3 m-85 -117.73 141.98 47.78 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.215 -177.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 5' ' ' HIS . . . -170.6 -168.68 32.73 Favored Glycine 0 C--N 1.289 -2.083 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -119.92 108.85 14.84 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -100.88 117.26 34.6 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 C--N 1.292 -1.917 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 179.848 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.605 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -105.88 144.79 32.12 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.3 m -113.34 97.61 6.58 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -144.53 -34.95 0.35 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.8 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -75.13 120.55 20.79 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -65.19 119.97 11.86 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.1 mt -94.15 -43.47 8.46 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.105 0.479 . . . . 0.0 110.043 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.427 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -177.53 -160.47 24.28 Favored Glycine 0 N--CA 1.419 -2.45 0 C-N-CA 119.49 -1.338 . . . . 0.0 112.98 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -131.69 131.22 42.92 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 123.677 0.791 . . . . 0.0 110.29 -171.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.56 143.96 44.82 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -89.09 111.1 0.53 Allowed 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 122.714 2.276 . . . . 0.0 112.558 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.4 t -132.12 104.05 7.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -138.21 124.01 12.62 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -74.58 147.45 89.42 Favored 'Cis proline' 0 C--N 1.347 0.466 0 C-N-CA 123.66 -1.392 . . . . 0.0 110.818 -2.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.5 t -91.23 142.17 28.01 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.367 0.603 . . . . 0.0 111.748 -174.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -137.03 152.77 50.48 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 172.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.25 -47.29 85.02 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.14 -40.44 86.74 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.076 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -61.11 -46.8 89.14 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.929 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t -59.3 -48.59 81.07 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 123.622 0.769 . . . . 0.0 109.712 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -55.77 -46.04 78.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.812 0.845 . . . . 0.0 110.182 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.3 t -64.66 -45.76 85.37 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.626 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 19' ' ' ALA . 94.5 t -64.51 -38.6 83.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 CA-C-O 121.048 0.451 . . . . 0.0 110.322 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 83.2 m -58.92 -38.9 80.0 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.24 175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -64.04 -37.58 87.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.908 0.385 . . . . 0.0 110.621 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.28 -47.57 79.02 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.838 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -81.94 -39.48 23.66 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 63.1 m-85 -127.5 112.93 15.49 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -60.2 -37.33 79.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.872 0.367 . . . . 0.0 111.81 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -89.3 6.76 38.96 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . . . -80.3 140.8 35.99 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.3 p -123.96 -28.75 3.73 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 121.013 0.435 . . . . 0.0 111.426 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -140.65 147.88 39.98 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.13 150.75 20.78 Favored Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -121.58 144.15 48.9 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 123.844 0.379 . . . . 0.0 110.197 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.5 m -84.83 102.1 12.8 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.486 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 8.4 mm-40 -92.14 109.38 20.74 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.135 0.493 . . . . 0.0 110.387 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -86.97 101.34 13.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.667 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -144.73 110.01 5.18 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.43 -159.48 28.47 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -88.93 -20.73 24.14 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.374 0.587 . . . . 0.0 110.692 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -91.94 146.39 23.78 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.11 124.4 67.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -98.3 123.75 42.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.927 -172.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 m -87.69 114.36 24.23 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.01 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.486 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 42.0 m170 -94.36 120.42 34.57 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 174.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.5 m -94.94 128.89 42.08 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.297 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -108.35 141.67 39.82 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.7 175.64 46.92 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 119.663 -1.256 . . . . 0.0 112.772 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -126.39 116.08 20.63 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.732 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -74.55 112.77 11.06 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.22 0.533 . . . . 0.0 111.452 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 . . . . . 0 C--N 1.294 -1.841 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.151 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.662 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -84.84 104.41 14.77 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.775 0.798 . . . . 0.0 110.832 178.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 88.1 m -113.5 96.94 6.15 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.013 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -117.83 -22.92 7.74 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.026 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 52.3 m80 -89.03 134.82 33.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.874 -176.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -66.58 131.14 45.36 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.855 0.36 . . . . 0.0 110.377 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' A' ' 31' ' ' ALA . 25.2 mt -103.04 -19.26 14.63 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.997 0.903 . . . . 0.0 108.849 175.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.07 -174.63 30.29 Favored Glycine 0 N--CA 1.409 -3.152 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -177.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -123.0 158.97 29.35 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.03 132.29 24.25 Favored Pre-proline 0 C--N 1.298 -1.633 0 O-C-N 123.318 0.386 . . . . 0.0 110.401 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HA ' ' NE2' ' A' ' 44' ' ' HIS . 58.8 Cg_endo -76.07 102.05 1.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.502 2.134 . . . . 0.0 112.752 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 m -143.95 140.75 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 123.357 0.663 . . . . 0.0 109.815 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.433 ' CD2' ' HA ' ' A' ' 14' ' ' PRO . 68.8 t80 -160.07 128.46 2.94 Favored Pre-proline 0 C--N 1.314 -0.96 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.433 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 8.9 Cg_exo -68.56 145.3 76.31 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 124.048 -1.23 . . . . 0.0 112.097 3.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.1 t -99.55 106.45 18.44 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -115.27 151.26 34.85 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.11 -41.55 68.42 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 124.049 0.843 . . . . 0.0 113.237 -175.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.6 -45.54 75.16 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.459 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.09 75.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.34 -51.12 69.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.878 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.27 -39.1 81.82 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.424 0.69 . . . . 0.0 111.149 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -70.12 -49.35 51.63 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.69 -40.9 80.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 123.39 0.676 . . . . 0.0 110.996 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 67.5 m -59.44 -44.07 92.99 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -72.61 -24.2 61.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.066 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -75.3 -47.72 26.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.397 177.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -79.99 -35.33 37.58 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.953 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -126.21 112.27 15.57 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -74.78 -18.21 60.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -92.17 8.81 36.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.098 0.475 . . . . 0.0 110.912 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB2' HD12 ' A' ' 7' ' ' LEU . . . -96.49 139.48 32.52 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.3 p -124.43 -20.07 5.28 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.103 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.58 134.78 35.99 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.55 -176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.05 148.71 16.84 Favored Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.24 138.9 33.59 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.1 m -87.91 122.11 31.14 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -128.73 143.23 50.88 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.12 100.81 10.76 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -115.8 100.49 8.05 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 -102.57 2.55 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.06 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -98.09 -55.61 2.73 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.173 0.511 . . . . 0.0 110.245 -177.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -99.53 167.36 10.65 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.404 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.3 p -99.17 135.94 32.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.522 ' NE2' ' HA ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -138.09 160.26 39.86 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.807 -178.699 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.6 t -85.97 114.79 23.14 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.276 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -102.61 125.72 49.44 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 68.4 m -95.59 127.06 41.31 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.854 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 80.6 m-85 -112.06 147.97 34.89 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.326 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.62 -141.57 6.3 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -113.64 127.24 55.98 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -108.88 146.69 33.32 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.813 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 . . . . . 0 C--N 1.29 -2.001 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.42 176.559 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.574 0 CA-C-O 121.262 0.553 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -93.13 141.9 27.9 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.527 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 58.6 m -119.42 70.59 0.85 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -121.3 -43.23 2.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.912 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -83.9 135.6 34.43 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.084 -177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -85.99 116.41 24.19 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.416 HD11 ' HA3' ' A' ' 49' ' ' GLY . 89.9 mt -74.86 -33.47 62.12 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.609 0.718 . . . . 0.0 109.125 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.63 -178.3 37.57 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.94 143.13 38.59 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.08 132.9 24.25 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.15 140.97 18.15 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.503 2.135 . . . . 0.0 111.36 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.443 HG11 ' SG ' ' A' ' 45' ' ' CYS . 13.8 p -141.8 143.68 26.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 120.73 0.3 . . . . 0.0 110.688 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 84.3 t80 -148.43 123.34 5.0 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 2.0 Cg_endo -84.98 163.88 61.92 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.822 -1.324 . . . . 0.0 110.939 -2.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.21 92.36 3.83 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.1 0.952 . . . . 0.0 112.78 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -117.77 141.92 47.86 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 168.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.08 -43.22 91.8 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 118.218 0.463 . . . . 0.0 111.63 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.65 -48.69 80.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.234 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.43 -42.36 92.52 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.034 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.7 t -56.44 -54.76 41.92 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 124.115 0.966 . . . . 0.0 110.983 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -59.44 -38.24 80.18 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 121.168 0.508 . . . . 0.0 110.098 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.578 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 49.1 m -66.78 -54.62 20.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.592 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.6 t -60.65 -37.46 75.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-O 121.241 0.543 . . . . 0.0 110.457 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.8 t -56.19 -46.28 79.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.009 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 60.6 mtpt -72.82 -19.78 61.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.627 0.371 . . . . 0.0 111.689 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 22' ' ' SER . 24.6 mm-40 -74.92 -42.51 57.59 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -75.83 -45.54 35.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.246 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 54.3 m-85 -123.51 104.97 9.39 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -65.63 -24.15 66.98 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -175.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -84.02 0.03 49.8 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.28 123.86 23.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.427 0.632 . . . . 0.0 111.531 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.0 p -101.61 -29.09 12.14 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.999 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -136.37 128.84 30.34 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.847 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -133.89 118.45 2.06 Favored Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -135.13 140.44 45.44 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.056 -0.658 . . . . 0.0 112.735 -177.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.7 m -63.1 120.38 11.35 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.991 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -118.14 114.22 22.75 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -77.72 102.48 7.15 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -126.55 97.06 4.88 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.95 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.56 -112.97 3.77 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.319 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -83.38 -46.11 12.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.205 0.526 . . . . 0.0 111.816 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -97.88 170.73 8.75 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.936 0.874 . . . . 0.0 112.481 -172.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.1 113.77 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -125.35 157.95 35.47 Favored 'General case' 0 C--N 1.277 -2.587 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.443 ' SG ' HG11 ' A' ' 12' ' ' VAL . 65.6 m -80.88 111.1 17.04 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.404 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 31.2 m170 -80.4 124.41 28.87 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 92.4 m -97.91 112.63 24.48 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.326 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -95.3 133.44 39.2 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 176.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.416 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -154.51 155.33 26.13 Favored Glycine 0 C--N 1.287 -2.159 0 C-N-CA 117.506 -2.283 . . . . 0.0 114.436 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -101.65 118.41 36.88 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -137.7 140.65 40.87 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.513 -174.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 . . . . . 0 C--N 1.296 -1.736 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 171.984 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.03 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.461 ' CD2' ' HB2' ' A' ' 4' ' ' ASP . 15.2 p-80 -87.7 172.9 9.35 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 123.326 0.391 . . . . 0.0 110.064 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.51 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 96.3 m -85.0 94.93 8.93 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.198 0.523 . . . . 0.0 110.987 178.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.461 ' HB2' ' CD2' ' A' ' 2' ' ' HIS . 29.9 t70 -119.43 -35.76 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.445 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -74.49 131.91 41.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.413 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.15 111.58 10.53 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.416 HD11 ' HA3' ' A' ' 49' ' ' GLY . 80.2 mt -79.26 -30.61 43.17 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-O 121.392 0.615 . . . . 0.0 109.551 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.407 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . 163.02 -154.22 25.08 Favored Glycine 0 N--CA 1.404 -3.462 0 C-N-CA 120.502 -0.856 . . . . 0.0 110.997 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -128.65 158.19 39.23 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HB1' HG12 ' A' ' 23' ' ' VAL . . . -135.94 139.96 31.94 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.863 176.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.17 114.2 2.49 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.36 2.04 . . . . 0.0 112.594 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 p -155.13 114.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -159.19 127.33 2.86 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.694 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.05 154.68 80.83 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.689 -1.379 . . . . 0.0 111.661 -3.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 51.3 t -117.41 137.59 52.39 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 19' ' ' ALA . 13.8 mptt -103.04 157.13 17.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.16 -41.73 97.3 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.709 0.766 . . . . 0.0 110.562 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -75.1 -25.74 58.76 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.518 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.403 ' HB3' ' H ' ' A' ' 16' ' ' LYS . . . -76.51 -36.69 57.62 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.038 -178.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.5 t -64.9 -36.5 84.56 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -60.98 -47.77 84.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.849 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.9 p -70.74 -43.48 68.75 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.288 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.413 HG12 ' HB1' ' A' ' 10' ' ' ALA . 88.1 t -63.54 -46.24 95.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.7 m -59.01 -38.05 78.31 Favored 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -64.02 -33.27 75.37 Favored 'General case' 0 N--CA 1.425 -1.685 0 C-N-CA 123.076 0.55 . . . . 0.0 111.14 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.83 -19.77 30.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -89.19 -38.1 14.52 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.748 -0.595 . . . . 0.0 111.066 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.407 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 57.4 m-85 -133.94 110.8 9.95 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -71.77 -8.29 53.34 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.699 0.762 . . . . 0.0 110.769 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -86.64 -6.23 58.92 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.306 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.38 132.16 39.3 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.766 -177.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 p -112.02 -21.25 11.63 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -132.73 141.45 48.56 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.792 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.87 147.23 18.98 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -138.52 119.49 14.36 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 118.371 1.085 . . . . 0.0 110.188 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 25.8 m -82.27 109.14 16.27 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.263 176.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -125.38 148.11 48.91 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.084 -177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 81.7 m-85 -73.9 103.0 4.26 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.647 0.736 . . . . 0.0 110.799 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -94.93 89.86 5.78 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.99 -98.69 2.45 Favored Glycine 0 N--CA 1.423 -2.179 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -176.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -108.15 -52.63 2.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.021 0.439 . . . . 0.0 110.414 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.95 170.73 9.22 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.343 -173.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 7.3 p -89.48 132.84 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-O 121.304 0.573 . . . . 0.0 110.312 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 11.6 m-70 -120.83 137.17 54.68 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.8 t -88.04 105.31 17.39 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -89.67 118.58 29.38 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.3 m -91.28 124.01 35.15 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.015 -176.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -108.01 138.81 43.61 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.51 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -167.87 -155.8 9.63 Favored Glycine 0 C--N 1.297 -1.611 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -120.19 133.26 55.53 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -140.8 134.05 29.62 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 . . . . . 0 C--N 1.303 -1.416 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.993 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.462 0.172 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -111.65 -178.4 3.43 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 74.3 m -68.6 38.02 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -101.79 -24.03 14.11 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -76.66 139.66 40.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.516 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.63 130.28 41.16 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.736 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.4 mt -89.69 -23.73 21.77 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.645 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.59 -179.92 25.04 Favored Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 12.0 pt-20 -105.9 146.34 30.09 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.29 138.98 32.7 Favored Pre-proline 0 C--N 1.302 -1.466 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.74 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.76 131.46 13.46 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.641 2.227 . . . . 0.0 112.019 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -160.63 134.01 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 122.558 0.343 . . . . 0.0 110.386 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.471 ' CG ' ' HA ' ' A' ' 14' ' ' PRO . 33.8 t80 -155.7 140.9 12.37 Favored Pre-proline 0 N--CA 1.435 -1.191 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.471 ' HA ' ' CG ' ' A' ' 13' ' ' TYR . 4.5 Cg_exo -76.12 168.36 77.5 Favored 'Cis proline' 0 C--O 1.25 1.124 0 C-N-CA 123.867 -1.305 . . . . 0.0 111.948 -0.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -78.85 114.1 17.5 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.851 0.834 . . . . 0.0 110.858 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 42.3 tptt -138.32 136.59 36.56 Favored 'General case' 0 N--CA 1.394 -3.252 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 175.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.51 -47.39 82.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 124.065 0.853 . . . . 0.0 110.085 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -64.68 -38.22 90.24 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.386 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.72 -43.42 72.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.6 t -59.08 -51.62 69.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.214 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.39 -38.67 84.7 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.296 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.2 m -66.27 -48.6 69.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.643 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.25 -40.25 88.35 Favored 'Isoleucine or valine' 0 C--O 1.255 1.361 0 CA-C-O 121.033 0.444 . . . . 0.0 109.894 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 57.8 m -54.81 -46.24 74.5 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.65 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 29' ' ' HIS . 96.5 mttt -57.17 -36.31 70.63 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 123.359 0.412 . . . . 0.0 111.913 177.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -73.12 -42.35 62.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.642 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -79.49 -39.43 32.13 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.969 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -134.52 102.63 5.38 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 72.6 m-70 -62.46 -22.1 65.97 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -169.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.418 ' CG ' ' HA ' ' A' ' 51' ' ' TYR . 67.3 m-70 -96.54 12.82 30.19 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.741 0.305 . . . . 0.0 111.466 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.73 127.77 33.53 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.015 0.436 . . . . 0.0 110.694 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.3 p -106.84 -20.9 13.19 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.988 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -156.51 157.38 35.33 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -140.23 150.18 21.38 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.692 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -124.17 127.59 47.99 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 69.5 m -83.32 107.8 16.09 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.373 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -116.93 133.28 56.21 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 98.9 m-85 -81.64 131.08 35.26 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.826 0.346 . . . . 0.0 110.705 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -125.47 106.49 9.83 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.9 -97.85 1.15 Allowed Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -126.2 -2.91 6.94 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 111.682 0.252 . . . . 0.0 111.682 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -126.66 147.46 49.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 9.5 p -90.43 137.83 20.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 120.683 0.278 . . . . 0.0 110.594 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -125.71 151.86 46.07 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 2.2 m -97.69 126.77 43.2 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 177.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -84.75 110.4 18.77 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 171.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.3 m -89.53 124.9 34.94 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.823 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -96.09 148.9 22.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.61 171.19 30.55 Favored Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.617 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -127.58 113.99 16.81 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.418 ' HA ' ' CG ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -99.22 170.6 8.55 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.209 -172.805 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 36.8 m80 . . . . . 0 C--N 1.318 -0.791 0 C-N-CA 125.489 1.516 . . . . 0.0 108.548 -175.212 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 98.3 m . . . . . 0 C--O 1.225 -0.236 0 CA-C-O 121.431 0.634 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -87.15 1.67 52.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.119 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 34.6 m80 -107.96 147.52 30.94 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -91.03 128.83 37.01 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.5 mt -91.5 -38.73 12.35 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.28 -151.62 14.07 Favored Glycine 0 N--CA 1.416 -2.658 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.855 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -131.67 151.04 51.93 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -122.03 137.23 27.1 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.77 94.73 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.123 1.882 . . . . 0.0 111.353 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.5 t -127.56 113.53 32.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -143.76 124.77 7.99 Favored Pre-proline 0 N--CA 1.434 -1.23 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.58 149.88 93.05 Favored 'Cis proline' 0 C--O 1.246 0.907 0 C-N-CA 123.421 -1.491 . . . . 0.0 110.429 -0.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.2 t -94.7 109.3 21.26 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.192 0.52 . . . . 0.0 110.564 -173.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.73 138.79 36.32 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 173.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -47.03 -49.24 21.5 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 124.35 1.031 . . . . 0.0 112.548 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -73.02 -37.67 66.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.945 0.403 . . . . 0.0 111.466 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -67.68 -39.38 84.48 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.8 t -59.2 -49.34 78.22 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.423 0.689 . . . . 0.0 109.461 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HG3' ' HA ' ' A' ' 33' ' ' LYS . 58.7 tttm -57.61 -34.87 69.73 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.256 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 m -76.54 -46.06 28.03 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.881 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 19' ' ' ALA . 73.3 t -68.04 -33.79 63.1 Favored 'Isoleucine or valine' 0 C--O 1.254 1.34 0 CA-C-O 121.297 0.57 . . . . 0.0 110.449 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.6 m -56.98 -38.72 73.42 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.304 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 51.5 mtpt -71.7 -21.79 61.73 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.925 0.393 . . . . 0.0 111.409 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -73.45 -48.54 32.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -77.35 -47.17 20.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.961 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -116.8 107.97 15.29 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -69.58 -21.43 63.6 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -98.26 16.71 20.57 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.159 0.504 . . . . 0.0 110.415 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.48 142.8 31.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.622 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 2.0 p -115.41 -44.01 3.01 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.855 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.471 ' HA ' ' HG3' ' A' ' 21' ' ' LYS . 82.3 tttt -120.46 153.35 36.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.411 ' N ' ' HG2' ' A' ' 33' ' ' LYS . . . -141.05 140.08 10.1 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 107.161 -2.376 . . . . 0.0 107.161 174.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -144.52 144.19 31.21 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 118.02 0.91 . . . . 0.0 109.977 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.5 m -92.58 127.07 37.94 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.2 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -137.73 147.16 44.52 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.424 ' CE2' ' HB ' ' A' ' 43' ' ' VAL . 74.5 m-85 -86.15 126.69 34.42 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.187 0.518 . . . . 0.0 110.485 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.36 111.03 14.02 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.531 ' O ' ' HD2' ' A' ' 41' ' ' ARG . . . 81.31 -101.59 2.12 Favored Glycine 0 N--CA 1.413 -2.847 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.531 ' HD2' ' O ' ' A' ' 40' ' ' GLY . 12.7 mmm180 -125.72 -31.87 2.9 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -87.29 159.94 18.6 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.201 0.524 . . . . 0.0 111.206 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.424 ' HB ' ' CE2' ' A' ' 38' ' ' TYR . 12.7 p -95.85 127.26 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.091 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -108.75 139.89 42.93 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.648 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 35.8 t -91.16 108.1 19.64 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -94.93 125.72 39.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.992 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.6 m -96.51 121.57 38.47 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.101 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.456 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 62.9 m-85 -105.24 141.25 37.11 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.622 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -178.96 -174.64 45.32 Favored Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--N 1.286 -2.195 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.676 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.435 -1.21 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -119.99 9.16 11.15 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -107.04 114.04 27.88 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -69.22 123.44 21.15 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.9 mt -96.95 -49.48 5.01 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.567 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.421 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -177.78 -179.33 47.87 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.5 127.99 56.29 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.082 0.468 . . . . 0.0 110.246 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.19 141.93 25.33 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.625 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.99 104.92 1.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.473 2.115 . . . . 0.0 111.104 176.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -123.25 103.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -136.24 122.81 14.04 Favored Pre-proline 0 C--N 1.304 -1.412 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.223 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.25 147.16 86.69 Favored 'Cis proline' 0 C--O 1.245 0.847 0 C-N-CA 123.66 -1.392 . . . . 0.0 111.826 1.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.4 t -68.31 120.17 14.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.477 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -141.54 140.82 33.53 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 17' ' ' GLU . 1.5 mp0 -56.98 -48.13 79.14 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.359 0.664 . . . . 0.0 111.109 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -62.47 -44.61 95.97 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.427 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.41 -45.16 94.61 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.566 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -54.67 -52.57 61.95 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.177 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 25.3 ttmm -59.71 -38.06 80.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 122.991 0.182 . . . . 0.0 110.938 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 t -72.37 -51.16 21.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.763 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.9 t -60.69 -37.98 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.584 0.354 . . . . 0.0 110.606 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.8 m -61.16 -37.99 84.86 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 21' ' ' LYS . 98.5 mttt -66.93 -35.25 79.58 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.713 0.768 . . . . 0.0 109.87 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.41 -35.39 70.97 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.474 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -84.32 -45.76 12.47 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.88 176.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 25.0 m-85 -126.28 130.42 50.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -72.95 -21.68 60.83 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.46 0.648 . . . . 0.0 110.916 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -94.5 -2.83 51.01 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.408 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . . . -83.82 126.73 33.24 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.397 0.617 . . . . 0.0 111.381 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.64 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 1.7 p -116.69 -28.86 6.25 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.44 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -124.32 135.18 53.16 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 122.07 -0.394 . . . . 0.0 110.77 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.94 136.04 9.17 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -147.28 131.51 17.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -175.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.6 m -91.21 137.16 32.58 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 120.985 0.421 . . . . 0.0 111.798 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -133.99 132.51 40.21 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.453 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 65.8 m-85 -88.57 136.23 33.1 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.328 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -127.46 90.09 3.07 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.54 -113.72 3.69 Favored Glycine 0 N--CA 1.432 -1.584 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -172.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -98.95 -33.46 10.83 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -76.21 150.98 36.99 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.938 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.453 ' HB ' ' CD1' ' A' ' 38' ' ' TYR . 7.8 p -146.58 133.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -126.28 160.34 30.6 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.691 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.5 t -97.74 119.92 37.19 Favored 'General case' 0 N--CA 1.41 -2.469 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -87.71 122.72 31.73 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.0 m -97.27 126.49 42.52 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.038 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -114.68 149.64 36.43 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.64 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -155.98 -170.13 20.96 Favored Glycine 0 C--N 1.288 -2.132 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 C--N 1.3 -1.564 0 CA-C-N 117.043 0.421 . . . . 0.0 109.871 176.874 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.0 m . . . . . 0 C--O 1.242 0.695 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -144.67 15.13 1.58 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.523 0.678 . . . . 0.0 110.441 175.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 14.0 t60 -105.64 136.27 45.54 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -81.82 126.92 32.43 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.704 0.288 . . . . 0.0 110.483 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.468 HD11 ' HA3' ' A' ' 49' ' ' GLY . 85.7 mt -86.13 -44.49 12.2 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.7 -168.93 42.06 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 12.2 pt-20 -115.75 149.88 37.77 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 120.767 0.318 . . . . 0.0 110.506 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.19 138.11 18.85 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.5 141.91 22.94 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 121.887 1.724 . . . . 0.0 111.307 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 p -140.23 149.71 21.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -160.01 123.7 2.01 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.83 169.85 45.15 Favored 'Cis proline' 0 C--O 1.241 0.651 0 C-N-CA 124.557 -1.018 . . . . 0.0 111.364 -1.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.1 t -75.84 94.81 3.38 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -126.94 139.66 52.89 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 168.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.16 -45.78 75.71 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 123.555 0.534 . . . . 0.0 112.315 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -61.01 -39.36 89.44 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.583 0.552 . . . . 0.0 111.32 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -41.47 67.16 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.163 0.506 . . . . 0.0 110.061 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -60.73 -48.77 80.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.775 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 88.2 tttt -59.85 -41.61 91.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.779 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.9 m -59.56 -55.01 39.87 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.614 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.456 ' O ' ' HD2' ' A' ' 27' ' ' HIS . 13.0 p -65.76 -36.3 77.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.525 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.0 m -59.01 -39.5 82.09 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.804 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 30.4 mtpp -73.06 -27.59 61.83 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.703 0.287 . . . . 0.0 111.066 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -67.55 -37.6 82.92 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.208 0.528 . . . . 0.0 110.2 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.456 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 40.4 m-70 -77.73 -60.02 2.54 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.502 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 18.6 m-85 -120.23 106.45 11.93 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -175.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -56.57 -31.46 64.23 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -174.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -79.53 4.86 14.49 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.44 126.97 30.5 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.381 0.61 . . . . 0.0 109.989 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 p -124.16 -11.19 7.54 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.022 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 58.1 tptt -148.16 123.82 10.49 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.797 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.32 135.75 13.09 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -122.71 127.16 48.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 93.0 m -76.38 116.45 17.07 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.092 0.472 . . . . 0.0 111.759 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -110.19 98.86 8.02 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -78.61 103.02 8.28 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -113.28 89.23 3.03 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -174.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.53 -81.99 0.6 Allowed Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.585 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -85.09 -68.37 0.73 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -128.3 -179.17 4.87 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -172.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.24 126.21 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 121.876 0.846 . . . . 0.0 112.583 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -107.34 133.33 52.03 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 5.3 m -92.03 126.75 37.24 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.342 176.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -87.45 113.07 22.83 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 m -90.77 109.73 20.92 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.09 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 97.8 m-85 -89.79 139.46 30.55 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -134.04 168.1 23.46 Favored Glycine 0 N--CA 1.419 -2.478 0 C-N-CA 118.997 -1.573 . . . . 0.0 114.544 -175.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--N 1.303 -1.437 0 CA-C-N 114.223 -0.989 . . . . 0.0 110.36 -178.753 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.439 -0.988 0 CA-C-O 120.924 0.392 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -122.15 -1.11 9.3 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.547 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 5.4 t-160 -80.38 110.79 16.16 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 -178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -66.67 104.88 1.39 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.56 -52.49 5.79 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.591 -177.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.52 -161.21 20.69 Favored Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -134.04 148.42 51.07 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.008 0.432 . . . . 0.0 110.741 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.566 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -129.12 151.82 78.33 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.194 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -93.06 131.68 0.88 Allowed 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 122.14 1.893 . . . . 0.0 112.878 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -160.65 127.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 123.125 0.57 . . . . 0.0 109.844 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -142.19 129.92 11.51 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.37 145.44 83.5 Favored 'Cis proline' 0 C--O 1.244 0.818 0 C-N-CA 123.344 -1.523 . . . . 0.0 110.63 -0.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 t -87.44 101.52 13.67 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.744 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -98.48 148.91 23.26 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.529 ' H ' ' CD ' ' A' ' 17' ' ' GLU . 1.9 mp0 -51.51 -54.57 25.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.211 0.604 . . . . 0.0 110.42 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.79 -42.07 99.55 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.256 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.85 95.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.418 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.9 t -61.04 -48.91 79.57 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 32' ' ' CYS . 87.6 tttt -56.24 -42.17 76.88 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.557 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -66.36 -52.41 47.19 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.869 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.5 t -62.01 -37.7 78.97 Favored 'Isoleucine or valine' 0 C--O 1.257 1.472 0 CA-C-O 121.292 0.568 . . . . 0.0 111.018 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.0 m -59.32 -33.24 70.87 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 21' ' ' LYS . 52.9 mtmt -75.43 -18.96 59.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.062 0.392 . . . . 0.0 111.033 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -83.76 -40.54 18.67 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -79.43 -44.25 21.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.9 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -121.64 108.21 13.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -67.01 -18.87 65.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -90.84 -5.19 55.92 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.49 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.1 140.42 37.84 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 121.108 0.48 . . . . 0.0 110.191 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.46 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -139.45 4.9 2.21 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.509 -178.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 60.0 tttm -150.87 142.66 23.77 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.77 139.36 10.14 Favored Glycine 0 C--N 1.298 -1.575 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -135.9 137.58 41.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 61.6 m -85.12 129.71 34.75 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.628 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -126.11 130.15 50.5 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -93.38 115.96 28.52 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.355 0.597 . . . . 0.0 111.454 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -111.3 92.27 3.98 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.72 -113.57 4.26 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -101.3 -12.77 18.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.84 125.8 40.65 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.568 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.3 p -95.02 125.74 47.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -107.61 139.24 42.45 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 35.4 t -96.65 109.65 22.23 Favored 'General case' 0 C--N 1.279 -2.462 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -92.63 124.51 36.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.235 0.54 . . . . 0.0 110.367 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.8 m -94.35 122.52 36.98 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.721 -173.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 67.5 m-85 -113.62 136.62 52.63 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.34 178.91 26.56 Favored Glycine 0 N--CA 1.416 -2.676 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.293 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.0 t70 . . . . . 0 C--N 1.288 -2.075 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 175.242 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.439 -0.999 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -131.16 -59.47 0.98 Allowed 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.628 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -89.65 153.61 20.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.084 0.468 . . . . 0.0 110.923 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -77.46 136.61 38.38 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.614 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.47 HD11 ' HA3' ' A' ' 49' ' ' GLY . 95.2 mt -95.27 -19.12 20.26 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.51 -178.99 34.5 Favored Glycine 0 N--CA 1.405 -3.386 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.338 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -112.75 149.93 32.28 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.85 152.75 77.99 Favored Pre-proline 0 C--N 1.283 -2.289 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -83.65 142.71 10.44 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.268 1.978 . . . . 0.0 110.766 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p -151.92 136.81 10.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.29 0.567 . . . . 0.0 111.822 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -160.42 132.01 4.04 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.07 159.51 93.12 Favored 'Cis proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.31 -1.121 . . . . 0.0 112.044 -0.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.582 ' SG ' HG21 ' A' ' 43' ' ' VAL . 48.3 t -78.48 127.82 32.71 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.488 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 23.4 tptp -166.66 143.67 4.87 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -48.05 76.84 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.79 -36.9 84.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 117.947 0.34 . . . . 0.0 111.714 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -62.9 -50.5 70.62 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.9 t -63.85 -40.11 95.8 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.545 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -62.74 -32.02 73.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 19.0 t -77.45 -46.9 21.12 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 19' ' ' ALA . 78.7 t -52.41 -47.96 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.138 0.575 . . . . 0.0 110.11 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 58.0 m -55.59 -43.14 75.73 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 32' ' ' CYS . 94.7 mttt -75.87 -25.93 56.62 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.931 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 22' ' ' SER . 45.0 mt-10 -81.07 -19.07 44.51 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.889 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.422 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 50.7 m-70 -102.53 -39.53 7.06 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.31 174.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -121.2 115.04 22.29 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -66.43 -29.07 69.13 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -84.81 3.69 36.57 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.18 137.65 39.0 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.146 0.498 . . . . 0.0 110.684 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.448 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 5.6 p -124.42 -23.47 4.45 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.297 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -136.21 142.2 44.07 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -136.13 125.25 3.47 Favored Glycine 0 C--N 1.292 -1.909 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -115.39 135.67 53.88 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 117.652 0.726 . . . . 0.0 110.974 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.508 ' SG ' HG21 ' A' ' 43' ' ' VAL . 9.6 t -96.0 100.61 12.27 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -174.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.95 131.01 53.49 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.003 0.43 . . . . 0.0 111.876 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 74.7 m-85 -75.94 126.24 30.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.042 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -140.21 130.83 25.63 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.164 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.28 -116.17 5.12 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -120.06 0.23 10.69 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.084 0.468 . . . . 0.0 111.005 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -130.63 -169.91 2.24 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.11 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.582 HG21 ' SG ' ' A' ' 15' ' ' CYS . 11.8 p -114.42 138.32 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-O 120.899 0.381 . . . . 0.0 110.731 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -111.71 137.12 50.03 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.6 t -94.85 109.12 21.14 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.433 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 28.5 m170 -89.52 113.68 25.11 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 121.156 0.503 . . . . 0.0 110.65 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.4 m -94.24 109.68 21.47 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.151 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -97.07 132.82 42.49 Favored 'General case' 0 C--O 1.255 1.385 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.47 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -135.2 -176.23 14.25 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 119.125 -1.512 . . . . 0.0 113.433 -176.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--N 1.3 -1.58 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.617 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 N--CA 1.439 -0.984 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -125.74 -32.04 2.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.81 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -70.69 124.12 23.51 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.478 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -70.63 105.96 3.33 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 124.238 0.961 . . . . 0.0 108.821 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.1 mt -77.65 -31.67 52.84 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.572 0.701 . . . . 0.0 109.155 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.68 -162.37 33.93 Favored Glycine 0 N--CA 1.412 -2.957 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 9.6 pt-20 -124.48 124.92 43.34 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 124.02 0.483 . . . . 0.0 109.699 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.13 138.05 21.24 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.914 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.31 103.26 1.71 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.157 1.904 . . . . 0.0 110.492 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 15' ' ' CYS . 19.4 t -129.99 108.89 16.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -136.94 123.7 13.82 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.54 139.33 60.51 Favored 'Cis proline' 0 C--O 1.24 0.612 0 C-N-CA 123.466 -1.473 . . . . 0.0 110.715 -1.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.45 ' HA ' HG12 ' A' ' 12' ' ' VAL . 29.1 t -81.53 118.41 22.72 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.32 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -130.23 161.06 32.03 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.19 -65.51 0.66 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 124.434 1.094 . . . . 0.0 111.537 -172.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -64.64 -37.26 86.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.771 0.319 . . . . 0.0 110.96 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -62.96 -43.19 99.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.948 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.8 t -68.9 -39.35 79.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.398 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HB3' ' NZ ' ' A' ' 21' ' ' LYS . 8.0 mtpm? -56.06 -38.06 70.13 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 120.935 0.398 . . . . 0.0 110.036 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 40.4 m -67.89 -55.56 12.38 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.978 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 19' ' ' ALA . 80.0 t -59.42 -38.0 72.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.215 0.606 . . . . 0.0 111.567 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.416 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 80.7 m -61.46 -31.45 71.41 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -79.27 -10.99 59.95 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.597 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 22' ' ' SER . 8.6 mm-40 -93.77 -33.0 13.76 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.283 0.563 . . . . 0.0 109.888 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -92.42 -21.46 20.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.255 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -136.23 172.59 12.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -105.96 -47.44 3.86 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.074 0.464 . . . . 0.0 110.495 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -82.0 19.28 1.16 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 24' ' ' CYS . . . -87.65 126.56 35.03 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.412 -175.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.632 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 1.6 p -121.96 -27.41 4.61 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.849 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 35' ' ' GLU . 46.2 tptt -131.28 131.4 43.82 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.63 130.11 8.33 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 7.9 tp10 -134.46 133.94 41.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 118.042 0.921 . . . . 0.0 110.72 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 60.0 m -77.78 128.61 34.29 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.264 -174.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -101.55 99.85 10.2 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.31 105.62 17.78 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.073 0.463 . . . . 0.0 110.4 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -146.58 111.46 5.32 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.63 -138.54 14.32 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -98.56 -30.6 12.41 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 116.949 0.374 . . . . 0.0 110.078 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -84.41 176.91 8.37 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.366 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.46 119.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.517 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -95.36 160.07 14.7 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 14.5 t -132.61 122.4 24.66 Favored 'General case' 0 C--N 1.282 -2.355 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.788 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -90.06 134.57 34.17 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 121.454 0.645 . . . . 0.0 112.03 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.1 m -96.46 110.83 23.13 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.439 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -99.87 142.22 31.63 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.43 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.632 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -163.95 -163.66 17.38 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 t70 . . . . . 0 C--N 1.295 -1.783 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 174.443 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.49 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 99.1 m . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 122.563 1.173 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -105.49 -28.22 10.94 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.541 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -85.32 121.96 28.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.729 -175.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -67.24 112.63 4.61 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.91 -29.59 17.39 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.705 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.407 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . 170.82 175.74 39.64 Favored Glycine 0 N--CA 1.422 -2.297 0 C-N-CA 119.713 -1.232 . . . . 0.0 111.957 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -116.97 121.51 41.59 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 123.63 0.772 . . . . 0.0 109.567 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.65 133.14 20.74 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.43 114.61 4.02 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.242 1.961 . . . . 0.0 111.166 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -133.33 115.22 22.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -140.18 124.28 10.76 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -80.85 -179.69 26.06 Favored 'Cis proline' 0 C--N 1.352 0.76 0 C-N-CA 124.43 -1.071 . . . . 0.0 112.174 1.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.7 t -85.15 132.72 34.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.623 0.725 . . . . 0.0 112.392 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.45 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 17.5 tptm -149.04 132.04 16.22 Favored 'General case' 0 N--CA 1.402 -2.855 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 169.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER -52.39 -42.85 64.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -72.88 -35.55 67.18 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.27 -45.49 91.24 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.2 t -56.53 -53.18 60.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.738 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 32' ' ' CYS . 87.8 tttt -61.17 -43.28 99.14 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.373 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -61.08 -46.57 90.11 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.542 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 19' ' ' ALA . 84.3 t -67.75 -39.82 82.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.583 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.5 m -57.8 -37.93 74.62 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.39 -15.32 60.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -81.6 -37.16 28.06 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -77.95 -48.99 15.02 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.772 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.407 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 29.2 m-85 -130.99 117.73 19.61 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -78.46 0.37 26.16 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.781 0.801 . . . . 0.0 110.861 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -96.71 -1.83 45.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.654 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.4 127.49 44.37 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.153 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.445 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 16.7 p -109.24 -20.52 12.93 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 61.6 tttp -121.52 136.31 54.96 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.097 -173.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.51 122.51 2.4 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -124.43 134.17 53.16 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.864 0.364 . . . . 0.0 110.894 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 81.7 m -72.65 133.82 44.82 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -126.43 110.64 13.54 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.265 0.555 . . . . 0.0 110.805 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.417 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 73.7 m-85 -78.35 108.6 11.81 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.286 175.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -118.46 97.46 5.77 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.05 -89.64 0.98 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.994 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -126.16 -17.72 5.18 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -103.62 123.05 46.26 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.417 ' HB ' ' CD1' ' A' ' 38' ' ' TYR . 9.9 p -100.07 122.49 52.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.452 0.644 . . . . 0.0 109.434 174.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -125.37 161.27 27.39 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.1 t -95.85 121.9 38.07 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -94.14 119.0 32.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.36 126.46 36.45 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.572 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.416 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 86.4 m-85 -117.95 140.75 49.28 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.073 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.49 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -173.37 -149.57 6.97 Favored Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--N 1.301 -1.543 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.527 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.577 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 84.1 m . . . . . 0 N--CA 1.44 -0.946 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -152.17 -33.77 0.13 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.81 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -75.21 123.75 25.83 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.853 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -63.55 119.66 10.24 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.679 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 31' ' ' ALA . 91.9 mt -96.7 -55.69 2.82 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.6 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.498 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -164.77 -172.91 32.82 Favored Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.095 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -118.28 131.48 56.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -175.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.25 138.92 23.21 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.123 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.23 94.25 0.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.185 1.924 . . . . 0.0 110.37 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.9 t -116.24 102.22 13.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 122.157 -0.339 . . . . 0.0 110.735 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.432 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 47.2 t80 -145.28 135.55 11.93 Favored Pre-proline 0 N--CA 1.432 -1.332 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 36.3 Cg_endo -65.12 151.49 76.43 Favored 'Cis proline' 0 C--O 1.249 1.074 0 C-N-CA 123.821 -1.325 . . . . 0.0 112.015 -1.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -81.56 112.29 18.64 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -174.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -125.66 146.27 49.8 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -69.22 -39.97 78.24 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -58.14 -37.08 73.94 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.404 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.4 -57.28 4.99 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.624 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.9 m -54.0 -46.41 71.76 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -66.09 -22.02 66.39 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 120.682 0.277 . . . . 0.0 110.9 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -88.99 -55.13 3.81 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.4 t -56.97 -38.07 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 C-N-CA 124.265 1.026 . . . . 0.0 111.782 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 90.1 m -63.35 -28.79 70.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -78.78 -22.43 46.36 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.335 0.588 . . . . 0.0 109.465 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -80.65 -39.73 26.81 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.691 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -75.7 -47.05 27.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.786 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.498 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 53.5 m-85 -125.43 117.99 24.87 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -70.77 -14.53 62.46 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.145 0.498 . . . . 0.0 111.127 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -91.36 -1.68 57.55 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.834 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HB2' HD12 ' A' ' 7' ' ' LEU . . . -100.01 141.64 32.56 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.5 p -137.33 -5.52 1.82 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.318 0.58 . . . . 0.0 110.865 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -131.04 130.03 42.75 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -148.98 137.04 6.1 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 120.328 -0.939 . . . . 0.0 110.966 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -150.46 145.36 25.98 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.685 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 34.2 m -78.93 152.0 31.36 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -132.57 107.49 8.47 Favored 'General case' 0 N--CA 1.422 -1.826 0 C-N-CA 125.418 1.487 . . . . 0.0 108.604 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -84.33 103.49 13.54 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.586 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -148.91 113.2 5.25 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.976 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.09 -155.06 21.35 Favored Glycine 0 C--N 1.299 -1.522 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.414 ' HD2' ' OE2' ' A' ' 42' ' ' GLU . 27.8 ttm180 -79.47 -37.76 36.1 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.414 ' OE2' ' HD2' ' A' ' 41' ' ' ARG . 55.4 mm-40 -92.53 154.19 18.6 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.359 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.52 130.56 52.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -106.84 116.16 31.45 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 53.2 t -93.6 120.83 34.35 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.45 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 24.7 m170 -85.44 117.84 24.6 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.778 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.8 m -97.49 116.56 29.93 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.712 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -105.35 143.59 33.31 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.56 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.577 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -161.89 -146.97 4.83 Favored Glycine 0 N--CA 1.427 -1.906 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 C--N 1.299 -1.617 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.009 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.43 -1.456 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -120.85 -51.89 2.12 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.528 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.0 m80 -91.88 150.06 21.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -82.64 115.76 21.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.991 -1.913 . . . . 0.0 108.237 -178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.8 mt -78.62 -30.0 46.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.11 179.34 40.05 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -99.93 158.55 15.73 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.69 125.57 26.72 Favored Pre-proline 0 C--N 1.287 -2.138 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.51 95.42 1.0 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.834 2.356 . . . . 0.0 114.31 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 m -137.13 116.86 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 28.2 t80 -154.17 127.8 4.39 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.422 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 42.4 Cg_endo -65.72 131.96 14.82 Favored 'Cis proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.698 0.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.8 t -80.87 139.6 35.84 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.579 -1.192 . . . . 0.0 111.953 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -131.9 150.83 52.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.376 1.07 . . . . 0.0 109.167 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.35 -50.81 70.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -64.61 -41.27 96.32 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.885 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.63 93.89 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 123.833 0.708 . . . . 0.0 110.096 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -59.01 -55.12 39.18 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.382 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.19 -24.02 65.82 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.305 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -68.78 -60.73 2.19 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.0 p -59.68 -35.55 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 123.858 0.724 . . . . 0.0 111.761 -175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.0 m -58.42 -45.51 88.31 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -82.3 -9.97 59.28 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.9 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -85.46 -42.05 14.83 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.62 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -80.89 -44.85 17.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.218 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -117.06 108.3 15.57 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -74.75 -10.07 59.16 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.415 0.626 . . . . 0.0 111.369 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -93.47 -2.33 54.6 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.106 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.5 140.8 35.71 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.136 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.407 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 5.5 p -115.41 -31.69 5.84 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.919 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -127.53 161.34 29.01 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 120.92 0.39 . . . . 0.0 110.679 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.62 110.95 0.5 Allowed Glycine 0 N--CA 1.42 -2.383 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -125.1 143.01 51.14 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.525 ' SG ' HG22 ' A' ' 43' ' ' VAL . 11.4 t -88.58 126.96 35.52 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.207 -174.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -139.37 161.26 37.89 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -71.34 124.64 25.01 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.058 0.456 . . . . 0.0 109.987 177.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -122.72 89.4 3.1 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.78 -106.74 2.39 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -103.49 -45.6 4.8 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.12 158.19 34.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.286 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.525 HG22 ' SG ' ' A' ' 36' ' ' CYS . 11.1 p -103.48 122.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.41 160.78 29.51 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.542 0.686 . . . . 0.0 112.217 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.68 126.5 32.94 Favored 'General case' 0 C--N 1.274 -2.683 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.508 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -110.94 125.97 54.24 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.307 0.575 . . . . 0.0 110.305 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.3 m -95.99 118.43 32.6 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.007 -175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -103.07 139.96 37.92 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.407 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -175.03 -163.79 28.7 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.096 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 t70 . . . . . 0 C--N 1.307 -1.279 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.529 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.1 m . . . . . 0 N--CA 1.441 -0.877 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -117.42 -16.47 10.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -83.26 129.5 35.01 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.95 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -79.58 130.58 35.51 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.921 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.469 HD11 ' HA3' ' A' ' 49' ' ' GLY . 82.3 mt -94.93 -44.24 7.81 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.357 0.599 . . . . 0.0 109.997 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.02 -174.42 47.06 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -123.99 164.36 19.51 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.919 0.36 . . . . 0.0 110.681 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.63 140.59 30.47 Favored Pre-proline 0 C--N 1.308 -1.213 0 O-C-N 123.807 0.692 . . . . 0.0 109.706 177.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.05 109.08 1.21 Allowed 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 123.027 2.485 . . . . 0.0 112.969 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 m -141.8 125.05 15.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 122.843 0.457 . . . . 0.0 110.399 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -156.4 130.73 4.95 Favored Pre-proline 0 C--N 1.308 -1.22 0 O-C-N 122.024 -0.423 . . . . 0.0 109.964 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.55 148.26 83.32 Favored 'Cis proline' 0 C--O 1.245 0.826 0 C-N-CA 123.601 -1.416 . . . . 0.0 111.024 -4.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -89.41 132.49 34.97 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.304 0.573 . . . . 0.0 111.801 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.467 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 3.0 mppt? -110.47 131.39 55.09 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 171.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.576 ' OE1' ' HG2' ' A' ' 18' ' ' LYS 0.302 0.0 OUTLIER -57.8 -43.98 86.0 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -177.954 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.576 ' HG2' ' OE1' ' A' ' 17' ' ' GLU . 47.5 mmtm -61.0 -41.72 97.04 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.734 0.302 . . . . 0.0 110.424 174.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.421 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.58 -47.84 79.83 Favored 'General case' 0 C--O 1.201 -1.469 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.465 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.8 t -55.56 -46.35 77.18 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.629 0.771 . . . . 0.0 109.685 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.4 -40.19 95.69 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.131 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -67.12 -47.14 72.04 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 19' ' ' ALA . 83.3 t -58.47 -42.33 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 122.841 0.456 . . . . 0.0 109.972 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.8 m -59.65 -46.38 89.21 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.472 173.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.25 -23.15 67.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.467 0.544 . . . . 0.0 112.467 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -94.63 -32.68 13.3 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -84.98 -51.96 6.32 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.046 -0.409 . . . . 0.0 111.031 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -118.39 102.16 8.72 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -75.31 -4.18 37.69 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -93.08 -4.74 51.84 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.11 144.09 31.94 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.775 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.7 p -119.08 -20.64 7.97 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.155 0.503 . . . . 0.0 109.705 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -138.85 164.0 30.8 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.98 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.05 133.65 4.11 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -143.42 131.69 22.02 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 89.8 m -85.05 114.29 22.1 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.016 0.436 . . . . 0.0 109.828 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.43 154.04 27.64 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.98 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -84.7 99.56 10.91 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.342 0.592 . . . . 0.0 112.125 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -149.28 102.72 3.24 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.54 -152.25 16.85 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -88.17 -45.26 10.26 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.168 0.509 . . . . 0.0 109.818 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -110.25 158.14 18.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' A' ' 36' ' ' CYS . 7.4 p -69.97 127.38 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 13.4 m170 -106.53 141.18 38.25 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.622 -0.674 . . . . 0.0 112.173 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.8 t -79.27 109.16 13.35 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.719 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -94.26 123.12 37.46 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 66.3 m -94.84 121.78 36.79 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.917 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -102.2 131.46 48.72 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.469 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -153.28 179.94 29.26 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 119.297 -1.43 . . . . 0.0 113.259 -177.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 C--N 1.302 -1.486 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.75 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 3.9 m . . . . . 0 N--CA 1.434 -1.267 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -114.19 -30.72 6.55 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 71.6 m80 -69.77 118.63 12.86 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.567 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -73.43 114.15 11.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.7 mt -92.84 -38.94 11.47 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.15 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.74 175.38 44.02 Favored Glycine 0 N--CA 1.423 -2.19 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -107.79 163.02 13.46 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 117.955 0.877 . . . . 0.0 108.979 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.577 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -131.8 144.46 53.36 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.63 113.06 2.78 Favored 'Trans proline' 0 C--O 1.249 1.06 0 C-N-CA 122.3 2.0 . . . . 0.0 111.428 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.1 t -137.52 123.37 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -150.24 127.57 5.54 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -69.01 134.45 28.1 Favored 'Cis proline' 0 C--N 1.356 0.952 0 C-N-CA 123.545 -1.44 . . . . 0.0 111.445 -1.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 9.0 t -79.11 103.13 8.84 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.308 -172.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.495 ' HG3' ' OE2' ' A' ' 17' ' ' GLU . 21.8 tptp -111.24 152.79 26.73 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.495 ' OE2' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -67.2 -39.54 86.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.488 0.585 . . . . 0.0 111.068 -178.078 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.81 -34.36 77.64 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.833 0.349 . . . . 0.0 110.392 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.37 83.08 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.3 m -60.99 -40.34 93.14 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -64.84 -17.69 64.48 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.254 0.549 . . . . 0.0 110.668 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -90.47 -56.18 3.3 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 26' ' ' GLU . 66.0 t -62.04 -36.14 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 123.414 0.686 . . . . 0.0 112.67 -175.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 91.6 m -66.78 -27.31 67.48 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.842 -0.536 . . . . 0.0 112.299 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.93 -17.81 36.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.655 0.741 . . . . 0.0 109.73 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 9.0 tp10 -77.07 -45.2 27.9 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.447 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -81.44 -44.08 17.99 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.776 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -118.39 148.56 42.4 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -173.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -92.66 -21.63 19.91 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -99.99 -5.09 28.71 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.779 0.323 . . . . 0.0 111.328 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.78 123.46 26.73 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.023 0.439 . . . . 0.0 110.005 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.602 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 2.3 p -116.7 -9.47 11.29 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.473 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 3' ' ' CYS . 87.9 tttt -144.4 152.88 41.3 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -153.68 130.39 2.94 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -134.38 146.32 49.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 117.231 0.515 . . . . 0.0 110.589 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.2 m -90.29 114.43 26.47 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -120.17 147.58 44.73 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.431 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 88.0 m-85 -93.28 143.51 26.19 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.047 0.451 . . . . 0.0 111.494 -173.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -131.56 89.51 2.72 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.12 -72.4 2.49 Favored Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.796 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -123.91 -59.71 1.49 Allowed 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.439 -0.448 . . . . 0.0 110.294 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -81.74 158.41 24.2 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.368 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.431 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 10.7 p -103.11 135.41 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.673 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -120.95 139.36 53.37 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.154 0.502 . . . . 0.0 109.924 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 41.3 t -88.42 114.69 25.3 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.988 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.405 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 40.2 m170 -102.77 126.11 49.77 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.129 -177.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.3 m -94.77 126.7 40.26 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.397 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 71.7 m-85 -115.58 145.99 42.17 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.602 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -170.56 -147.81 5.72 Favored Glycine 0 C--N 1.287 -2.186 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--N 1.296 -1.72 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.115 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.431 -1.403 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -123.97 -21.35 5.12 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.994 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -74.23 118.15 16.85 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.374 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -67.35 111.15 3.87 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.76 -42.05 18.44 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.581 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.92 -170.91 44.04 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -110.92 119.29 38.57 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 124.07 0.512 . . . . 0.0 109.809 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.1 127.28 26.99 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.31 110.99 3.21 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.25 1.967 . . . . 0.0 111.283 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.7 t -119.73 123.44 70.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -142.88 133.78 12.58 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.25 168.54 76.96 Favored 'Cis proline' 0 C--O 1.241 0.64 0 C-N-CA 123.705 -1.373 . . . . 0.0 112.154 -0.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -80.23 114.52 19.2 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.768 0.794 . . . . 0.0 111.237 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -144.05 138.93 28.67 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 174.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.44 -44.79 95.44 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.465 0.478 . . . . 0.0 110.332 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.88 -42.68 99.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.732 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.48 -49.4 69.2 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.097 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -55.6 -53.61 54.31 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 124.113 0.965 . . . . 0.0 110.55 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -63.49 -29.5 70.76 Favored 'General case' 0 CA--C 1.554 1.135 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.705 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -79.86 -45.47 18.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.548 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.21 -31.42 53.8 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 CA-C-O 121.242 0.544 . . . . 0.0 109.845 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.0 m -58.6 -29.0 66.12 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.694 173.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -85.4 -10.78 55.79 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -87.57 -30.86 20.22 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -86.32 -44.27 12.23 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.011 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.69 161.05 25.88 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -98.07 -40.03 8.63 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.633 0.254 . . . . 0.0 111.306 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -76.57 -2.58 33.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.74 112.48 7.88 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.14 0.495 . . . . 0.0 110.894 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.2 p -116.09 -1.55 12.43 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.261 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 64.6 tttp -155.71 150.25 26.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.57 129.68 2.66 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -122.59 142.17 50.92 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.637 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 85.3 m -71.06 116.01 10.86 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 123.686 0.616 . . . . 0.0 109.824 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.537 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 7.6 mm-40 -104.14 105.44 15.6 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -86.08 123.65 31.62 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.407 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -141.81 89.52 2.2 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.15 -115.34 6.04 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.115 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -82.66 -52.29 6.94 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 122.498 0.319 . . . . 0.0 111.537 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -89.0 114.73 25.94 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.63 123.62 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -120.25 152.92 37.07 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 36.4 m -96.17 119.58 34.9 Favored 'General case' 0 C--N 1.267 -2.997 0 CA-C-O 120.817 0.341 . . . . 0.0 110.998 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.537 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 15.3 m170 -83.54 110.84 18.55 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 170.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -84.82 122.36 29.04 Favored 'General case' 0 N--CA 1.412 -2.343 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.462 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.41 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 97.3 m-85 -99.1 133.07 43.9 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.134 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -130.76 178.07 17.94 Favored Glycine 0 N--CA 1.413 -2.843 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.401 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.5 t70 . . . . . 0 C--N 1.298 -1.667 0 C-N-CA 123.138 0.575 . . . . 0.0 109.725 -176.608 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.1 m . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 120.905 0.383 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -106.02 -0.19 25.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.423 0.63 . . . . 0.0 110.025 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 35.5 t60 -108.18 125.91 52.18 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.936 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -81.15 119.75 23.98 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.337 0.655 . . . . 0.0 110.162 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.4 mt -94.88 -50.58 5.06 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.288 0.566 . . . . 0.0 110.395 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.426 ' HA3' ' CZ ' ' A' ' 28' ' ' TYR . . . -165.07 -170.58 30.21 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.264 -176.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -131.97 144.73 51.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -128.04 138.58 33.26 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.7 111.82 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.257 1.972 . . . . 0.0 110.948 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.412 ' CG2' HG21 ' A' ' 23' ' ' VAL . 40.7 t -128.73 120.55 52.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 122.116 -0.365 . . . . 0.0 110.643 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.43 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 61.0 t80 -158.4 120.07 1.95 Allowed Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 50.0 Cg_endo -65.71 150.61 77.8 Favored 'Cis proline' 0 C--N 1.356 0.968 0 C-N-CA 124.133 -1.195 . . . . 0.0 113.17 3.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.5 t -115.01 124.38 51.48 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.61 -174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -138.75 168.36 19.96 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -58.52 -57.11 14.38 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.815 0.697 . . . . 0.0 112.74 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.65 -37.31 85.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.431 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -51.86 63.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.273 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.3 t -61.87 -45.66 92.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.138 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HG3' ' HA ' ' A' ' 33' ' ' LYS . 38.7 ttpt -64.78 -37.53 87.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -65.96 -57.59 7.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.435 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.412 HG21 ' CG2' ' A' ' 12' ' ' VAL . 33.6 m -62.77 -33.19 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.081 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.3 m -61.05 -33.67 73.67 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -85.43 -9.43 57.53 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.817 0.342 . . . . 0.0 111.231 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.67 -37.71 10.69 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.582 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -72.24 -43.98 63.57 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.426 ' CZ ' ' HA3' ' A' ' 8' ' ' GLY . 46.6 m-85 -124.65 99.52 6.21 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -68.03 -2.95 8.65 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.316 0.579 . . . . 0.0 112.322 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -97.82 -9.09 27.06 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.585 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.11 162.41 26.68 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.342 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.8 p -119.6 -41.88 2.67 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.901 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.482 ' HA ' ' HG3' ' A' ' 21' ' ' LYS . 57.5 tttm -142.71 149.34 38.68 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.676 -176.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -116.69 165.02 12.29 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 174.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -151.47 130.69 12.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 118.03 0.915 . . . . 0.0 110.261 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.51 103.55 16.23 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.185 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -125.68 138.25 53.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.292 -172.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.56 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 88.8 m-85 -85.32 103.56 14.36 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 172.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -126.93 118.56 24.78 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.888 -172.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.51 -72.15 2.69 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -130.04 -67.4 0.75 Allowed 'General case' 0 C--N 1.311 -1.071 0 O-C-N 122.71 -0.288 . . . . 0.0 110.25 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -108.36 -172.52 2.08 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.191 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.56 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 7.3 p -88.35 140.18 16.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.545 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -129.28 146.87 51.1 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 39.3 t -95.33 102.27 14.06 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -85.96 130.23 34.6 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.4 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.0 m -100.54 123.68 45.07 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 123.388 0.43 . . . . 0.0 110.158 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 70.5 m-85 -114.03 151.87 31.82 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 122.551 0.341 . . . . 0.0 111.243 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.8 -150.95 22.62 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 C--N 1.299 -1.618 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.082 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -116.63 -17.82 10.47 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.949 -167.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -76.43 114.74 15.47 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.393 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.33 118.56 10.86 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.893 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.5 mt -92.88 -57.6 2.6 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.844 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.493 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -163.24 -168.59 25.44 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.647 -176.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -124.33 125.0 43.61 Favored 'General case' 0 C--O 1.249 1.043 0 C-N-CA 123.636 0.774 . . . . 0.0 110.521 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -107.86 148.61 37.73 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.808 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -86.82 113.06 1.02 Allowed 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 121.955 1.77 . . . . 0.0 110.695 174.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 47.8 t -139.75 113.54 6.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -177.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -144.35 128.26 8.98 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.92 143.87 78.32 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 123.914 -1.286 . . . . 0.0 110.391 -2.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 16.2 t -96.15 134.76 38.84 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.225 -174.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -136.02 156.65 48.42 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -48.38 -51.14 27.91 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.492 1.117 . . . . 0.0 112.053 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -76.5 -35.65 58.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.005 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.43 92.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.565 0.221 . . . . 0.0 110.434 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.3 t -61.65 -47.33 85.85 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -55.11 -46.98 75.61 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.674 0.789 . . . . 0.0 110.493 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.8 t -67.62 -46.33 72.82 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.828 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.83 -31.41 41.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.172 0 CA-C-O 121.422 0.63 . . . . 0.0 110.715 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 60.2 m -60.16 -28.09 67.63 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.557 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -80.83 -15.07 57.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 0.0 111.371 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -85.53 -33.38 21.79 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -87.51 -43.17 12.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.939 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.493 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 87.6 m-85 -120.61 140.99 50.75 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.091 0.472 . . . . 0.0 110.645 -175.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -85.03 -27.56 26.3 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -91.42 6.92 43.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.39 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.33 159.92 29.19 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.531 0.681 . . . . 0.0 111.222 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.0 t -143.95 -48.45 0.28 Allowed 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.617 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -125.72 153.42 43.94 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -140.87 131.2 4.83 Favored Glycine 0 N--CA 1.423 -2.219 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -119.37 144.22 47.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 120.959 0.409 . . . . 0.0 110.972 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 59.8 m -100.26 117.48 34.56 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.502 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -113.81 105.73 13.62 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 120.926 0.393 . . . . 0.0 111.096 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.498 ' CD2' ' HB ' ' A' ' 43' ' ' VAL . 88.6 m-85 -81.32 99.67 8.78 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -118.81 105.3 11.39 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.84 -123.68 6.72 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.0 mtm180 -89.26 -32.83 17.2 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -96.44 165.23 12.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.322 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.498 ' HB ' ' CD2' ' A' ' 38' ' ' TYR . 7.4 p -124.12 130.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.43 -0.805 . . . . 0.0 108.926 174.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -101.54 117.26 34.55 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.543 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 37.2 t -88.19 104.15 16.44 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.544 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 66.7 m170 -83.68 110.95 18.7 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.053 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 65.4 m -88.77 112.67 23.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.143 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -102.82 148.36 25.73 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.96 -148.66 6.8 Favored Glycine 0 C--N 1.294 -1.752 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 . . . . . 0 C--N 1.304 -1.388 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.883 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 91.9 m . . . . . 0 C--O 1.233 0.23 0 CA-C-O 121.502 0.668 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.34 -2.54 2.48 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.692 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 55.3 m80 -81.08 126.12 31.05 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -73.04 102.83 3.62 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.864 0.728 . . . . 0.0 109.993 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.8 mt -81.07 -35.14 32.14 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.079 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.29 -174.06 41.8 Favored Glycine 0 N--CA 1.427 -1.943 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -124.97 143.64 50.78 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 117.287 0.543 . . . . 0.0 110.855 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.61 142.07 33.47 Favored Pre-proline 0 C--N 1.297 -1.686 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.601 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.83 106.43 2.09 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.405 2.07 . . . . 0.0 111.438 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.4 t -128.02 103.73 10.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 O-C-N 121.859 -0.526 . . . . 0.0 109.866 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -142.35 132.21 12.34 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -74.65 167.86 78.88 Favored 'Cis proline' 0 C--O 1.237 0.474 0 C-N-CA 123.744 -1.357 . . . . 0.0 111.434 -2.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 t -83.67 131.65 34.93 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 122.018 0.913 . . . . 0.0 112.86 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 56.2 tptt -137.62 125.77 23.01 Favored 'General case' 0 N--CA 1.387 -3.622 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 170.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -41.41 70.0 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -176.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.74 -41.04 84.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.576 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . . . -63.81 -47.01 82.55 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.038 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.5 t -54.96 -50.55 68.63 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.359 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.72 -41.23 99.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.164 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 27.4 t -61.78 -55.51 29.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.417 ' O ' ' HD2' ' A' ' 27' ' ' HIS . 98.2 t -55.35 -43.89 73.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 123.684 0.615 . . . . 0.0 110.511 -177.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.1 m -58.06 -42.21 84.99 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.845 0.684 . . . . 0.0 112.845 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 54.9 mtpt -75.34 -23.96 57.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.279 0.562 . . . . 0.0 111.431 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 22' ' ' SER . 45.1 mt-10 -77.89 -33.46 51.96 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.957 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.417 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 44.4 m-70 -85.27 -44.86 12.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.152 0.501 . . . . 0.0 110.285 175.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -116.7 107.16 14.33 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -64.62 -19.74 65.86 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -89.96 0.93 56.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.452 ' O ' ' HG2' ' A' ' 25' ' ' LYS . . . -78.07 138.14 38.61 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.095 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.41 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 2.5 p -134.82 1.0 3.0 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.722 0.772 . . . . 0.0 110.454 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 59.2 tptt -148.94 142.42 25.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.19 126.63 2.07 Favored Glycine 0 CA--C 1.481 -2.08 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.85 140.08 52.62 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.621 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.43 ' HB3' HG21 ' A' ' 43' ' ' VAL . 59.6 m -76.14 102.31 5.7 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 5.9 mm-40 -94.61 110.69 22.49 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.458 0.647 . . . . 0.0 109.762 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -77.61 103.93 7.84 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.839 -174.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -127.05 99.38 5.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.53 -149.72 21.34 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -175.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -95.95 -50.59 4.81 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.014 0.435 . . . . 0.0 110.603 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -78.64 103.08 8.34 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.6 0.714 . . . . 0.0 109.797 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 36' ' ' CYS . 14.8 p -76.21 150.0 6.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.621 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -123.51 151.52 42.72 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 39.3 m -96.87 126.29 41.91 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-O 120.72 0.295 . . . . 0.0 110.492 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.408 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 46.7 m170 -90.61 117.99 29.71 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.9 m -92.5 123.1 35.56 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.912 -174.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 67.3 m-85 -117.73 141.98 47.78 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.215 -177.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 5' ' ' HIS . . . -170.6 -168.68 32.73 Favored Glycine 0 C--N 1.289 -2.083 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 C--N 1.293 -1.865 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.267 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.432 -1.362 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -144.53 -34.95 0.35 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.8 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -75.13 120.55 20.79 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -65.19 119.97 11.86 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.1 mt -94.15 -43.47 8.46 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.105 0.479 . . . . 0.0 110.043 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.427 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -177.53 -160.47 24.28 Favored Glycine 0 N--CA 1.419 -2.45 0 C-N-CA 119.49 -1.338 . . . . 0.0 112.98 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -131.69 131.22 42.92 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 123.677 0.791 . . . . 0.0 110.29 -171.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.56 143.96 44.82 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -89.09 111.1 0.53 Allowed 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 122.714 2.276 . . . . 0.0 112.558 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.4 t -132.12 104.05 7.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -138.21 124.01 12.62 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -74.58 147.45 89.42 Favored 'Cis proline' 0 C--N 1.347 0.466 0 C-N-CA 123.66 -1.392 . . . . 0.0 110.818 -2.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.5 t -91.23 142.17 28.01 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.367 0.603 . . . . 0.0 111.748 -174.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -137.03 152.77 50.48 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 172.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.25 -47.29 85.02 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.14 -40.44 86.74 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.076 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -61.11 -46.8 89.14 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.929 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t -59.3 -48.59 81.07 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 123.622 0.769 . . . . 0.0 109.712 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -55.77 -46.04 78.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.812 0.845 . . . . 0.0 110.182 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.3 t -64.66 -45.76 85.37 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.626 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 19' ' ' ALA . 94.5 t -64.51 -38.6 83.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 CA-C-O 121.048 0.451 . . . . 0.0 110.322 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 83.2 m -58.92 -38.9 80.0 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.24 175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -64.04 -37.58 87.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.908 0.385 . . . . 0.0 110.621 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.28 -47.57 79.02 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.838 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -81.94 -39.48 23.66 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 63.1 m-85 -127.5 112.93 15.49 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -60.2 -37.33 79.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.872 0.367 . . . . 0.0 111.81 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -89.3 6.76 38.96 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . . . -80.3 140.8 35.99 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.3 p -123.96 -28.75 3.73 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 121.013 0.435 . . . . 0.0 111.426 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -140.65 147.88 39.98 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.13 150.75 20.78 Favored Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -121.58 144.15 48.9 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 123.844 0.379 . . . . 0.0 110.197 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.5 m -84.83 102.1 12.8 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.486 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 8.4 mm-40 -92.14 109.38 20.74 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.135 0.493 . . . . 0.0 110.387 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -86.97 101.34 13.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.667 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -144.73 110.01 5.18 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.43 -159.48 28.47 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -88.93 -20.73 24.14 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.374 0.587 . . . . 0.0 110.692 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -91.94 146.39 23.78 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.11 124.4 67.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -98.3 123.75 42.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.927 -172.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 m -87.69 114.36 24.23 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.01 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.486 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 42.0 m170 -94.36 120.42 34.57 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 174.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.5 m -94.94 128.89 42.08 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.297 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -108.35 141.67 39.82 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.7 175.64 46.92 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 119.663 -1.256 . . . . 0.0 112.772 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 C--N 1.3 -1.548 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.732 -176.431 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 88.1 m . . . . . 0 N--CA 1.417 -2.096 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -117.83 -22.92 7.74 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.026 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 52.3 m80 -89.03 134.82 33.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.874 -176.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -66.58 131.14 45.36 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.855 0.36 . . . . 0.0 110.377 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' A' ' 31' ' ' ALA . 25.2 mt -103.04 -19.26 14.63 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.997 0.903 . . . . 0.0 108.849 175.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.07 -174.63 30.29 Favored Glycine 0 N--CA 1.409 -3.152 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -177.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -123.0 158.97 29.35 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.03 132.29 24.25 Favored Pre-proline 0 C--N 1.298 -1.633 0 O-C-N 123.318 0.386 . . . . 0.0 110.401 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HA ' ' NE2' ' A' ' 44' ' ' HIS . 58.8 Cg_endo -76.07 102.05 1.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.502 2.134 . . . . 0.0 112.752 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 m -143.95 140.75 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 123.357 0.663 . . . . 0.0 109.815 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.433 ' CD2' ' HA ' ' A' ' 14' ' ' PRO . 68.8 t80 -160.07 128.46 2.94 Favored Pre-proline 0 C--N 1.314 -0.96 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.433 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 8.9 Cg_exo -68.56 145.3 76.31 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 124.048 -1.23 . . . . 0.0 112.097 3.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.1 t -99.55 106.45 18.44 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -115.27 151.26 34.85 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.11 -41.55 68.42 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 124.049 0.843 . . . . 0.0 113.237 -175.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.6 -45.54 75.16 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.459 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.09 75.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.34 -51.12 69.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.878 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.27 -39.1 81.82 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.424 0.69 . . . . 0.0 111.149 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -70.12 -49.35 51.63 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.69 -40.9 80.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 123.39 0.676 . . . . 0.0 110.996 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 67.5 m -59.44 -44.07 92.99 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -72.61 -24.2 61.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.066 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -75.3 -47.72 26.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.397 177.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -79.99 -35.33 37.58 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.953 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -126.21 112.27 15.57 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -74.78 -18.21 60.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -92.17 8.81 36.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.098 0.475 . . . . 0.0 110.912 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB2' HD12 ' A' ' 7' ' ' LEU . . . -96.49 139.48 32.52 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.3 p -124.43 -20.07 5.28 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.103 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.58 134.78 35.99 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.55 -176.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.05 148.71 16.84 Favored Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.24 138.9 33.59 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.1 m -87.91 122.11 31.14 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -128.73 143.23 50.88 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.12 100.81 10.76 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -115.8 100.49 8.05 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 -102.57 2.55 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.06 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -98.09 -55.61 2.73 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.173 0.511 . . . . 0.0 110.245 -177.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -99.53 167.36 10.65 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.404 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.3 p -99.17 135.94 32.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.522 ' NE2' ' HA ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -138.09 160.26 39.86 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.807 -178.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.6 t -85.97 114.79 23.14 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.276 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -102.61 125.72 49.44 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 68.4 m -95.59 127.06 41.31 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.854 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 80.6 m-85 -112.06 147.97 34.89 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.326 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.62 -141.57 6.3 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 C--N 1.306 -1.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.11 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.422 -1.855 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -121.3 -43.23 2.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.912 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -83.9 135.6 34.43 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.084 -177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -85.99 116.41 24.19 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.416 HD11 ' HA3' ' A' ' 49' ' ' GLY . 89.9 mt -74.86 -33.47 62.12 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.609 0.718 . . . . 0.0 109.125 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.63 -178.3 37.57 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.94 143.13 38.59 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.08 132.9 24.25 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.15 140.97 18.15 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.503 2.135 . . . . 0.0 111.36 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.443 HG11 ' SG ' ' A' ' 45' ' ' CYS . 13.8 p -141.8 143.68 26.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 120.73 0.3 . . . . 0.0 110.688 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 84.3 t80 -148.43 123.34 5.0 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 2.0 Cg_endo -84.98 163.88 61.92 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.822 -1.324 . . . . 0.0 110.939 -2.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.21 92.36 3.83 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.1 0.952 . . . . 0.0 112.78 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -117.77 141.92 47.86 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 168.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.08 -43.22 91.8 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 118.218 0.463 . . . . 0.0 111.63 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.65 -48.69 80.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.234 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.43 -42.36 92.52 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.034 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.7 t -56.44 -54.76 41.92 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 124.115 0.966 . . . . 0.0 110.983 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -59.44 -38.24 80.18 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 121.168 0.508 . . . . 0.0 110.098 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.578 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 49.1 m -66.78 -54.62 20.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.592 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.6 t -60.65 -37.46 75.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-O 121.241 0.543 . . . . 0.0 110.457 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.8 t -56.19 -46.28 79.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.009 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 60.6 mtpt -72.82 -19.78 61.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.627 0.371 . . . . 0.0 111.689 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 22' ' ' SER . 24.6 mm-40 -74.92 -42.51 57.59 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -75.83 -45.54 35.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.246 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 54.3 m-85 -123.51 104.97 9.39 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -65.63 -24.15 66.98 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -175.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -84.02 0.03 49.8 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.28 123.86 23.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.427 0.632 . . . . 0.0 111.531 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.0 p -101.61 -29.09 12.14 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.999 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -136.37 128.84 30.34 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.847 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -133.89 118.45 2.06 Favored Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -135.13 140.44 45.44 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.056 -0.658 . . . . 0.0 112.735 -177.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.7 m -63.1 120.38 11.35 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.991 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -118.14 114.22 22.75 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -77.72 102.48 7.15 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -126.55 97.06 4.88 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.95 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.56 -112.97 3.77 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.319 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -83.38 -46.11 12.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.205 0.526 . . . . 0.0 111.816 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -97.88 170.73 8.75 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.936 0.874 . . . . 0.0 112.481 -172.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.1 113.77 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -125.35 157.95 35.47 Favored 'General case' 0 C--N 1.277 -2.587 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.443 ' SG ' HG11 ' A' ' 12' ' ' VAL . 65.6 m -80.88 111.1 17.04 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.404 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 31.2 m170 -80.4 124.41 28.87 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 92.4 m -97.91 112.63 24.48 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.326 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -95.3 133.44 39.2 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 176.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.416 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -154.51 155.33 26.13 Favored Glycine 0 C--N 1.287 -2.159 0 C-N-CA 117.506 -2.283 . . . . 0.0 114.436 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t0 . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 177.786 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.51 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 96.3 m . . . . . 0 N--CA 1.442 -0.842 0 CA-C-O 121.198 0.523 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -119.43 -35.76 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.445 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -74.49 131.91 41.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.413 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.15 111.58 10.53 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.416 HD11 ' HA3' ' A' ' 49' ' ' GLY . 80.2 mt -79.26 -30.61 43.17 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-O 121.392 0.615 . . . . 0.0 109.551 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.407 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . 163.02 -154.22 25.08 Favored Glycine 0 N--CA 1.404 -3.462 0 C-N-CA 120.502 -0.856 . . . . 0.0 110.997 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -128.65 158.19 39.23 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HB1' HG12 ' A' ' 23' ' ' VAL . . . -135.94 139.96 31.94 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.863 176.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.17 114.2 2.49 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.36 2.04 . . . . 0.0 112.594 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 p -155.13 114.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -159.19 127.33 2.86 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.694 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.05 154.68 80.83 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.689 -1.379 . . . . 0.0 111.661 -3.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 51.3 t -117.41 137.59 52.39 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 19' ' ' ALA . 13.8 mptt -103.04 157.13 17.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.16 -41.73 97.3 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.709 0.766 . . . . 0.0 110.562 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -75.1 -25.74 58.76 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.518 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.403 ' HB3' ' H ' ' A' ' 16' ' ' LYS . . . -76.51 -36.69 57.62 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.038 -178.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.5 t -64.9 -36.5 84.56 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -60.98 -47.77 84.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.849 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.9 p -70.74 -43.48 68.75 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.288 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.413 HG12 ' HB1' ' A' ' 10' ' ' ALA . 88.1 t -63.54 -46.24 95.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.7 m -59.01 -38.05 78.31 Favored 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -64.02 -33.27 75.37 Favored 'General case' 0 N--CA 1.425 -1.685 0 C-N-CA 123.076 0.55 . . . . 0.0 111.14 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.83 -19.77 30.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -89.19 -38.1 14.52 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.748 -0.595 . . . . 0.0 111.066 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.407 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 57.4 m-85 -133.94 110.8 9.95 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -71.77 -8.29 53.34 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.699 0.762 . . . . 0.0 110.769 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -86.64 -6.23 58.92 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.306 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.38 132.16 39.3 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.766 -177.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 p -112.02 -21.25 11.63 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -132.73 141.45 48.56 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.792 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.87 147.23 18.98 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -138.52 119.49 14.36 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 118.371 1.085 . . . . 0.0 110.188 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 25.8 m -82.27 109.14 16.27 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.263 176.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -125.38 148.11 48.91 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.084 -177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 81.7 m-85 -73.9 103.0 4.26 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.647 0.736 . . . . 0.0 110.799 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -94.93 89.86 5.78 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.99 -98.69 2.45 Favored Glycine 0 N--CA 1.423 -2.179 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -176.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -108.15 -52.63 2.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.021 0.439 . . . . 0.0 110.414 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.95 170.73 9.22 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.343 -173.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 7.3 p -89.48 132.84 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-O 121.304 0.573 . . . . 0.0 110.312 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 11.6 m-70 -120.83 137.17 54.68 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.8 t -88.04 105.31 17.39 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -89.67 118.58 29.38 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.3 m -91.28 124.01 35.15 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.015 -176.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -108.01 138.81 43.61 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.51 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -167.87 -155.8 9.63 Favored Glycine 0 C--N 1.297 -1.611 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 C--N 1.301 -1.528 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.119 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 74.3 m . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -101.79 -24.03 14.11 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -76.66 139.66 40.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.516 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.63 130.28 41.16 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.736 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.4 mt -89.69 -23.73 21.77 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.645 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.59 -179.92 25.04 Favored Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 12.0 pt-20 -105.9 146.34 30.09 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.29 138.98 32.7 Favored Pre-proline 0 C--N 1.302 -1.466 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.74 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.76 131.46 13.46 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.641 2.227 . . . . 0.0 112.019 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -160.63 134.01 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 122.558 0.343 . . . . 0.0 110.386 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.471 ' CG ' ' HA ' ' A' ' 14' ' ' PRO . 33.8 t80 -155.7 140.9 12.37 Favored Pre-proline 0 N--CA 1.435 -1.191 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.471 ' HA ' ' CG ' ' A' ' 13' ' ' TYR . 4.5 Cg_exo -76.12 168.36 77.5 Favored 'Cis proline' 0 C--O 1.25 1.124 0 C-N-CA 123.867 -1.305 . . . . 0.0 111.948 -0.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -78.85 114.1 17.5 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.851 0.834 . . . . 0.0 110.858 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 42.3 tptt -138.32 136.59 36.56 Favored 'General case' 0 N--CA 1.394 -3.252 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 175.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.51 -47.39 82.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 124.065 0.853 . . . . 0.0 110.085 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -64.68 -38.22 90.24 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.386 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.72 -43.42 72.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.6 t -59.08 -51.62 69.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.214 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.39 -38.67 84.7 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.296 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.2 m -66.27 -48.6 69.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.643 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.25 -40.25 88.35 Favored 'Isoleucine or valine' 0 C--O 1.255 1.361 0 CA-C-O 121.033 0.444 . . . . 0.0 109.894 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 57.8 m -54.81 -46.24 74.5 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.65 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 29' ' ' HIS . 96.5 mttt -57.17 -36.31 70.63 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 123.359 0.412 . . . . 0.0 111.913 177.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -73.12 -42.35 62.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.642 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -79.49 -39.43 32.13 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.969 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -134.52 102.63 5.38 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 72.6 m-70 -62.46 -22.1 65.97 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -169.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -96.54 12.82 30.19 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.741 0.305 . . . . 0.0 111.466 -178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.73 127.77 33.53 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.015 0.436 . . . . 0.0 110.694 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.3 p -106.84 -20.9 13.19 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.988 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -156.51 157.38 35.33 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -140.23 150.18 21.38 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.692 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -124.17 127.59 47.99 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 69.5 m -83.32 107.8 16.09 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.373 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -116.93 133.28 56.21 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 98.9 m-85 -81.64 131.08 35.26 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.826 0.346 . . . . 0.0 110.705 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -125.47 106.49 9.83 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.9 -97.85 1.15 Allowed Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -126.2 -2.91 6.94 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 111.682 0.252 . . . . 0.0 111.682 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -126.66 147.46 49.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 9.5 p -90.43 137.83 20.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 120.683 0.278 . . . . 0.0 110.594 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -125.71 151.86 46.07 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 2.2 m -97.69 126.77 43.2 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 177.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -84.75 110.4 18.77 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 171.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.3 m -89.53 124.9 34.94 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.823 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -96.09 148.9 22.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.61 171.19 30.55 Favored Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.617 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 C--N 1.289 -2.036 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.383 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.437 ' HA ' ' CG ' ' A' ' 50' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 120.851 0.358 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -120.44 137.23 54.45 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 48' ' ' TYR . 98.3 m -88.26 16.29 6.47 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.431 0.634 . . . . 0.0 110.051 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -87.15 1.67 52.28 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.119 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 34.6 m80 -107.96 147.52 30.94 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -91.03 128.83 37.01 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.5 mt -91.5 -38.73 12.35 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.28 -151.62 14.07 Favored Glycine 0 N--CA 1.416 -2.658 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.855 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -131.67 151.04 51.93 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -122.03 137.23 27.1 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.77 94.73 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.123 1.882 . . . . 0.0 111.353 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.5 t -127.56 113.53 32.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -143.76 124.77 7.99 Favored Pre-proline 0 N--CA 1.434 -1.23 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.58 149.88 93.05 Favored 'Cis proline' 0 C--O 1.246 0.907 0 C-N-CA 123.421 -1.491 . . . . 0.0 110.429 -0.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.2 t -94.7 109.3 21.26 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.192 0.52 . . . . 0.0 110.564 -173.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.73 138.79 36.32 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 173.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -47.03 -49.24 21.5 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 124.35 1.031 . . . . 0.0 112.548 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -73.02 -37.67 66.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.945 0.403 . . . . 0.0 111.466 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -67.68 -39.38 84.48 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.8 t -59.2 -49.34 78.22 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.423 0.689 . . . . 0.0 109.461 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HG3' ' HA ' ' A' ' 33' ' ' LYS . 58.7 tttm -57.61 -34.87 69.73 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.256 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 m -76.54 -46.06 28.03 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.881 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 19' ' ' ALA . 73.3 t -68.04 -33.79 63.1 Favored 'Isoleucine or valine' 0 C--O 1.254 1.34 0 CA-C-O 121.297 0.57 . . . . 0.0 110.449 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 54.6 m -56.98 -38.72 73.42 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.304 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 51.5 mtpt -71.7 -21.79 61.73 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.925 0.393 . . . . 0.0 111.409 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -73.45 -48.54 32.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -77.35 -47.17 20.63 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.961 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -116.8 107.97 15.29 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -69.58 -21.43 63.6 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -98.26 16.71 20.57 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.159 0.504 . . . . 0.0 110.415 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.48 142.8 31.59 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.622 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 2.0 p -115.41 -44.01 3.01 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.855 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.471 ' HA ' ' HG3' ' A' ' 21' ' ' LYS . 82.3 tttt -120.46 153.35 36.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.411 ' N ' ' HG2' ' A' ' 33' ' ' LYS . . . -141.05 140.08 10.1 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 107.161 -2.376 . . . . 0.0 107.161 174.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -144.52 144.19 31.21 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 118.02 0.91 . . . . 0.0 109.977 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.5 m -92.58 127.07 37.94 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.2 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -137.73 147.16 44.52 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.424 ' CE2' ' HB ' ' A' ' 43' ' ' VAL . 74.5 m-85 -86.15 126.69 34.42 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.187 0.518 . . . . 0.0 110.485 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.36 111.03 14.02 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.531 ' O ' ' HD2' ' A' ' 41' ' ' ARG . . . 81.31 -101.59 2.12 Favored Glycine 0 N--CA 1.413 -2.847 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.531 ' HD2' ' O ' ' A' ' 40' ' ' GLY . 12.7 mmm180 -125.72 -31.87 2.9 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -87.29 159.94 18.6 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.201 0.524 . . . . 0.0 111.206 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.424 ' HB ' ' CE2' ' A' ' 38' ' ' TYR . 12.7 p -95.85 127.26 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.091 178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -108.75 139.89 42.93 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.648 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 35.8 t -91.16 108.1 19.64 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 176.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -94.93 125.72 39.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.992 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.6 m -96.51 121.57 38.47 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.101 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.456 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 62.9 m-85 -105.24 141.25 37.11 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.622 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -178.96 -174.64 45.32 Favored Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.437 ' CG ' ' HA ' ' A' ' 1' ' ' ALA . 26.1 t70 -95.62 124.5 39.67 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -89.03 112.05 22.9 Favored 'General case' 0 N--CA 1.425 -1.685 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.737 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.4 p80 . . . . . 0 C--N 1.285 -2.235 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.452 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.444 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -76.02 151.54 37.15 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.0 m -97.19 85.9 3.81 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -119.99 9.16 11.15 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.845 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -107.04 114.04 27.88 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -69.22 123.44 21.15 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.9 mt -96.95 -49.48 5.01 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.567 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.421 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -177.78 -179.33 47.87 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.5 127.99 56.29 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.082 0.468 . . . . 0.0 110.246 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.19 141.93 25.33 Favored Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.625 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.99 104.92 1.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.473 2.115 . . . . 0.0 111.104 176.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -123.25 103.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -136.24 122.81 14.04 Favored Pre-proline 0 C--N 1.304 -1.412 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.223 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.25 147.16 86.69 Favored 'Cis proline' 0 C--O 1.245 0.847 0 C-N-CA 123.66 -1.392 . . . . 0.0 111.826 1.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.4 t -68.31 120.17 14.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.477 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -141.54 140.82 33.53 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 17' ' ' GLU . 1.5 mp0 -56.98 -48.13 79.14 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.359 0.664 . . . . 0.0 111.109 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -62.47 -44.61 95.97 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.427 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.41 -45.16 94.61 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.566 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -54.67 -52.57 61.95 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.177 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 25.3 ttmm -59.71 -38.06 80.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 122.991 0.182 . . . . 0.0 110.938 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.1 t -72.37 -51.16 21.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.763 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.9 t -60.69 -37.98 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.584 0.354 . . . . 0.0 110.606 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 98.8 m -61.16 -37.99 84.86 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 21' ' ' LYS . 98.5 mttt -66.93 -35.25 79.58 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.713 0.768 . . . . 0.0 109.87 177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.41 -35.39 70.97 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.474 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -84.32 -45.76 12.47 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.88 176.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 25.0 m-85 -126.28 130.42 50.84 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -72.95 -21.68 60.83 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.46 0.648 . . . . 0.0 110.916 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -94.5 -2.83 51.01 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.408 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . . . -83.82 126.73 33.24 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.397 0.617 . . . . 0.0 111.381 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.64 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 1.7 p -116.69 -28.86 6.25 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.44 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -124.32 135.18 53.16 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 122.07 -0.394 . . . . 0.0 110.77 -174.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.94 136.04 9.17 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -147.28 131.51 17.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -175.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 71.6 m -91.21 137.16 32.58 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 120.985 0.421 . . . . 0.0 111.798 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -133.99 132.51 40.21 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.453 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 65.8 m-85 -88.57 136.23 33.1 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.328 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -127.46 90.09 3.07 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.54 -113.72 3.69 Favored Glycine 0 N--CA 1.432 -1.584 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -172.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -98.95 -33.46 10.83 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -76.21 150.98 36.99 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.938 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.453 ' HB ' ' CD1' ' A' ' 38' ' ' TYR . 7.8 p -146.58 133.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 -177.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -126.28 160.34 30.6 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.691 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.5 t -97.74 119.92 37.19 Favored 'General case' 0 N--CA 1.41 -2.469 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -87.71 122.72 31.73 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.0 m -97.27 126.49 42.52 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.038 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -114.68 149.64 36.43 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.64 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -155.98 -170.13 20.96 Favored Glycine 0 C--N 1.288 -2.132 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -140.55 151.81 45.02 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 117.043 0.421 . . . . 0.0 109.871 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -112.32 119.13 37.25 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.815 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 . . . . . 0 C--O 1.247 0.924 0 C-N-CA 125.259 1.424 . . . . 0.0 112.577 172.76 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -121.43 146.52 46.82 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 121.896 -0.503 . . . . 0.0 110.071 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.0 m -86.24 71.89 10.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -144.67 15.13 1.58 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.523 0.678 . . . . 0.0 110.441 175.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 14.0 t60 -105.64 136.27 45.54 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -81.82 126.92 32.43 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.704 0.288 . . . . 0.0 110.483 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.468 HD11 ' HA3' ' A' ' 49' ' ' GLY . 85.7 mt -86.13 -44.49 12.2 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.7 -168.93 42.06 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 12.2 pt-20 -115.75 149.88 37.77 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 120.767 0.318 . . . . 0.0 110.506 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.19 138.11 18.85 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.5 141.91 22.94 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 121.887 1.724 . . . . 0.0 111.307 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 p -140.23 149.71 21.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -160.01 123.7 2.01 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 173.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.83 169.85 45.15 Favored 'Cis proline' 0 C--O 1.241 0.651 0 C-N-CA 124.557 -1.018 . . . . 0.0 111.364 -1.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.1 t -75.84 94.81 3.38 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -126.94 139.66 52.89 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 168.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -55.16 -45.78 75.71 Favored 'General case' 0 CA--C 1.501 -0.909 0 O-C-N 123.555 0.534 . . . . 0.0 112.315 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -61.01 -39.36 89.44 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.583 0.552 . . . . 0.0 111.32 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -41.47 67.16 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.163 0.506 . . . . 0.0 110.061 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -60.73 -48.77 80.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.775 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 88.2 tttt -59.85 -41.61 91.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.779 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 61.9 m -59.56 -55.01 39.87 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.614 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.456 ' O ' ' HD2' ' A' ' 27' ' ' HIS . 13.0 p -65.76 -36.3 77.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.525 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 23.0 m -59.01 -39.5 82.09 Favored 'General case' 0 C--O 1.209 -1.056 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.804 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 30.4 mtpp -73.06 -27.59 61.83 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.703 0.287 . . . . 0.0 111.066 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -67.55 -37.6 82.92 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.208 0.528 . . . . 0.0 110.2 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.456 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 40.4 m-70 -77.73 -60.02 2.54 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.502 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 18.6 m-85 -120.23 106.45 11.93 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -175.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -56.57 -31.46 64.23 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -174.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -79.53 4.86 14.49 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.44 126.97 30.5 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.381 0.61 . . . . 0.0 109.989 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 p -124.16 -11.19 7.54 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.022 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 58.1 tptt -148.16 123.82 10.49 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.797 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.32 135.75 13.09 Favored Glycine 0 N--CA 1.427 -1.909 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -122.71 127.16 48.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 93.0 m -76.38 116.45 17.07 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.092 0.472 . . . . 0.0 111.759 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -110.19 98.86 8.02 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -78.61 103.02 8.28 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -113.28 89.23 3.03 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -174.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.53 -81.99 0.6 Allowed Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.585 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -85.09 -68.37 0.73 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -128.3 -179.17 4.87 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -172.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.24 126.21 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 121.876 0.846 . . . . 0.0 112.583 -174.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -107.34 133.33 52.03 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 5.3 m -92.03 126.75 37.24 Favored 'General case' 0 C--N 1.27 -2.858 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.342 176.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -87.45 113.07 22.83 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 m -90.77 109.73 20.92 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.09 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 97.8 m-85 -89.79 139.46 30.55 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -134.04 168.1 23.46 Favored Glycine 0 N--CA 1.419 -2.478 0 C-N-CA 118.997 -1.573 . . . . 0.0 114.544 -175.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -109.86 113.02 25.41 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.223 -0.989 . . . . 0.0 110.36 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -88.0 127.74 35.39 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 . . . . . 0 C--N 1.298 -1.649 0 O-C-N 123.877 0.736 . . . . 0.0 109.563 -178.01 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.76 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -84.47 156.31 21.79 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.07 0.462 . . . . 0.0 111.202 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.1 m -87.44 78.74 8.59 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.722 -174.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -122.15 -1.11 9.3 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.547 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 5.4 t-160 -80.38 110.79 16.16 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 -178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -66.67 104.88 1.39 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.56 -52.49 5.79 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.591 -177.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.52 -161.21 20.69 Favored Glycine 0 N--CA 1.417 -2.576 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -134.04 148.42 51.07 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.008 0.432 . . . . 0.0 110.741 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.566 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -129.12 151.82 78.33 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.194 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -93.06 131.68 0.88 Allowed 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 122.14 1.893 . . . . 0.0 112.878 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -160.65 127.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 123.125 0.57 . . . . 0.0 109.844 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -142.19 129.92 11.51 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.37 145.44 83.5 Favored 'Cis proline' 0 C--O 1.244 0.818 0 C-N-CA 123.344 -1.523 . . . . 0.0 110.63 -0.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 t -87.44 101.52 13.67 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.221 -0.591 . . . . 0.0 109.744 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -98.48 148.91 23.26 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.529 ' H ' ' CD ' ' A' ' 17' ' ' GLU . 1.9 mp0 -51.51 -54.57 25.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.211 0.604 . . . . 0.0 110.42 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.79 -42.07 99.55 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.256 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.85 95.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.418 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.9 t -61.04 -48.91 79.57 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 32' ' ' CYS . 87.6 tttt -56.24 -42.17 76.88 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.557 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -66.36 -52.41 47.19 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.869 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.5 t -62.01 -37.7 78.97 Favored 'Isoleucine or valine' 0 C--O 1.257 1.472 0 CA-C-O 121.292 0.568 . . . . 0.0 111.018 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.0 m -59.32 -33.24 70.87 Favored 'General case' 0 C--O 1.205 -1.256 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 21' ' ' LYS . 52.9 mtmt -75.43 -18.96 59.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.062 0.392 . . . . 0.0 111.033 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -83.76 -40.54 18.67 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -79.43 -44.25 21.75 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.9 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -121.64 108.21 13.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -67.01 -18.87 65.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -90.84 -5.19 55.92 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.49 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.1 140.42 37.84 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 121.108 0.48 . . . . 0.0 110.191 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.46 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -139.45 4.9 2.21 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.509 -178.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 60.0 tttm -150.87 142.66 23.77 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.77 139.36 10.14 Favored Glycine 0 C--N 1.298 -1.575 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -135.9 137.58 41.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 61.6 m -85.12 129.71 34.75 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.628 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -126.11 130.15 50.5 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -93.38 115.96 28.52 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.355 0.597 . . . . 0.0 111.454 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -111.3 92.27 3.98 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.72 -113.57 4.26 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -101.3 -12.77 18.41 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -95.84 125.8 40.65 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.568 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.3 p -95.02 125.74 47.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -107.61 139.24 42.45 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 35.4 t -96.65 109.65 22.23 Favored 'General case' 0 C--N 1.279 -2.462 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -92.63 124.51 36.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.235 0.54 . . . . 0.0 110.367 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.8 m -94.35 122.52 36.98 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.721 -173.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 67.5 m-85 -113.62 136.62 52.63 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.34 178.91 26.56 Favored Glycine 0 N--CA 1.416 -2.676 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.293 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -140.94 123.65 16.12 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -67.77 109.1 3.21 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 69.0 m80 . . . . . 0 C--N 1.3 -1.546 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 173.513 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 120.417 0.151 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.415 ' CE1' ' HB2' ' A' ' 4' ' ' ASP . 11.5 t-160 -120.94 119.85 33.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.246 0.546 . . . . 0.0 111.25 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 m -87.21 107.62 18.56 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.415 ' HB2' ' CE1' ' A' ' 2' ' ' HIS . 24.2 t70 -131.16 -59.47 0.98 Allowed 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.628 -176.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -89.65 153.61 20.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.084 0.468 . . . . 0.0 110.923 -174.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -77.46 136.61 38.38 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.614 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.47 HD11 ' HA3' ' A' ' 49' ' ' GLY . 95.2 mt -95.27 -19.12 20.26 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.51 -178.99 34.5 Favored Glycine 0 N--CA 1.405 -3.386 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.338 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -112.75 149.93 32.28 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.85 152.75 77.99 Favored Pre-proline 0 C--N 1.283 -2.289 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -83.65 142.71 10.44 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.268 1.978 . . . . 0.0 110.766 174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p -151.92 136.81 10.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.29 0.567 . . . . 0.0 111.822 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -160.42 132.01 4.04 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.07 159.51 93.12 Favored 'Cis proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.31 -1.121 . . . . 0.0 112.044 -0.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.582 ' SG ' HG21 ' A' ' 43' ' ' VAL . 48.3 t -78.48 127.82 32.71 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.488 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 23.4 tptp -166.66 143.67 4.87 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -48.05 76.84 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.79 -36.9 84.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 117.947 0.34 . . . . 0.0 111.714 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -62.9 -50.5 70.62 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.9 t -63.85 -40.11 95.8 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.545 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -62.74 -32.02 73.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 19.0 t -77.45 -46.9 21.12 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 19' ' ' ALA . 78.7 t -52.41 -47.96 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.138 0.575 . . . . 0.0 110.11 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 58.0 m -55.59 -43.14 75.73 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 32' ' ' CYS . 94.7 mttt -75.87 -25.93 56.62 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.931 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 22' ' ' SER . 45.0 mt-10 -81.07 -19.07 44.51 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.889 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.422 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 50.7 m-70 -102.53 -39.53 7.06 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.31 174.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -121.2 115.04 22.29 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -66.43 -29.07 69.13 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -174.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -84.81 3.69 36.57 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.18 137.65 39.0 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.146 0.498 . . . . 0.0 110.684 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.448 ' HA ' ' HE2' ' A' ' 25' ' ' LYS . 5.6 p -124.42 -23.47 4.45 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.297 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -136.21 142.2 44.07 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -136.13 125.25 3.47 Favored Glycine 0 C--N 1.292 -1.909 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -115.39 135.67 53.88 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 117.652 0.726 . . . . 0.0 110.974 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.508 ' SG ' HG21 ' A' ' 43' ' ' VAL . 9.6 t -96.0 100.61 12.27 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -174.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -124.95 131.01 53.49 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.003 0.43 . . . . 0.0 111.876 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 74.7 m-85 -75.94 126.24 30.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.042 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -140.21 130.83 25.63 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.164 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.28 -116.17 5.12 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -120.06 0.23 10.69 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.084 0.468 . . . . 0.0 111.005 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -130.63 -169.91 2.24 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.11 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.582 HG21 ' SG ' ' A' ' 15' ' ' CYS . 11.8 p -114.42 138.32 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-O 120.899 0.381 . . . . 0.0 110.731 -178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -111.71 137.12 50.03 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.6 t -94.85 109.12 21.14 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.433 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 28.5 m170 -89.52 113.68 25.11 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-O 121.156 0.503 . . . . 0.0 110.65 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.4 m -94.24 109.68 21.47 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.151 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -97.07 132.82 42.49 Favored 'General case' 0 C--O 1.255 1.385 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.47 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -135.2 -176.23 14.25 Favored Glycine 0 N--CA 1.423 -2.225 0 C-N-CA 119.125 -1.512 . . . . 0.0 113.433 -176.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -129.1 118.57 22.7 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -77.13 108.73 10.43 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 . . . . . 0 C--N 1.299 -1.589 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -174.248 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -84.99 149.64 25.46 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 121.922 -0.486 . . . . 0.0 111.565 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 86.1 m -87.72 77.5 8.63 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -125.74 -32.04 2.88 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.81 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -70.69 124.12 23.51 Favored 'General case' 0 C--O 1.249 1.028 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.478 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -70.63 105.96 3.33 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 124.238 0.961 . . . . 0.0 108.821 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.1 mt -77.65 -31.67 52.84 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.572 0.701 . . . . 0.0 109.155 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.68 -162.37 33.93 Favored Glycine 0 N--CA 1.412 -2.957 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 9.6 pt-20 -124.48 124.92 43.34 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 124.02 0.483 . . . . 0.0 109.699 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.13 138.05 21.24 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.914 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.31 103.26 1.71 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.157 1.904 . . . . 0.0 110.492 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 15' ' ' CYS . 19.4 t -129.99 108.89 16.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -136.94 123.7 13.82 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -75.54 139.33 60.51 Favored 'Cis proline' 0 C--O 1.24 0.612 0 C-N-CA 123.466 -1.473 . . . . 0.0 110.715 -1.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.45 ' HA ' HG12 ' A' ' 12' ' ' VAL . 29.1 t -81.53 118.41 22.72 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.32 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -130.23 161.06 32.03 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.19 -65.51 0.66 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 124.434 1.094 . . . . 0.0 111.537 -172.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -64.64 -37.26 86.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.771 0.319 . . . . 0.0 110.96 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -62.96 -43.19 99.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.948 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.8 t -68.9 -39.35 79.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.398 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HB3' ' NZ ' ' A' ' 21' ' ' LYS . 8.0 mtpm? -56.06 -38.06 70.13 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 120.935 0.398 . . . . 0.0 110.036 175.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 40.4 m -67.89 -55.56 12.38 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.978 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 19' ' ' ALA . 80.0 t -59.42 -38.0 72.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.215 0.606 . . . . 0.0 111.567 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.416 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 80.7 m -61.46 -31.45 71.41 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -79.27 -10.99 59.95 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.597 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 22' ' ' SER . 8.6 mm-40 -93.77 -33.0 13.76 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.283 0.563 . . . . 0.0 109.888 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -92.42 -21.46 20.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.255 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -136.23 172.59 12.78 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -105.96 -47.44 3.86 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.074 0.464 . . . . 0.0 110.495 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -82.0 19.28 1.16 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 24' ' ' CYS . . . -87.65 126.56 35.03 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.412 -175.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.632 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 1.6 p -121.96 -27.41 4.61 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.849 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 35' ' ' GLU . 46.2 tptt -131.28 131.4 43.82 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -119.63 130.11 8.33 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 7.9 tp10 -134.46 133.94 41.0 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 118.042 0.921 . . . . 0.0 110.72 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 60.0 m -77.78 128.61 34.29 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.264 -174.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -101.55 99.85 10.2 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.31 105.62 17.78 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.073 0.463 . . . . 0.0 110.4 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -146.58 111.46 5.32 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.63 -138.54 14.32 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -98.56 -30.6 12.41 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 116.949 0.374 . . . . 0.0 110.078 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -84.41 176.91 8.37 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.366 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.46 119.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.517 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -95.36 160.07 14.7 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 14.5 t -132.61 122.4 24.66 Favored 'General case' 0 C--N 1.282 -2.355 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.788 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -90.06 134.57 34.17 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-O 121.454 0.645 . . . . 0.0 112.03 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.1 m -96.46 110.83 23.13 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.439 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -99.87 142.22 31.63 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.43 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.632 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -163.95 -163.66 17.38 Favored Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -121.55 113.48 19.86 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -108.19 165.46 11.47 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -169.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 8.7 t60 . . . . . 0 C--N 1.29 -2.019 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 178.616 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.875 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -101.76 144.09 30.88 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.49 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 99.1 m -84.07 71.35 10.56 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 122.563 1.173 . . . . 0.0 109.288 175.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -105.49 -28.22 10.94 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.541 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -85.32 121.96 28.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.729 -175.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -67.24 112.63 4.61 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.91 -29.59 17.39 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.705 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.407 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . 170.82 175.74 39.64 Favored Glycine 0 N--CA 1.422 -2.297 0 C-N-CA 119.713 -1.232 . . . . 0.0 111.957 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -116.97 121.51 41.59 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 123.63 0.772 . . . . 0.0 109.567 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.65 133.14 20.74 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.43 114.61 4.02 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.242 1.961 . . . . 0.0 111.166 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -133.33 115.22 22.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -140.18 124.28 10.76 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -80.85 -179.69 26.06 Favored 'Cis proline' 0 C--N 1.352 0.76 0 C-N-CA 124.43 -1.071 . . . . 0.0 112.174 1.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.7 t -85.15 132.72 34.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.623 0.725 . . . . 0.0 112.392 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.45 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 17.5 tptm -149.04 132.04 16.22 Favored 'General case' 0 N--CA 1.402 -2.855 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 169.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.259 0.0 OUTLIER -52.39 -42.85 64.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -72.88 -35.55 67.18 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.27 -45.49 91.24 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.2 t -56.53 -53.18 60.57 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.738 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 32' ' ' CYS . 87.8 tttt -61.17 -43.28 99.14 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.373 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -61.08 -46.57 90.11 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.542 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 19' ' ' ALA . 84.3 t -67.75 -39.82 82.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.583 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.5 m -57.8 -37.93 74.62 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.39 -15.32 60.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -81.6 -37.16 28.06 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -77.95 -48.99 15.02 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.772 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.407 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 29.2 m-85 -130.99 117.73 19.61 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -78.46 0.37 26.16 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.781 0.801 . . . . 0.0 110.861 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -96.71 -1.83 45.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.654 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.4 127.49 44.37 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.153 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.445 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 16.7 p -109.24 -20.52 12.93 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 61.6 tttp -121.52 136.31 54.96 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.097 -173.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.51 122.51 2.4 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -124.43 134.17 53.16 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.864 0.364 . . . . 0.0 110.894 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 81.7 m -72.65 133.82 44.82 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -126.43 110.64 13.54 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.265 0.555 . . . . 0.0 110.805 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.417 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 73.7 m-85 -78.35 108.6 11.81 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.286 175.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -118.46 97.46 5.77 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.05 -89.64 0.98 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.994 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -126.16 -17.72 5.18 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -103.62 123.05 46.26 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.417 ' HB ' ' CD1' ' A' ' 38' ' ' TYR . 9.9 p -100.07 122.49 52.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.452 0.644 . . . . 0.0 109.434 174.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -125.37 161.27 27.39 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.1 t -95.85 121.9 38.07 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -94.14 119.0 32.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -91.36 126.46 36.45 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.572 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.416 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 86.4 m-85 -117.95 140.75 49.28 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.073 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.49 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -173.37 -149.57 6.97 Favored Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -140.66 122.03 14.97 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -99.94 153.47 19.15 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 . . . . . 0 C--N 1.28 -2.439 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.962 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.663 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -74.32 113.13 11.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.577 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 84.1 m -56.92 121.84 10.87 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 124.071 0.948 . . . . 0.0 112.661 -176.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -152.17 -33.77 0.13 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.81 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -75.21 123.75 25.83 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.853 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -63.55 119.66 10.24 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.679 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 31' ' ' ALA . 91.9 mt -96.7 -55.69 2.82 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.6 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.498 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -164.77 -172.91 32.82 Favored Glycine 0 N--CA 1.424 -2.118 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.095 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -118.28 131.48 56.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -175.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.25 138.92 23.21 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.123 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.23 94.25 0.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.185 1.924 . . . . 0.0 110.37 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.9 t -116.24 102.22 13.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 O-C-N 122.157 -0.339 . . . . 0.0 110.735 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.432 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 47.2 t80 -145.28 135.55 11.93 Favored Pre-proline 0 N--CA 1.432 -1.332 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 36.3 Cg_endo -65.12 151.49 76.43 Favored 'Cis proline' 0 C--O 1.249 1.074 0 C-N-CA 123.821 -1.325 . . . . 0.0 112.015 -1.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -81.56 112.29 18.64 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -174.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -125.66 146.27 49.8 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -69.22 -39.97 78.24 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -58.14 -37.08 73.94 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.404 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.4 -57.28 4.99 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.624 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.9 m -54.0 -46.41 71.76 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -66.09 -22.02 66.39 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 120.682 0.277 . . . . 0.0 110.9 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -88.99 -55.13 3.81 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.4 t -56.97 -38.07 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 C-N-CA 124.265 1.026 . . . . 0.0 111.782 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 90.1 m -63.35 -28.79 70.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -78.78 -22.43 46.36 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.335 0.588 . . . . 0.0 109.465 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -80.65 -39.73 26.81 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.691 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -75.7 -47.05 27.79 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.786 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.498 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 53.5 m-85 -125.43 117.99 24.87 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -70.77 -14.53 62.46 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.145 0.498 . . . . 0.0 111.127 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -91.36 -1.68 57.55 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.834 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HB2' HD12 ' A' ' 7' ' ' LEU . . . -100.01 141.64 32.56 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.5 p -137.33 -5.52 1.82 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.318 0.58 . . . . 0.0 110.865 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -131.04 130.03 42.75 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -148.98 137.04 6.1 Favored Glycine 0 CA--C 1.491 -1.411 0 C-N-CA 120.328 -0.939 . . . . 0.0 110.966 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -150.46 145.36 25.98 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.685 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 34.2 m -78.93 152.0 31.36 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -132.57 107.49 8.47 Favored 'General case' 0 N--CA 1.422 -1.826 0 C-N-CA 125.418 1.487 . . . . 0.0 108.604 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -84.33 103.49 13.54 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.586 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -148.91 113.2 5.25 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.976 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.09 -155.06 21.35 Favored Glycine 0 C--N 1.299 -1.522 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.414 ' HD2' ' OE2' ' A' ' 42' ' ' GLU . 27.8 ttm180 -79.47 -37.76 36.1 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.414 ' OE2' ' HD2' ' A' ' 41' ' ' ARG . 55.4 mm-40 -92.53 154.19 18.6 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.359 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.52 130.56 52.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -106.84 116.16 31.45 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 53.2 t -93.6 120.83 34.35 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.45 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 24.7 m170 -85.44 117.84 24.6 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.778 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.8 m -97.49 116.56 29.93 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.712 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -105.35 143.59 33.31 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.56 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.577 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -161.89 -146.97 4.83 Favored Glycine 0 N--CA 1.427 -1.906 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -140.2 133.76 30.18 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -136.14 115.2 12.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 58.4 m80 . . . . . 0 C--N 1.287 -2.122 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.163 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.462 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -87.2 130.5 34.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.405 0.621 . . . . 0.0 110.946 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.2 m -100.72 82.55 2.44 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.032 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -120.85 -51.89 2.12 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.528 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.0 m80 -91.88 150.06 21.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -82.64 115.76 21.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.991 -1.913 . . . . 0.0 108.237 -178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.8 mt -78.62 -30.0 46.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.11 179.34 40.05 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -99.93 158.55 15.73 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.69 125.57 26.72 Favored Pre-proline 0 C--N 1.287 -2.138 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.51 95.42 1.0 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.834 2.356 . . . . 0.0 114.31 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 m -137.13 116.86 15.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 28.2 t80 -154.17 127.8 4.39 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.422 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 42.4 Cg_endo -65.72 131.96 14.82 Favored 'Cis proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.698 0.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.8 t -80.87 139.6 35.84 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.579 -1.192 . . . . 0.0 111.953 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -131.9 150.83 52.04 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.376 1.07 . . . . 0.0 109.167 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.35 -50.81 70.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -64.61 -41.27 96.32 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.885 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.81 -42.63 93.89 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 123.833 0.708 . . . . 0.0 110.096 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -59.01 -55.12 39.18 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.382 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.19 -24.02 65.82 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.305 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -68.78 -60.73 2.19 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.0 p -59.68 -35.55 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 O-C-N 123.858 0.724 . . . . 0.0 111.761 -175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.0 m -58.42 -45.51 88.31 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -82.3 -9.97 59.28 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.9 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -85.46 -42.05 14.83 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.62 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -80.89 -44.85 17.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.218 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -117.06 108.3 15.57 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -74.75 -10.07 59.16 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.415 0.626 . . . . 0.0 111.369 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -93.47 -2.33 54.6 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.106 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.5 140.8 35.71 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.136 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.407 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 5.5 p -115.41 -31.69 5.84 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.919 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -127.53 161.34 29.01 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 120.92 0.39 . . . . 0.0 110.679 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.62 110.95 0.5 Allowed Glycine 0 N--CA 1.42 -2.383 0 N-CA-C 107.432 -2.267 . . . . 0.0 107.432 176.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -125.1 143.01 51.14 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.525 ' SG ' HG22 ' A' ' 43' ' ' VAL . 11.4 t -88.58 126.96 35.52 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.207 -174.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -139.37 161.26 37.89 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -71.34 124.64 25.01 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.058 0.456 . . . . 0.0 109.987 177.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -122.72 89.4 3.1 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.78 -106.74 2.39 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -103.49 -45.6 4.8 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.12 158.19 34.65 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.286 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.525 HG22 ' SG ' ' A' ' 36' ' ' CYS . 11.1 p -103.48 122.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 175.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.41 160.78 29.51 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.542 0.686 . . . . 0.0 112.217 -174.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.9 t -83.68 126.5 32.94 Favored 'General case' 0 C--N 1.274 -2.683 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.508 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -110.94 125.97 54.24 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.307 0.575 . . . . 0.0 110.305 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.3 m -95.99 118.43 32.6 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.007 -175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -103.07 139.96 37.92 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.407 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -175.03 -163.79 28.7 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.096 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.76 114.27 18.55 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -86.57 140.27 30.03 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -174.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 . . . . . 0 C--N 1.292 -1.92 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.627 -179.756 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.43 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -120.0 121.66 39.42 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.1 m -135.99 132.51 36.41 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -117.42 -16.47 10.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -83.26 129.5 35.01 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.95 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -79.58 130.58 35.51 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.921 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.469 HD11 ' HA3' ' A' ' 49' ' ' GLY . 82.3 mt -94.93 -44.24 7.81 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.357 0.599 . . . . 0.0 109.997 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.02 -174.42 47.06 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -123.99 164.36 19.51 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.919 0.36 . . . . 0.0 110.681 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.63 140.59 30.47 Favored Pre-proline 0 C--N 1.308 -1.213 0 O-C-N 123.807 0.692 . . . . 0.0 109.706 177.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.05 109.08 1.21 Allowed 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 123.027 2.485 . . . . 0.0 112.969 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 m -141.8 125.05 15.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 122.843 0.457 . . . . 0.0 110.399 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -156.4 130.73 4.95 Favored Pre-proline 0 C--N 1.308 -1.22 0 O-C-N 122.024 -0.423 . . . . 0.0 109.964 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.55 148.26 83.32 Favored 'Cis proline' 0 C--O 1.245 0.826 0 C-N-CA 123.601 -1.416 . . . . 0.0 111.024 -4.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -89.41 132.49 34.97 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.304 0.573 . . . . 0.0 111.801 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.467 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 3.0 mppt? -110.47 131.39 55.09 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 171.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.576 ' OE1' ' HG2' ' A' ' 18' ' ' LYS 0.302 0.0 OUTLIER -57.8 -43.98 86.0 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -177.954 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.576 ' HG2' ' OE1' ' A' ' 17' ' ' GLU . 47.5 mmtm -61.0 -41.72 97.04 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 120.734 0.302 . . . . 0.0 110.424 174.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.421 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -63.58 -47.84 79.83 Favored 'General case' 0 C--O 1.201 -1.469 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.465 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.8 t -55.56 -46.35 77.18 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.629 0.771 . . . . 0.0 109.685 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -62.4 -40.19 95.69 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.131 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -67.12 -47.14 72.04 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 19' ' ' ALA . 83.3 t -58.47 -42.33 84.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 122.841 0.456 . . . . 0.0 109.972 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 79.8 m -59.65 -46.38 89.21 Favored 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.472 173.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.25 -23.15 67.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.467 0.544 . . . . 0.0 112.467 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -94.63 -32.68 13.3 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -84.98 -51.96 6.32 Favored 'General case' 0 C--N 1.316 -0.865 0 O-C-N 122.046 -0.409 . . . . 0.0 111.031 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -118.39 102.16 8.72 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -75.31 -4.18 37.69 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -93.08 -4.74 51.84 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.11 144.09 31.94 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.775 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.7 p -119.08 -20.64 7.97 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.155 0.503 . . . . 0.0 109.705 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -138.85 164.0 30.8 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.98 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.05 133.65 4.11 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -143.42 131.69 22.02 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 89.8 m -85.05 114.29 22.1 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.016 0.436 . . . . 0.0 109.828 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.43 154.04 27.64 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.98 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -84.7 99.56 10.91 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.342 0.592 . . . . 0.0 112.125 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -149.28 102.72 3.24 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.54 -152.25 16.85 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -88.17 -45.26 10.26 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.168 0.509 . . . . 0.0 109.818 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -110.25 158.14 18.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.48 HG22 ' HB3' ' A' ' 36' ' ' CYS . 7.4 p -69.97 127.38 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 13.4 m170 -106.53 141.18 38.25 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.622 -0.674 . . . . 0.0 112.173 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.8 t -79.27 109.16 13.35 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.719 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -94.26 123.12 37.46 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 66.3 m -94.84 121.78 36.79 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.917 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -102.2 131.46 48.72 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.469 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -153.28 179.94 29.26 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 119.297 -1.43 . . . . 0.0 113.259 -177.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.65 107.65 19.31 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.435 ' HB2' ' CD2' ' A' ' 7' ' ' LEU . 72.1 t80 -120.92 136.13 55.02 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.381 -175.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 39.3 m80 . . . . . 0 C--N 1.31 -1.147 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.362 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.655 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -87.45 120.57 28.89 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 3.9 m -92.25 120.94 33.29 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.82 -175.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -114.19 -30.72 6.55 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 71.6 m80 -69.77 118.63 12.86 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.567 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -73.43 114.15 11.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.7 mt -92.84 -38.94 11.47 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.15 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.74 175.38 44.02 Favored Glycine 0 N--CA 1.423 -2.19 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -107.79 163.02 13.46 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 117.955 0.877 . . . . 0.0 108.979 176.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.577 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -131.8 144.46 53.36 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.63 113.06 2.78 Favored 'Trans proline' 0 C--O 1.249 1.06 0 C-N-CA 122.3 2.0 . . . . 0.0 111.428 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.1 t -137.52 123.37 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -150.24 127.57 5.54 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -69.01 134.45 28.1 Favored 'Cis proline' 0 C--N 1.356 0.952 0 C-N-CA 123.545 -1.44 . . . . 0.0 111.445 -1.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 9.0 t -79.11 103.13 8.84 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.308 -172.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.495 ' HG3' ' OE2' ' A' ' 17' ' ' GLU . 21.8 tptp -111.24 152.79 26.73 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.495 ' OE2' ' HG3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -67.2 -39.54 86.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.488 0.585 . . . . 0.0 111.068 -178.078 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.81 -34.36 77.64 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.833 0.349 . . . . 0.0 110.392 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.37 83.08 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.3 m -60.99 -40.34 93.14 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -64.84 -17.69 64.48 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.254 0.549 . . . . 0.0 110.668 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 t -90.47 -56.18 3.3 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 26' ' ' GLU . 66.0 t -62.04 -36.14 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 123.414 0.686 . . . . 0.0 112.67 -175.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 91.6 m -66.78 -27.31 67.48 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.842 -0.536 . . . . 0.0 112.299 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.93 -17.81 36.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.655 0.741 . . . . 0.0 109.73 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 9.0 tp10 -77.07 -45.2 27.9 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.447 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -81.44 -44.08 17.99 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.776 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -118.39 148.56 42.4 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -173.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -92.66 -21.63 19.91 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -99.99 -5.09 28.71 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.779 0.323 . . . . 0.0 111.328 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.78 123.46 26.73 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 121.023 0.439 . . . . 0.0 110.005 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.602 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 2.3 p -116.7 -9.47 11.29 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.473 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 3' ' ' CYS . 87.9 tttt -144.4 152.88 41.3 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -153.68 130.39 2.94 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -134.38 146.32 49.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 117.231 0.515 . . . . 0.0 110.589 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.2 m -90.29 114.43 26.47 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -120.17 147.58 44.73 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.431 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 88.0 m-85 -93.28 143.51 26.19 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.047 0.451 . . . . 0.0 111.494 -173.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -131.56 89.51 2.72 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.12 -72.4 2.49 Favored Glycine 0 C--N 1.312 -0.766 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.796 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -123.91 -59.71 1.49 Allowed 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.439 -0.448 . . . . 0.0 110.294 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -81.74 158.41 24.2 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.368 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.431 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 10.7 p -103.11 135.41 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.967 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.673 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -120.95 139.36 53.37 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.154 0.502 . . . . 0.0 109.924 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 41.3 t -88.42 114.69 25.3 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.988 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.405 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 40.2 m170 -102.77 126.11 49.77 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.129 -177.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.3 m -94.77 126.7 40.26 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.397 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 71.7 m-85 -115.58 145.99 42.17 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.602 ' HA2' ' SG ' ' A' ' 32' ' ' CYS . . . -170.56 -147.81 5.72 Favored Glycine 0 C--N 1.287 -2.186 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -108.57 136.18 48.59 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -97.1 109.95 22.6 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 . . . . . 0 C--N 1.284 -2.24 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -178.759 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.495 0 CA-C-O 120.46 0.171 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -120.94 127.34 51.73 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 121.059 0.457 . . . . 0.0 110.246 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.5 m -85.64 86.28 7.37 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -123.97 -21.35 5.12 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.994 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -74.23 118.15 16.85 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.374 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -67.35 111.15 3.87 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.76 -42.05 18.44 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.581 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.92 -170.91 44.04 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -110.92 119.29 38.57 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 124.07 0.512 . . . . 0.0 109.809 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.1 127.28 26.99 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.31 110.99 3.21 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.25 1.967 . . . . 0.0 111.283 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.7 t -119.73 123.44 70.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -142.88 133.78 12.58 Favored Pre-proline 0 N--CA 1.422 -1.861 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.25 168.54 76.96 Favored 'Cis proline' 0 C--O 1.241 0.64 0 C-N-CA 123.705 -1.373 . . . . 0.0 112.154 -0.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.6 t -80.23 114.52 19.2 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.768 0.794 . . . . 0.0 111.237 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -144.05 138.93 28.67 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 103.156 -2.905 . . . . 0.0 103.156 174.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.44 -44.79 95.44 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 123.465 0.478 . . . . 0.0 110.332 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.88 -42.68 99.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.732 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.48 -49.4 69.2 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.097 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.8 t -55.6 -53.61 54.31 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 124.113 0.965 . . . . 0.0 110.55 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -63.49 -29.5 70.76 Favored 'General case' 0 CA--C 1.554 1.135 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.705 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -79.86 -45.47 18.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.548 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.21 -31.42 53.8 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 CA-C-O 121.242 0.544 . . . . 0.0 109.845 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.0 m -58.6 -29.0 66.12 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.694 173.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -85.4 -10.78 55.79 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -87.57 -30.86 20.22 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -86.32 -44.27 12.23 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.011 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.69 161.05 25.88 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -98.07 -40.03 8.63 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.633 0.254 . . . . 0.0 111.306 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -76.57 -2.58 33.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.74 112.48 7.88 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.14 0.495 . . . . 0.0 110.894 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.2 p -116.09 -1.55 12.43 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.261 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 64.6 tttp -155.71 150.25 26.05 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.57 129.68 2.66 Favored Glycine 0 C--N 1.297 -1.622 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -122.59 142.17 50.92 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.637 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 85.3 m -71.06 116.01 10.86 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 123.686 0.616 . . . . 0.0 109.824 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.537 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 7.6 mm-40 -104.14 105.44 15.6 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -86.08 123.65 31.62 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.407 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -141.81 89.52 2.2 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.15 -115.34 6.04 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.115 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -82.66 -52.29 6.94 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 122.498 0.319 . . . . 0.0 111.537 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -89.0 114.73 25.94 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.63 123.62 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -120.25 152.92 37.07 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 36.4 m -96.17 119.58 34.9 Favored 'General case' 0 C--N 1.267 -2.997 0 CA-C-O 120.817 0.341 . . . . 0.0 110.998 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.537 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 15.3 m170 -83.54 110.84 18.55 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 170.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -84.82 122.36 29.04 Favored 'General case' 0 N--CA 1.412 -2.343 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.462 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.41 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 97.3 m-85 -99.1 133.07 43.9 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.134 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -130.76 178.07 17.94 Favored Glycine 0 N--CA 1.413 -2.843 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.401 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -131.77 142.46 49.77 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 123.138 0.575 . . . . 0.0 109.725 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -128.47 109.25 11.23 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 . . . . . 0 C--N 1.301 -1.523 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.266 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 120.744 0.307 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -112.25 136.79 51.25 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.0 0.428 . . . . 0.0 110.845 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.1 m -95.24 27.59 3.21 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.963 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -106.02 -0.19 25.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.423 0.63 . . . . 0.0 110.025 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 35.5 t60 -108.18 125.91 52.18 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.936 -177.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -81.15 119.75 23.98 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 123.337 0.655 . . . . 0.0 110.162 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.4 mt -94.88 -50.58 5.06 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.288 0.566 . . . . 0.0 110.395 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.426 ' HA3' ' CZ ' ' A' ' 28' ' ' TYR . . . -165.07 -170.58 30.21 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.264 -176.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -131.97 144.73 51.02 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -128.04 138.58 33.26 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 177.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -82.7 111.82 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.257 1.972 . . . . 0.0 110.948 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.412 ' CG2' HG21 ' A' ' 23' ' ' VAL . 40.7 t -128.73 120.55 52.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 122.116 -0.365 . . . . 0.0 110.643 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.43 ' HA ' ' C ' ' A' ' 14' ' ' PRO . 61.0 t80 -158.4 120.07 1.95 Allowed Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 13' ' ' TYR . 50.0 Cg_endo -65.71 150.61 77.8 Favored 'Cis proline' 0 C--N 1.356 0.968 0 C-N-CA 124.133 -1.195 . . . . 0.0 113.17 3.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 39.5 t -115.01 124.38 51.48 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.61 -174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -138.75 168.36 19.96 Favored 'General case' 0 C--O 1.247 0.973 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -58.52 -57.11 14.38 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.815 0.697 . . . . 0.0 112.74 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.65 -37.31 85.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.431 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -51.86 63.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.273 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.3 t -61.87 -45.66 92.8 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.138 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HG3' ' HA ' ' A' ' 33' ' ' LYS . 38.7 ttpt -64.78 -37.53 87.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -65.96 -57.59 7.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.435 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.412 HG21 ' CG2' ' A' ' 12' ' ' VAL . 33.6 m -62.77 -33.19 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.081 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -175.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 32.3 m -61.05 -33.67 73.67 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -85.43 -9.43 57.53 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.817 0.342 . . . . 0.0 111.231 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.67 -37.71 10.69 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.582 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -72.24 -43.98 63.57 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.426 ' CZ ' ' HA3' ' A' ' 8' ' ' GLY . 46.6 m-85 -124.65 99.52 6.21 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -68.03 -2.95 8.65 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.316 0.579 . . . . 0.0 112.322 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.466 ' HB3' ' H ' ' A' ' 52' ' ' HIS . 56.0 m-70 -97.82 -9.09 27.06 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.585 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.11 162.41 26.68 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.342 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.8 p -119.6 -41.88 2.67 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.901 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.482 ' HA ' ' HG3' ' A' ' 21' ' ' LYS . 57.5 tttm -142.71 149.34 38.68 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.676 -176.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -116.69 165.02 12.29 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 174.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -151.47 130.69 12.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 118.03 0.915 . . . . 0.0 110.261 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.51 103.55 16.23 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.185 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -125.68 138.25 53.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.292 -172.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.56 ' CE1' ' HB ' ' A' ' 43' ' ' VAL . 88.8 m-85 -85.32 103.56 14.36 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 172.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -126.93 118.56 24.78 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.888 -172.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.51 -72.15 2.69 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -130.04 -67.4 0.75 Allowed 'General case' 0 C--N 1.311 -1.071 0 O-C-N 122.71 -0.288 . . . . 0.0 110.25 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -108.36 -172.52 2.08 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.191 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.56 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 7.3 p -88.35 140.18 16.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.545 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -129.28 146.87 51.1 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 39.3 t -95.33 102.27 14.06 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 172.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -85.96 130.23 34.6 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.4 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.0 m -100.54 123.68 45.07 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 123.388 0.43 . . . . 0.0 110.158 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 70.5 m-85 -114.03 151.87 31.82 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 122.551 0.341 . . . . 0.0 111.243 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.8 -150.95 22.62 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -139.55 156.45 46.89 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -81.49 109.08 15.62 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 172.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.466 ' H ' ' HB3' ' A' ' 30' ' ' HIS . 70.5 m80 . . . . . 0 C--N 1.295 -1.762 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.693 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.61 0.243 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -101.08 132.13 46.67 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 60.0 m -73.41 93.7 1.98 Allowed 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -116.63 -17.82 10.47 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.949 -167.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -76.43 114.74 15.47 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.393 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.33 118.56 10.86 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.893 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.5 mt -92.88 -57.6 2.6 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.844 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.493 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -163.24 -168.59 25.44 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.647 -176.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -124.33 125.0 43.61 Favored 'General case' 0 C--O 1.249 1.043 0 C-N-CA 123.636 0.774 . . . . 0.0 110.521 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 45' ' ' CYS . . . -107.86 148.61 37.73 Favored Pre-proline 0 C--N 1.293 -1.873 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.808 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -86.82 113.06 1.02 Allowed 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 121.955 1.77 . . . . 0.0 110.695 174.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 47.8 t -139.75 113.54 6.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -177.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -144.35 128.26 8.98 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.92 143.87 78.32 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 123.914 -1.286 . . . . 0.0 110.391 -2.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 16.2 t -96.15 134.76 38.84 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.225 -174.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -136.02 156.65 48.42 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -48.38 -51.14 27.91 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.492 1.117 . . . . 0.0 112.053 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -76.5 -35.65 58.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.005 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.43 92.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.565 0.221 . . . . 0.0 110.434 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.3 t -61.65 -47.33 85.85 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -55.11 -46.98 75.61 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.674 0.789 . . . . 0.0 110.493 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.8 t -67.62 -46.33 72.82 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.828 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.83 -31.41 41.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.172 0 CA-C-O 121.422 0.63 . . . . 0.0 110.715 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 60.2 m -60.16 -28.09 67.63 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.557 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -80.83 -15.07 57.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.036 0.446 . . . . 0.0 111.371 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -85.53 -33.38 21.79 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -87.51 -43.17 12.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.939 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.493 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 87.6 m-85 -120.61 140.99 50.75 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.091 0.472 . . . . 0.0 110.645 -175.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -85.03 -27.56 26.3 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -91.42 6.92 43.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.39 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.33 159.92 29.19 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.531 0.681 . . . . 0.0 111.222 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.0 t -143.95 -48.45 0.28 Allowed 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.617 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -125.72 153.42 43.94 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -140.87 131.2 4.83 Favored Glycine 0 N--CA 1.423 -2.219 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -119.37 144.22 47.0 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 120.959 0.409 . . . . 0.0 110.972 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 59.8 m -100.26 117.48 34.56 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.502 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -113.81 105.73 13.62 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 120.926 0.393 . . . . 0.0 111.096 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.498 ' CD2' ' HB ' ' A' ' 43' ' ' VAL . 88.6 m-85 -81.32 99.67 8.78 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -118.81 105.3 11.39 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.84 -123.68 6.72 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.0 mtm180 -89.26 -32.83 17.2 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -96.44 165.23 12.28 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.322 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.498 ' HB ' ' CD2' ' A' ' 38' ' ' TYR . 7.4 p -124.12 130.11 73.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.43 -0.805 . . . . 0.0 108.926 174.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -101.54 117.26 34.55 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.543 ' HB3' ' O ' ' A' ' 10' ' ' ALA . 37.2 t -88.19 104.15 16.44 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.544 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 66.7 m170 -83.68 110.95 18.7 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.053 -177.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 65.4 m -88.77 112.67 23.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.143 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -102.82 148.36 25.73 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.96 -148.66 6.8 Favored Glycine 0 C--N 1.294 -1.752 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -139.19 145.41 39.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -125.56 165.62 18.17 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.446 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 . . . . . 0 C--N 1.289 -2.055 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.638 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.532 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.485 ' HB2' ' CE1' ' A' ' 5' ' ' HIS . 12.5 m170 -99.31 110.92 23.38 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 91.9 m -79.69 47.98 0.9 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.502 0.668 . . . . 0.0 110.943 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.34 -2.54 2.48 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.692 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 55.3 m80 -81.08 126.12 31.05 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -73.04 102.83 3.62 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.864 0.728 . . . . 0.0 109.993 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.8 mt -81.07 -35.14 32.14 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.079 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.29 -174.06 41.8 Favored Glycine 0 N--CA 1.427 -1.943 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -124.97 143.64 50.78 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 117.287 0.543 . . . . 0.0 110.855 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.61 142.07 33.47 Favored Pre-proline 0 C--N 1.297 -1.686 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.601 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.83 106.43 2.09 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.405 2.07 . . . . 0.0 111.438 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.4 t -128.02 103.73 10.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 O-C-N 121.859 -0.526 . . . . 0.0 109.866 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -142.35 132.21 12.34 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -74.65 167.86 78.88 Favored 'Cis proline' 0 C--O 1.237 0.474 0 C-N-CA 123.744 -1.357 . . . . 0.0 111.434 -2.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 t -83.67 131.65 34.93 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 122.018 0.913 . . . . 0.0 112.86 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 56.2 tptt -137.62 125.77 23.01 Favored 'General case' 0 N--CA 1.387 -3.622 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 170.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -41.41 70.0 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -176.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.74 -41.04 84.04 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.576 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 16' ' ' LYS . . . -63.81 -47.01 82.55 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.038 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.5 t -54.96 -50.55 68.63 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.359 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.72 -41.23 99.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.164 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 27.4 t -61.78 -55.51 29.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.417 ' O ' ' HD2' ' A' ' 27' ' ' HIS . 98.2 t -55.35 -43.89 73.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 O-C-N 123.684 0.615 . . . . 0.0 110.511 -177.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.1 m -58.06 -42.21 84.99 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.845 0.684 . . . . 0.0 112.845 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 54.9 mtpt -75.34 -23.96 57.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.279 0.562 . . . . 0.0 111.431 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 22' ' ' SER . 45.1 mt-10 -77.89 -33.46 51.96 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.957 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.417 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 44.4 m-70 -85.27 -44.86 12.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.152 0.501 . . . . 0.0 110.285 175.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -116.7 107.16 14.33 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -64.62 -19.74 65.86 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -89.96 0.93 56.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.452 ' O ' ' HG2' ' A' ' 25' ' ' LYS . . . -78.07 138.14 38.61 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.095 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.41 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 2.5 p -134.82 1.0 3.0 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.722 0.772 . . . . 0.0 110.454 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 59.2 tptt -148.94 142.42 25.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.19 126.63 2.07 Favored Glycine 0 CA--C 1.481 -2.08 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -126.85 140.08 52.62 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.621 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.43 ' HB3' HG21 ' A' ' 43' ' ' VAL . 59.6 m -76.14 102.31 5.7 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 5.9 mm-40 -94.61 110.69 22.49 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.458 0.647 . . . . 0.0 109.762 -178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -77.61 103.93 7.84 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.839 -174.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -127.05 99.38 5.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.53 -149.72 21.34 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -175.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -95.95 -50.59 4.81 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.014 0.435 . . . . 0.0 110.603 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -78.64 103.08 8.34 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.6 0.714 . . . . 0.0 109.797 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 36' ' ' CYS . 14.8 p -76.21 150.0 6.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.621 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -123.51 151.52 42.72 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 39.3 m -96.87 126.29 41.91 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-O 120.72 0.295 . . . . 0.0 110.492 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.408 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 46.7 m170 -90.61 117.99 29.71 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.9 m -92.5 123.1 35.56 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.912 -174.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 67.3 m-85 -117.73 141.98 47.78 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.215 -177.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 5' ' ' HIS . . . -170.6 -168.68 32.73 Favored Glycine 0 C--N 1.289 -2.083 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -119.92 108.85 14.84 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -100.88 117.26 34.6 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 C--N 1.292 -1.917 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 179.848 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.605 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -105.88 144.79 32.12 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.3 m -113.34 97.61 6.58 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -144.53 -34.95 0.35 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.8 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -75.13 120.55 20.79 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -65.19 119.97 11.86 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.1 mt -94.15 -43.47 8.46 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.105 0.479 . . . . 0.0 110.043 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.427 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . -177.53 -160.47 24.28 Favored Glycine 0 N--CA 1.419 -2.45 0 C-N-CA 119.49 -1.338 . . . . 0.0 112.98 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -131.69 131.22 42.92 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 123.677 0.791 . . . . 0.0 110.29 -171.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.56 143.96 44.82 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -89.09 111.1 0.53 Allowed 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 122.714 2.276 . . . . 0.0 112.558 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 36.4 t -132.12 104.05 7.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -138.21 124.01 12.62 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -74.58 147.45 89.42 Favored 'Cis proline' 0 C--N 1.347 0.466 0 C-N-CA 123.66 -1.392 . . . . 0.0 110.818 -2.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.5 t -91.23 142.17 28.01 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.367 0.603 . . . . 0.0 111.748 -174.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -137.03 152.77 50.48 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 172.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.25 -47.29 85.02 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -67.14 -40.44 86.74 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.076 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -61.11 -46.8 89.14 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.929 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.7 t -59.3 -48.59 81.07 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 123.622 0.769 . . . . 0.0 109.712 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -55.77 -46.04 78.01 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.812 0.845 . . . . 0.0 110.182 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.3 t -64.66 -45.76 85.37 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.626 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 19' ' ' ALA . 94.5 t -64.51 -38.6 83.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 CA-C-O 121.048 0.451 . . . . 0.0 110.322 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 83.2 m -58.92 -38.9 80.0 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.24 175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -64.04 -37.58 87.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.908 0.385 . . . . 0.0 110.621 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.28 -47.57 79.02 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.838 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -81.94 -39.48 23.66 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 63.1 m-85 -127.5 112.93 15.49 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -60.2 -37.33 79.92 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.872 0.367 . . . . 0.0 111.81 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -89.3 6.76 38.96 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . . . -80.3 140.8 35.99 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.3 p -123.96 -28.75 3.73 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 121.013 0.435 . . . . 0.0 111.426 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -140.65 147.88 39.98 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.13 150.75 20.78 Favored Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -121.58 144.15 48.9 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 123.844 0.379 . . . . 0.0 110.197 176.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.5 m -84.83 102.1 12.8 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.486 ' HG3' ' ND1' ' A' ' 46' ' ' HIS . 8.4 mm-40 -92.14 109.38 20.74 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.135 0.493 . . . . 0.0 110.387 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -86.97 101.34 13.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.667 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -144.73 110.01 5.18 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.43 -159.48 28.47 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -88.93 -20.73 24.14 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.374 0.587 . . . . 0.0 110.692 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -91.94 146.39 23.78 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.11 124.4 67.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -98.3 123.75 42.57 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.927 -172.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.1 m -87.69 114.36 24.23 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.01 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.486 ' ND1' ' HG3' ' A' ' 37' ' ' GLU . 42.0 m170 -94.36 120.42 34.57 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 174.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.5 m -94.94 128.89 42.08 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.297 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -108.35 141.67 39.82 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.7 175.64 46.92 Favored Glycine 0 N--CA 1.432 -1.614 0 C-N-CA 119.663 -1.256 . . . . 0.0 112.772 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -126.39 116.08 20.63 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.732 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -74.55 112.77 11.06 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.22 0.533 . . . . 0.0 111.452 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 . . . . . 0 C--N 1.294 -1.841 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.151 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.662 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -84.84 104.41 14.77 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.775 0.798 . . . . 0.0 110.832 178.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 88.1 m -113.5 96.94 6.15 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.013 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -117.83 -22.92 7.74 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.026 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 52.3 m80 -89.03 134.82 33.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.874 -176.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -66.58 131.14 45.36 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.855 0.36 . . . . 0.0 110.377 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' A' ' 31' ' ' ALA . 25.2 mt -103.04 -19.26 14.63 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.997 0.903 . . . . 0.0 108.849 175.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.07 -174.63 30.29 Favored Glycine 0 N--CA 1.409 -3.152 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -177.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -123.0 158.97 29.35 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.03 132.29 24.25 Favored Pre-proline 0 C--N 1.298 -1.633 0 O-C-N 123.318 0.386 . . . . 0.0 110.401 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HA ' ' NE2' ' A' ' 44' ' ' HIS . 58.8 Cg_endo -76.07 102.05 1.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.502 2.134 . . . . 0.0 112.752 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 m -143.95 140.75 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 123.357 0.663 . . . . 0.0 109.815 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.433 ' CD2' ' HA ' ' A' ' 14' ' ' PRO . 68.8 t80 -160.07 128.46 2.94 Favored Pre-proline 0 C--N 1.314 -0.96 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.433 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 8.9 Cg_exo -68.56 145.3 76.31 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 124.048 -1.23 . . . . 0.0 112.097 3.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.1 t -99.55 106.45 18.44 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -115.27 151.26 34.85 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.11 -41.55 68.42 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 124.049 0.843 . . . . 0.0 113.237 -175.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.6 -45.54 75.16 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.459 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.09 75.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.34 -51.12 69.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.878 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.27 -39.1 81.82 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.424 0.69 . . . . 0.0 111.149 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -70.12 -49.35 51.63 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.69 -40.9 80.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 123.39 0.676 . . . . 0.0 110.996 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 67.5 m -59.44 -44.07 92.99 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -72.61 -24.2 61.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.066 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -75.3 -47.72 26.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.397 177.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -79.99 -35.33 37.58 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.953 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -126.21 112.27 15.57 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -74.78 -18.21 60.51 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -92.17 8.81 36.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.098 0.475 . . . . 0.0 110.912 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB2' HD12 ' A' ' 7' ' ' LEU . . . -96.49 139.48 32.52 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.3 p -124.43 -20.07 5.28 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.103 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.58 134.78 35.99 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.55 -176.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -125.05 148.71 16.84 Favored Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.24 138.9 33.59 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.1 m -87.91 122.11 31.14 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -128.73 143.23 50.88 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.12 100.81 10.76 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -115.8 100.49 8.05 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 -102.57 2.55 Favored Glycine 0 N--CA 1.433 -1.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.06 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.4 mmt85 -98.09 -55.61 2.73 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.173 0.511 . . . . 0.0 110.245 -177.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -99.53 167.36 10.65 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.404 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.3 p -99.17 135.94 32.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.522 ' NE2' ' HA ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -138.09 160.26 39.86 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.807 -178.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.6 t -85.97 114.79 23.14 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.276 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -102.61 125.72 49.44 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 68.4 m -95.59 127.06 41.31 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.854 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 80.6 m-85 -112.06 147.97 34.89 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.326 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.62 -141.57 6.3 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -113.64 127.24 55.98 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -108.88 146.69 33.32 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.813 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 . . . . . 0 C--N 1.29 -2.001 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.42 176.559 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.574 0 CA-C-O 121.262 0.553 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -93.13 141.9 27.9 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.527 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 58.6 m -119.42 70.59 0.85 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -121.3 -43.23 2.42 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.912 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -83.9 135.6 34.43 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.084 -177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -85.99 116.41 24.19 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.416 HD11 ' HA3' ' A' ' 49' ' ' GLY . 89.9 mt -74.86 -33.47 62.12 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.609 0.718 . . . . 0.0 109.125 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.63 -178.3 37.57 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.94 143.13 38.59 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.08 132.9 24.25 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.15 140.97 18.15 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.503 2.135 . . . . 0.0 111.36 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.443 HG11 ' SG ' ' A' ' 45' ' ' CYS . 13.8 p -141.8 143.68 26.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 120.73 0.3 . . . . 0.0 110.688 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 84.3 t80 -148.43 123.34 5.0 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 13' ' ' TYR . 2.0 Cg_endo -84.98 163.88 61.92 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.822 -1.324 . . . . 0.0 110.939 -2.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.21 92.36 3.83 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 122.1 0.952 . . . . 0.0 112.78 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -117.77 141.92 47.86 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 168.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.08 -43.22 91.8 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 118.218 0.463 . . . . 0.0 111.63 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.65 -48.69 80.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.234 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.43 -42.36 92.52 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.034 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.7 t -56.44 -54.76 41.92 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 124.115 0.966 . . . . 0.0 110.983 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -59.44 -38.24 80.18 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 121.168 0.508 . . . . 0.0 110.098 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.578 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 49.1 m -66.78 -54.62 20.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.592 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.6 t -60.65 -37.46 75.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-O 121.241 0.543 . . . . 0.0 110.457 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.8 t -56.19 -46.28 79.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.009 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 60.6 mtpt -72.82 -19.78 61.27 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.627 0.371 . . . . 0.0 111.689 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 22' ' ' SER . 24.6 mm-40 -74.92 -42.51 57.59 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -75.83 -45.54 35.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.246 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 54.3 m-85 -123.51 104.97 9.39 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -65.63 -24.15 66.98 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -175.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -84.02 0.03 49.8 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.28 123.86 23.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.427 0.632 . . . . 0.0 111.531 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.0 p -101.61 -29.09 12.14 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.999 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -136.37 128.84 30.34 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.847 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 46' ' ' HIS . . . -133.89 118.45 2.06 Favored Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -135.13 140.44 45.44 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.056 -0.658 . . . . 0.0 112.735 -177.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.7 m -63.1 120.38 11.35 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.991 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -118.14 114.22 22.75 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -77.72 102.48 7.15 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -126.55 97.06 4.88 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.95 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.56 -112.97 3.77 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.319 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -83.38 -46.11 12.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.205 0.526 . . . . 0.0 111.816 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -97.88 170.73 8.75 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.936 0.874 . . . . 0.0 112.481 -172.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.1 113.77 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.747 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 172.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -125.35 157.95 35.47 Favored 'General case' 0 C--N 1.277 -2.587 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.443 ' SG ' HG11 ' A' ' 12' ' ' VAL . 65.6 m -80.88 111.1 17.04 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.404 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 31.2 m170 -80.4 124.41 28.87 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 92.4 m -97.91 112.63 24.48 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.326 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -95.3 133.44 39.2 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 176.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.416 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -154.51 155.33 26.13 Favored Glycine 0 C--N 1.287 -2.159 0 C-N-CA 117.506 -2.283 . . . . 0.0 114.436 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -101.65 118.41 36.88 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -137.7 140.65 40.87 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.513 -174.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 . . . . . 0 C--N 1.296 -1.736 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 171.984 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.03 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.461 ' CD2' ' HB2' ' A' ' 4' ' ' ASP . 15.2 p-80 -87.7 172.9 9.35 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 123.326 0.391 . . . . 0.0 110.064 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.51 ' SG ' ' HA2' ' A' ' 49' ' ' GLY . 96.3 m -85.0 94.93 8.93 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.198 0.523 . . . . 0.0 110.987 178.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.461 ' HB2' ' CD2' ' A' ' 2' ' ' HIS . 29.9 t70 -119.43 -35.76 3.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.445 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -74.49 131.91 41.43 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.413 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -75.15 111.58 10.53 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.416 HD11 ' HA3' ' A' ' 49' ' ' GLY . 80.2 mt -79.26 -30.61 43.17 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-O 121.392 0.615 . . . . 0.0 109.551 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.407 ' HA3' ' OH ' ' A' ' 28' ' ' TYR . . . 163.02 -154.22 25.08 Favored Glycine 0 N--CA 1.404 -3.462 0 C-N-CA 120.502 -0.856 . . . . 0.0 110.997 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -128.65 158.19 39.23 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HB1' HG12 ' A' ' 23' ' ' VAL . . . -135.94 139.96 31.94 Favored Pre-proline 0 C--N 1.297 -1.713 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.863 176.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.17 114.2 2.49 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.36 2.04 . . . . 0.0 112.594 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 p -155.13 114.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -159.19 127.33 2.86 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.694 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.05 154.68 80.83 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.689 -1.379 . . . . 0.0 111.661 -3.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 51.3 t -117.41 137.59 52.39 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -173.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 19' ' ' ALA . 13.8 mptt -103.04 157.13 17.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.16 -41.73 97.3 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.709 0.766 . . . . 0.0 110.562 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -75.1 -25.74 58.76 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.518 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.403 ' HB3' ' H ' ' A' ' 16' ' ' LYS . . . -76.51 -36.69 57.62 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.038 -178.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.5 t -64.9 -36.5 84.56 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -60.98 -47.77 84.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.849 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.9 p -70.74 -43.48 68.75 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.288 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.413 HG12 ' HB1' ' A' ' 10' ' ' ALA . 88.1 t -63.54 -46.24 95.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.921 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.7 m -59.01 -38.05 78.31 Favored 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -64.02 -33.27 75.37 Favored 'General case' 0 N--CA 1.425 -1.685 0 C-N-CA 123.076 0.55 . . . . 0.0 111.14 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.83 -19.77 30.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -89.19 -38.1 14.52 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.748 -0.595 . . . . 0.0 111.066 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.407 ' OH ' ' HA3' ' A' ' 8' ' ' GLY . 57.4 m-85 -133.94 110.8 9.95 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -71.77 -8.29 53.34 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.699 0.762 . . . . 0.0 110.769 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -86.64 -6.23 58.92 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.306 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.38 132.16 39.3 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.766 -177.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 p -112.02 -21.25 11.63 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -132.73 141.45 48.56 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.792 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.87 147.23 18.98 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -138.52 119.49 14.36 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 118.371 1.085 . . . . 0.0 110.188 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 25.8 m -82.27 109.14 16.27 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.263 176.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -125.38 148.11 48.91 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.084 -177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 81.7 m-85 -73.9 103.0 4.26 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.647 0.736 . . . . 0.0 110.799 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -94.93 89.86 5.78 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.99 -98.69 2.45 Favored Glycine 0 N--CA 1.423 -2.179 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -176.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -108.15 -52.63 2.74 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.021 0.439 . . . . 0.0 110.414 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.95 170.73 9.22 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.343 -173.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 7.3 p -89.48 132.84 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-O 121.304 0.573 . . . . 0.0 110.312 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 11.6 m-70 -120.83 137.17 54.68 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.8 t -88.04 105.31 17.39 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -89.67 118.58 29.38 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.3 m -91.28 124.01 35.15 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.015 -176.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -108.01 138.81 43.61 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.51 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . -167.87 -155.8 9.63 Favored Glycine 0 C--N 1.297 -1.611 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -120.19 133.26 55.53 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -140.8 134.05 29.62 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 . . . . . 0 C--N 1.303 -1.416 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.993 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.462 0.172 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -111.65 -178.4 3.43 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 74.3 m -68.6 38.02 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -175.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -101.79 -24.03 14.11 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -76.66 139.66 40.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.516 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -94.63 130.28 41.16 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.736 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.4 mt -89.69 -23.73 21.77 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.645 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.59 -179.92 25.04 Favored Glycine 0 N--CA 1.424 -2.118 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 12.0 pt-20 -105.9 146.34 30.09 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.29 138.98 32.7 Favored Pre-proline 0 C--N 1.302 -1.466 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.74 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.76 131.46 13.46 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.641 2.227 . . . . 0.0 112.019 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -160.63 134.01 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 122.558 0.343 . . . . 0.0 110.386 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.471 ' CG ' ' HA ' ' A' ' 14' ' ' PRO . 33.8 t80 -155.7 140.9 12.37 Favored Pre-proline 0 N--CA 1.435 -1.191 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.471 ' HA ' ' CG ' ' A' ' 13' ' ' TYR . 4.5 Cg_exo -76.12 168.36 77.5 Favored 'Cis proline' 0 C--O 1.25 1.124 0 C-N-CA 123.867 -1.305 . . . . 0.0 111.948 -0.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -78.85 114.1 17.5 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.851 0.834 . . . . 0.0 110.858 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 42.3 tptt -138.32 136.59 36.56 Favored 'General case' 0 N--CA 1.394 -3.252 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 175.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.51 -47.39 82.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 124.065 0.853 . . . . 0.0 110.085 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -64.68 -38.22 90.24 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.386 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.72 -43.42 72.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.6 t -59.08 -51.62 69.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.214 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.39 -38.67 84.7 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.296 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 70.2 m -66.27 -48.6 69.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.643 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.25 -40.25 88.35 Favored 'Isoleucine or valine' 0 C--O 1.255 1.361 0 CA-C-O 121.033 0.444 . . . . 0.0 109.894 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 57.8 m -54.81 -46.24 74.5 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.65 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 29' ' ' HIS . 96.5 mttt -57.17 -36.31 70.63 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 123.359 0.412 . . . . 0.0 111.913 177.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -73.12 -42.35 62.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.642 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -79.49 -39.43 32.13 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.969 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -134.52 102.63 5.38 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -178.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 72.6 m-70 -62.46 -22.1 65.97 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -169.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.418 ' CG ' ' HA ' ' A' ' 51' ' ' TYR . 67.3 m-70 -96.54 12.82 30.19 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.741 0.305 . . . . 0.0 111.466 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.73 127.77 33.53 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.015 0.436 . . . . 0.0 110.694 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.3 p -106.84 -20.9 13.19 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.988 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -156.51 157.38 35.33 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -140.23 150.18 21.38 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.692 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -124.17 127.59 47.99 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 69.5 m -83.32 107.8 16.09 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.777 0.322 . . . . 0.0 110.373 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -116.93 133.28 56.21 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 98.9 m-85 -81.64 131.08 35.26 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.826 0.346 . . . . 0.0 110.705 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -125.47 106.49 9.83 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.9 -97.85 1.15 Allowed Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -126.2 -2.91 6.94 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 111.682 0.252 . . . . 0.0 111.682 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -126.66 147.46 49.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 9.5 p -90.43 137.83 20.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 120.683 0.278 . . . . 0.0 110.594 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -125.71 151.86 46.07 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 2.2 m -97.69 126.77 43.2 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 177.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -84.75 110.4 18.77 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 171.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.3 m -89.53 124.9 34.94 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.823 -175.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -96.09 148.9 22.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.61 171.19 30.55 Favored Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.617 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -127.58 113.99 16.81 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.418 ' HA ' ' CG ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -99.22 170.6 8.55 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.209 -172.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 36.8 m80 . . . . . 0 C--N 1.318 -0.791 0 C-N-CA 125.489 1.516 . . . . 0.0 108.548 -175.212 . . . . . . . . 0 0 . 1 stop_ save_